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ABSTRACT
Longitudinal Trends in Postpartum Mental Health, Cognition and Steroid
Hormones
by
Chandler R. Marrs
Dr. Douglas P. Ferraro, Examination Committee Chair 
Professor of Psychology 
University of Nevada, Las Vegas
The temporal association between psychiatric and cognitive disturbances 
during pregnancy and postpartum is clear in the literature. However, associations 
between these disturbances and puerperal hormones are equivocal. The present study 
followed nine primigravid women from late pregnancy through one year postpartum 
to investigate trends in psychiatric and cognitive disturbances relative to postpartum 
hormone changes. Participants completed a battery of neuropsychological instruments 
at 37 weeks of pregnancy, at 10 days and four-, eight- and twelve-months postpartum 
and provided salivary specimen from which dehydroepiandrosterone sulfate 
(DHEAS), testosterone, estradiol and estriol concentrations were quantified. Results 
showed psychiatric disturbances and cognitive decrements in late pregnancy that 
often worsened following parturition. Psychiatric symptoms generally resolved by 
four months postpartum and were associated predominantly with elevated DHEAS.
Ill
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Cognitive performance improved across the year but spatial and verbal working 
memory remained impaired. Cognitive performance was not associated with hormone 
changes and inconsistently associated with mood symptoms.
IV
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CHAPTER 1 
INTRODUCTION
The two years surrounding pregnancy and childbirth are particularly difficult 
for many women with the risk of serious mental illness reportedly being 20 times 
higher than at any other period in a woman’s life (Panay, Sands & Studd, 1998). 
Despite the clear temporal relationship between childbearing and the onset of mental 
illness, researchers have yet to identify a causal relationship between them. Although 
most agree that the hormonal and metabolic adaptations required to sustain a 
pregnancy are profound and often confer significant risk to maternal physical health, 
there is no consensus that puerperal hormone changes mediate, or in any way elicit, 
disruptions in maternal mental health. Consequently, the prevailing hypothesis 
suggests that puerperal mental illness, commonly referred to and investigated as 
postpartum depression, is not the result of endocrine pathophysiology, but rather, a 
maladaptive psychosocial response to normal changes in reproductive hormones 
(Bloch et al., 2000).
This hypothesis, while understandable in light of the inconclusive endocrine 
research, contradicts epidemiological data that supports a clear temporal relationship 
between childbirth and psychiatric disturbances (Munk-Olsen, Laursen, Pederson, 
Mors & Mortensen, 2006). It also disregards a basic tenet of maternal endocrinology, 
namely, that the changes in puerperal hormone concentrations are vast and systemic
1
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and, thus, not limited to the traditionally investigated reproductive hormones of 
progesterone, estradiol and estriol.
An abundance of epidemiological research shows that the immediate 
postpartum period is marked by considerable mood lability that is experienced by 
approximately 80% of women (Dalton & Holton, 2001; Miller, 1999; O’Hara, 
Schlecte, Lewis & Wright, 1986; Spinelli, 1998). Approximately 15% of women 
suffer an episode of clinical depression following parturition (Cooper, Larouche, 
Drista & Bender, 2000; Dalton & Holton, 2001; Miller, 1999; Spinelli, 1998; O’Hara 
& Swain, 1996). Clinically significant anxiety is estimated to be present in 9-50% of 
women following parturition (Austin, 2004; Eberhard-Gran, Tambs, Opjordmoen, 
Skrondal & Eskild, 2003; Gard, Handley, Parsons & Waldron, 1986; Heron, 
O’Connor, Evans, Golding & Glover, 2004; Ross, Sellers, Evans & Romach, 2002). 
Upwards of 30% of women with obsessive compulsive disorder recognize the onset 
of their disorder as having coincided with pregnancy (Neziroglu, Anemone & 
Yariyura-Tobias, 1992; Abramowitz, Schwartz, Moore & Luenzman, 2003). 
Moreover, the postpartum period confers an increased risk for psychosis with 1-2 per 
1000 pregnancies resulting in psychiatric hospitalization (Brockington & Meakin 
1994, Klompenhouwer & van Hulst, 1991; Kumar, Marks, Platz, Yoshida, 1995 
Vedibech & Gouliacv, 1995; Wisner, Peindl & Hanusa, 1993). With postpartum 
psychosis suicidality increases some 70-fold (Sharma, 2003).
Given the temporal association between childbirth and significant psychiatric 
disturbances, it seems likely that endocrine factors are responsible. However, 
according to the published research they are not, with most research showing only
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tenuous connections between changes in the traditional reproductive hormones and 
depressed mood, (Harris et al., 1994; Kuevi et al., 1983; Meakin et al., 1995; Nappi, 
et al., 2001; Nott et al., 1976; O’Hara, et al., 1996; Paoletti, et al., 2006). Very few 
researchers have investigated other hormones potentially altered by pregnancy and 
the spectrum of psychiatric symptoms that might emerge concurrently (Buckwalter et 
al., 1999; Marrs 2006). Perhaps because of the paucity of conclusive research, 
puerperal psychiatric disturbances are not considered by the Diagnostic and Statistic 
Manual Version IV (DSM-IV) (American Psychiatric Association, 1994) to be related 
to an organic or general medical condition, but instead, are considered as time course 
specifiers attributable to any mood disorder that develops within 30 days following 
parturition (AP A, 1994).
In the popular and, indeed, in the scientific press, the DSM-IV designation has 
been translated into a rubric of three disorders around which the vast majority of 
research is modeled. The mildest form of mood disturbance, called the “baby blues,’’ 
is marked by mild anhedonia and mood lability and is the most commonly 
investigated phenomena within this spectrum (Dalton & Holton, 2001; Miller, 1999; 
Spinelli, 1998). A more serious disorder called postpartum depression (PPD) 
typically, although not formally designated as such, refers to major depressive 
disorder (Andrews-Fike, 1999; Astuler, Hendrick & Cohen, 2000; Dean & Kendell, 
1981; Gard, et al. 1986; Miller, 1999; O’Hara & Swain, 1996). This is followed by 
the most severe and arguably rarest form of puerperal mental illness, postpartum 
psychosis (Brockington, 2004; Brockington & Meakin 1994; Dean & Kendell; 
Klompenhouwer & van Hulst, 1991).
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None of these “disorders” carry with them clearly identified or even agreed 
upon diagnostic criteria (Kumar, 2001; Kumar, et al., 1995; McGorry & Connell, 
1990), nor do they address the probability of co-morbidity or the possibility of 
endocrine mediators. Rather, both the baby blues and postpartum depression are 
characterized according to varying levels of anhedonic depression, often measured by 
the popular 10-item Edinburgh Postnatal Depression Scale (EPDS) (Cox, Holden & 
Sagovsky, 1987; Dennis, 2004; Gueyney, Fermanian, Guelfi & Kumar, 2000) and 
other depression scales. Postpartum psychosis, on the other hand, has been variously 
linked to either bipolar 1 or an ambiguously defined affective psychosis (Brockington 
& Meakin 1994; Cooper, Campbell, Day & Kennerly, 1988; Dean & Kendell ,1981; 
Dean, Wiliams & Brockington, 1989).
Disagreement regarding the onset and course of these disorders is apparent in 
the research literature with psychiatric disturbances considered postpartum when they 
develop anytime within the first postpartum year (Andrews-Fike, 1999; Gavin, et al., 
2005; Mowery & Lennon, 2001; Pfühlmann et al., 1998; Sing & Kauer, 1999;
Wisner, Peindl & Hanusa, 1993; Wisner, Peindl & Hanusa, 1995) even though data 
exists showing that from 50-70 % of all cases of puerperal mental illness develop 
within days of parturition (Klopemhouwer & van Hulst, 1991; Kumar, Marks, Platz 
& Yoshida, 1995; Munk-Olsen, Laursen, Pederson, Mors & Mortensen 2006; Stowe, 
Hostetter & Newport, 2005).
With the disparities in the definition and onset of puerperal mental illness and 
the limited range of psychiatric symptoms and reproductive hormones typically 
investigated, it is clear why endocrine antecedents have not been associated
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conclusively with puerperal psychiatric disturbances. Since the medical literature is 
replete with evidence that endocrine disturbances elicit a myriad of psychiatric 
symptoms (for a review see Brambilla 1992; Hochberg, Pacak & Chourous, 2003), 
there is no reason to suspect that the vast hormone changes associated with 
pregnancy, parturition an even breastfeeding cessation and menstrual cycle 
resumption, would not do the same. It is also reasonable to presume that the sheer 
magnitude of hormone changes associated with childbearing, albeit considered 
“normal,” might elicit abnormal reactions in other endocrine parameters and that 
psychiatric disturbances might be the markers of these changes.
During pregnancy, hormone production is up-regulated significantly and 
systemically to support the growing fetus. Steroidogenesis formally under maternal 
control becomes a dynamic multi-compartment endeavor with contributions from 
fetal, placental and maternal endocrine glands (Carr, 2001; Goland, Conwell, Warren 
& Wardlow, 1992; Mastorakos & Illias, 2003; O’Leary, Boyne, Flett, Beilby, James, 
1991; Weiss, 2000). Once tightly controlled feedback loops are up-regulated and even 
overridden as steroid synthesis increases exponentially to support the pregnancy 
(Carr, 2001; Challis & Lye, 1998). Synthesis of hormone binding proteins and 
enzymatic metabolism are up-regulated in an attempt to compensate for the increased 
steroids, but even so, maternal concentrations of these hormones increase drastically 
throughout gestation (Carr, 2001; Challis & Lye, 1998; Harris, Lovett, Roberts, Read, 
Riad-Fahmy, 1993; Mastorokas & Illias, 2003)
Upon delivery, the fetal and placental components of this system are removed, 
precipitating an abrupt reduction in previously supra-physiological concentrations of
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maternal steroids. Hormone values fall to below pre-pregnancy levels within three to 
four days and are thought to remain low until breastfeeding ceases and menstruation 
begins (Carr, 2001; Illingworth & McNeilly, 1998). Even under normal 
circumstances, such an abrupt change in internal chemistry would be expected to 
elicit both physiological and psychological reactions. As such, the widely experienced 
baby blues may represent a “normal” and expected response to these changes.
However, inter-individual variability in hormone metabolism is tremendous. 
The abrupt withdrawal of puerperal hormones and consequent shift back to maternal 
control of steroidogenesis might elicit in some women aberrant compensatory 
reactions in steroid metabolism, which in turn might initiate psychiatric disturbances. 
Alternatively, puerperal hormone changes could un-mask previously unidentified 
impairments in maternal steroidogenesis. Since years of research have not identified 
any anomalies in the reproductive hormones related to psychiatric disturbances, it is 
likely that “non-reproductive” hormones are culpable. Indeed, new evidence suggests 
that this may be the case.
Unlike most investigations of puerperal mental health that examine 
relationships between the baby blues or postpartum depression and traditional 
reproductive hormones, Marrs (2006) examined a broader range of psychiatric 
symptoms using the Symptom Checklist-90-R (SCL-90-R) and administered a 
complete battery of neurocognitive instruments to a cohort of healthy, primigravid 
women. The SCL-90-R measures nine clusters of psychiatric symptoms including, 
anxiety, hostility, phobia, paranoia, psychoticism, somatization, obsessive compulsive 
behavior, interpersonal sensitivity and depression as well as a composite score that
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estimates the severity of overall psychiatric distress. The psychiatric symptoms and 
cognitive variables were compared to salivary concentrations of progesterone, 
dehydroepiandrosterone sulfate (DHEAS), testosterone, estrone, estradiol and estriol 
measured concurrently both in late pregnancy (n=32) and in the immediate 
postpartum (n=28). With these considerations, Marrs (2006) demonstrated that 
puerperal psychiatric disturbances were significantly and uniquely associated with 
puerperal hormone changes. Specifically, diminished late pregnancy testosterone and 
elevated pre- and postpartal DHEAS concentrations were correlated with the 
spectrum of psychiatric symptoms measured by the SCL-90-R. Moreover, these 
disturbances developed early, sometimes during pregnancy, were not limited to 
depressive symptoms and were significantly more severe and more common than had 
previously been reported. Fully 50 % of the women tested by Marrs exhibited 
clinically relevant postpartal elevations in four or more symptom clusters including 
elevations in psychoticism. SCL-90-R T-scores greater than 60 were considered 
elevated.
In addition to identifying correlations between hormones and psychiatric 
symptoms, the Marrs study uncovered atypical patterns in adrenal androgen 
concentrations, namely elevated DHEAS concurrent with relatively low testosterone. 
Serum DHEAS values, which have been investigated in relation to the onset of labor, 
are reported to increase in the first two trimesters, remain stable in the third and return 
to non-pregnant values following parturition (Milewich et al., 1978; Soldin et al., 
2005; Tagawa et al., 2004). In the Marrs study, salivary DHEAS concentrations were 
high in late pregnancy and increased by an average of 34 % following parturition.
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with those participants exhibiting the largest increases in DHEAS also suffering the 
most severe psychiatric disturbances. Moreover, four participants exceeded and 
others approached the clinical cutoff range that typically merits further testing for 
adrenal pathology.
Elevated DHEAS concentrations typically lead to elevated testosterone 
concentrations. Testosterone is presumed to increase significantly during pregnancy 
but fall to pre-pregnancy concentrations following parturition (Bammann, Coulam & 
Jiang, 1980). This appeared not to be the case in the Marrs study. Both pregnancy and 
postpartum testosterone concentrations were very low when compared to healthy non­
pregnant women and were found to increase rather than decrease in five women 
following parturition, although as a group testosterone concentrations fell by 49 %.
In addition, low late pregnancy testosterone concentrations were associated with a 
myriad of psychiatric symptoms during pregnancy but more importantly heralded the 
onset and exacerbation of postpartal psychiatric disturbances. Thus, lower late 
pregnancy testosterone combined with higher pre- and postpartum DHEAS 
concentrations not only represented an atypical pattern in hormone metabolism but 
also were linked with significant psychopathology.
The Marrs study also investigated cognitive performance and its relationship 
to hormone concentrations and psychiatric symptoms. The data revealed moderate 
cognitive impairment both pre- and post delivery across multiple cognitive domains 
including verbal and spatial memory, attention and cognitive processing speed. 
Impairment was most pronounced in verbal and spatial memory. When compared to 
age and IQ-adjusted normative standards, participants exhibited single digit to only
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50* percentile rankings, with most verbal recall scores remaining below the 20* 
percentile for pregnancy and postpartum. These findings were consistent with results 
reported by Buckwalter and colleagues (1999) who reported equally low verbal 
memory scores at 36 weeks of pregnancy and one month postpartum. Although 
individual hormones were significantly associated with specific cognitive variables, 
in both the Buckwalter et al. (1999) and Marrs (2006) there were no consistent 
patterns across variables in these relationships. However, elevated hormone 
concentrations were significantly related to poorer cognitive performance in general 
on multiple cognitive tests (Marrs 2006).
Marrs (2006) provides perhaps the first evidence supporting a relationship 
between hormones and psychiatric symptoms. More importantly however, this study 
provided preliminary evidence for the development of an endocrine pathophysiology 
either related to, or un-masked by, puerperal hormone changes. In order to examine 
this possibility further, the current longitudinal research was undertaken. Building 
upon the Marrs (2006) study and continuing with women from that cohort, this 
research examined the relative changes in puerperal hormones, psychiatric symptoms 
and cognitive performance occurring from late pregnancy through the first 
postpartum year.
It was hypothesized that if the puerperal psychiatric symptoms were truly 
affiliated with endogenous endocrine factors, then the degree to which these hormone 
factors changed over the postpartum period would correspond to symptom severity. It 
was further hypothesized that elevated DHEAS would contribute significantly to the 
severity of psychiatric symptoms, particularly those associated with anxiety type
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
disorders, and to the equilibrium of other hormones along the androgen pathway. 
Specifically, it was proposed that if DHEAS concentrations remained elevated and 
above clinical reference ranges, psychiatric symptoms would continue and other 
hormone values would be altered. Finally, it was expected that cognitive deficits 
observed during pregnancy and postpartum would improve over the course of the 
postpartum year.
10
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CHAPTER 2
LITERATURE REVIEW 
Puerperal psychiatric disturbances develop in a significant number of women, 
sometimes with tragic consequences, yet their existence as distinct psychiatric entities 
remains under debate. Disparate definitions and diagnostic criteria plague much of the 
research with etiological investigations limited to a narrowly agreed upon set of 
anhedonic symptoms within a broadly defined time of onset. The possibility and, 
indeed, the probability that the postpartum period confers at least an equal risk for a 
wide range of psychiatric disorders is summarily disregarded with the vast 
preponderance of research focused on the baby blues and postpartum depression. 
Nonetheless, there is accumulating evidence suggesting that perinatal psychiatric 
disorders are unique phenomena whose symptoms: 1) may be more clearly delineated 
along a continuum of symptoms and severity rather than by categorical distinction, 
and 2) are temporally, if not causatively, related to the puerperium and the endocrine 
changes associated therein. Admittedly, the research is limited and consensus has 
been elusive making a thorough review of the literature necessary. The purpose of the 
first part of this literature review is: 1) to discern what is known about psychiatric co­
morbidity during pregnancy and postpartum; 2) to delineate the onset and course of 
said disorders; and 3) to review potential hormonal factors associated therewith.
11
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Marrs (2006) identified an array of neurocognitive decrements temporally 
associated with pregnancy and postpartum. As had been the case with other 
investigations, cognitive performance did not appear causally related to any one 
hormone or specific cluster of psychiatric symptoms. Rather cognitive impairment 
was associated with elevated hormones in general and only inconsistently associated 
with psychiatric symptoms. Given the degree of cognitive impairment observed by 
Marrs, particularly in verbal and spatial memory and the temporal association among 
the variables it is difficult to discount a relationship entirely. Thus, second section of 
this literature review will address both the short- and long-term cognitive sequelae 
associated with pregnancy and parturition and where applicable, with other clinical 
endocrine disorders.
Marrs (2006) also identified relationships amongst the adrenal androgens 
DHEAS and testosterone and a myriad of puerperal psychiatric symptoms. Inasmuch 
as this pattern of adrenal hormones has not been associated with known endocrine 
disorders and adrenal hormones in general have not been considered to be major 
determinants of pregnancy related psychiatric disruptions, a thorough review of the 
literature pertaining to these hormones is presented. The purpose of the final section 
of this literature review is: 1) to discuss the biological and pharmacological actions of 
these hormones; 2) to provide evidence of endocrine involvement in mental illness 
and the mental health issues associated with clinical endocrine disorders; 3) to discuss 
the potential physiological mechanism by which high DHEAS and low testosterone 
might develop.
12
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Puerperal Mental Illness
Definition and Diagnosis
Heretofore puerperal mental illness has almost exclusively been regarded as 
either “baby blues,” postpartum depression (PPD) and/or, in rare cases, postpartum 
psychosis. Baby blues, defined loosely as excessive crying and mood lability, is said 
to occur in up to 80% of all women in the days following parturition (Miller, 1999; 
Spinelli, 1998). Postpartum depression, considered a more severe form of baby blues, 
occurs in approximately 10-15% of all women (Miller, 1999; Spinelli, 1998). 
Postpartum psychosis on the other hand, occurs in 1-2/1000 births (Brockington, 
2004; Jones et al. 2001; Kumar, 2001; Miller, 1999; Spinelli, 1998; Wisner, Peindl & 
Hanusa, 1993). Although baby blues are considered a normal consequence of 
childbirth, there is no consensus amongst researchers, clinicians or women’s groups 
regarding the definition, diagnosis, course or treatment of either postpartum 
depression or postpartum psychosis. Accordingly, the postpartum period has only 
recently been recognized as a time course specifier applied to mood disorders by the 
Diagnostic and Statistical Manual IV (DSM-IV) and the International Classification 
of Diseases version 10 (ICD-10) of the World Health Organization when the illness 
arises within 30 or 45 days following childbirth, respectively (Kumar, 2001).
Consistent with the prevailing theoretical assumption, that childbirth confers 
no special vulnerability or etiological connection to mental illness, previous versions 
of both diagnostic manuals allowed for no designation of puerperal onset of mental 
illness. In fact, clinicians using the ICD-8 were instructed not to classify psychiatric 
disturbances associated with childbirth unless no other classification was deemed
13
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appropriate. It is reported that most psychiatrists ignored those instructions (Kumar, 
2001). In response, all mention of puerperal psychosis was deleted from the ICD-9, 
only to be reinstated in the ICD-10 in a fashion similar to the ICD-8.
Amongst the research community, the debate is no less controversial and 
contentious. The existence of puerperally induced mental illness was deemed 
impossible almost by caveat, based upon the findings of a few researchers. 
Specifically, Stecker and Edbaugh (1926) argued that “Old names die hard.. .all 
others who have studied this problem are unanimous in the belief that there is no 
psychosis which may be diagnosed as puerperal” (Kumar, 2001). This was followed 
by Founder et al. (1957) who stated unequivocally that “since these patients whose 
mental illness was apparently precipitated by childbirth did not differ substantially 
from control groups as regards diagnosis, previous mental illness or prognosis, the 
conclusion seems justified that postpartum illness is not a psychiatric entity.”
Fast forward almost fifty years and the debate has yet to be settled. As 
recently as 2004, a prominent researcher declared that postpartum psychiatric 
disorders were not discrete entities and any notion that this was the case “was 
disproved long-ago” (Brockington, 2004). Indeed, if it were not for some highly 
publicized tragedies presumably involving postpartum psychosis, it is not likely that 
research about this phenomenon would be moving forward at all. What research 
there is in this area has focused primarily upon baby blues and PPD. Moreover, 
perhaps because postpartum mental illness is not considered a true clinical entity, this 
research has involved an exceedingly narrow range of symptoms that occurs within a 
very broadly and inconsistently defined period of time.
14
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Both popular and scientific research argue that PPD includes symptoms such 
as weeping, irritability, guilt, mood lability, low sex drive, forgetfulness, fatigue and 
anxiety (Dalton, 2001; Miller, 1999; Spinelli, 1998). The instrument of choice for 
detection of PPD has been the Edinburgh Postnatal Depression Scale (EPDS) 
developed by Cox, Holden and Sagovsky, (1987). The EPDS is alO-item self-report 
measure that focuses on symptoms associated with anhedonic dysphoria. Each item in 
the EPDS is scored on a scale of 0-3 with three being the most severe. The EPDS has 
been well validated with over 20 studies published to date and is said to reliably 
identify baby blues and postpartum depression in 82% of the cases (Dennis, 2004) 
leaving 18% of the women undiagnosed. But what is postpartum depression? Judging 
from the accumulated literature it is a form of major or minor depression whose onset 
somehow coincides with childbirth. Coinciding with childbirth is variously defined as 
occurring during pregnancy (Spinelli, 1998; Johanson et al., 2000) or within 30 days 
following parturition (DSM-IV); is sometimes classified as the re-emergence of a 
previous depression during pregnancy or postpartum (Wisner et al., 1993); and/or 
depression occurring sometime within the first year postpartum (Andrews-Fike, 1999; 
Gavin et al., 2005). With such a narrowly defined disorder (depression as measured 
by the EPDS) and a vaguely defined onset and course, inconsistencies in research 
findings are not unexpected.
Similarly, postpartum psychosis is variously defined as affective psychosis, 
non-affective psychosis or mania (Brockington, 1990; Brockington & Meakin, 1993; 
Brockington, 2004; Sing & Kaur, 1999; Stewart. Klompenhouwer, Kendell & Hulst, 
1991; Wisner et ah, 1993; Wisner et ah, 1995). Unlike PPD, the onset of postpartum
15
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
psychosis is accepted as rapid with research indicating that approximately 50-70% of 
all cases occur within the first two weeks following childbirth (Brockington, 1990; 
Brockington & Meakin, 1993; Brockington, 2004; Klompenhauer & Van Hulst 1991; 
Sing & Kaur, 1999; Stewart et al., 1991; Wisner et al., 1993; Wisner et al., 1995). 
However, even given consensus on the time of onset, extant research on postpartum 
psychosis is still problematic. For example, many studies are retrospective, based 
upon either hospital or physician referral records, and are confounded by the presence 
of participants with previous histories of serious mental illness. This necessarily 
limits the possibility of discerning a relationship between childbirth and the 
precipitation of mental illness. At best, the research can only conclude that the stress 
of childbirth, like any other stressor, confers a risk of onset in women so disposed or a 
risk of relapse for women with histories of serious mental illness.
There is a small but emerging literature recognizing the need for more precise 
definitions of the psychiatric disturbances associated with childbearing. Such research 
suggests that psychiatric illnesses related to childbearing are; 1) distinct clinical 
entities; 2) are potentially hormonally mediated, although the research has yet to 
definitely bear this out; and 3) follow a continuum of severity and symptomatology 
from endpoints of baby blues to psychosis with varying degrees of depression, 
anxiety and obsessive compulsive behavior in between (Austin, 2004; Cooper & 
Murray, 1995; Halbreich, 2005; Pfuhlmann, Stober, Fransek & Beckman, 1998).
Data from Marrs (2006) support these generalizations. Results from this study 
indicated that psychiatric morbidity covered the spectrum of clinical disorders and 
began appearing in late pregnancy. Using the Symptom SCL-90-R to assess
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psychiatrie symptoms, Marrs found that fully half of the women tested had elevated 
postpartum SCL-90-R T-scores (>60) in four or more symptom clusters. The most 
severe participants showed significant psychiatric distress across all nine psychiatric 
symptom clusters measured. For some of these women SCL-90-R symptom T-scores 
were two and three standard deviations above the normative means. The Marrs 
research demonstrated that the current investigative focus on baby blues and PPD 
may underestimate the prevalence and depth of psychological suffering in otherwise 
healthy women.
Prevalence
A vast body of literature suggests that PPD occurs in 10-15% of all 
pregnancies (Bloch, Rotenberg, Koren & Klein, 2005; Gavin et al., 2005). A 
frequently cited meta-analysis by O’Hara and Swain (1996) found the prevalence of 
PPD to be 13%. Onset of PPD has been variously defined as occurring within the first 
month postpartum (DSM-IV), within three months (Wisner et al., 2004), within six 
months (Boyce et al., 2000; Ross et al., 2003) or one year following parturition 
(Gavin et al., 2005). A report by Stowe, Hostetter and Newport (2005) found that 
66% PPD cases developed within three weeks of parturition and argues that a re­
appraisal of onset criteria in many research paradigms is needed. The incidence of 
postpartum psychosis is estimated at 1-2 per 1000 births (Brockington, 1990; 
Brockington & Meakin, 1993; Brockington, 2004; Klompenhauer et al. 1991; Jones et 
al., 2001; Klompenhouwer & Van Hulst 1991; Sing and Kaur, 1999; Stewart, et al. 
1991; Wisner, et al. 1993; Wisner et al. 1995) and is generally accepted as rapid with 
many cases reported in the days following parturition and up to 70% of all cases
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developing within the first two weeks postpartum (Brockington & Meakin, 1993; 
Klompehouwer & Van Hulst, 1991; Kumar, Marks, Platz, Yoshida, 1995). Both 
postpartum depression and postpartum psychosis are generally accepted as clinical 
disorders and researched as such, but are not technically clinical entities. Rather 
postpartum is a time course specifier that can be applied to the “current or most recent 
major depressive, manic, or mixed episode in major depressive disorder, bipolar 1 
disorder or bipolar 2 disorder; or to brief psychotic disorder” (p. 387, DSM-IV) that 
occurs within 30 days of parturition. This specifier is not applied to anxiety disorders 
or other psychotic disorders such as schizophrenia. This is likely due to the rapidity 
with which disorders of postpartum manifest and the consequent failure to meet the 
DSM-IV duration of illness criteria for the anxiety and schizophrenic disorders.
Both popular and scientific research suggest that PPD includes symptoms 
such as weeping, irritability, guilt, mood lability, low sex drive, forgetfulness, fatigue 
and anxiety (Dalton, 2001; Miller, 1991, Spinelli, 1998). The diagnostic instrument of 
choice has been the EPDS, which measures symptoms of anhedonic depression, with 
three questions regarding anxiety. The Hamilton Depression Rating Scale or the Beck 
Depression Inventory are sometimes used concurrently (for a review see Gavin et al. 
2005). Most recently, researchers interested in assessing co-morbid anxiety have 
begun supplementing EPDS assessments with separate anxiety scales. However, the 
many researchers still rely on post hoc analysis of the three anxiety questions 
contained in the EPDS. The range of total scores on the EPDS that are considered 
symptomatic has varied from as low as 10 to as high as 16 (Heron et al., 2004; Gavin 
et al., 2005; Johanson et al., 2000; Nappi et al., 2001; Ross et al., 2003).
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As would be expected, given the limited scope of the EPDS scale, the 
discrepancies in scoring and arguments over time of onset, previous attempts to 
reliably predict postpartum depression during pregnancy have faltered. Over 70 
psychosocial risk factors for PPD have been identified and tested, including but not 
limited to, a history of depression or mental illness, socioeconomic factors and 
difficult or abusive family relations (Halbreich, 2005). However, none of these risk 
factors has been shown to reliably predict the onset of PPD (Bemaazzani, Saucier, 
David & Borgeat, 1996; Bloch et al. 2005; Costa, LaRouche, Drista & Brender, 2000; 
Halbeich, 2005; Honey, Bennett & Morgan, 2003).
The lack of methodological consistency amongst researchers has led some to 
revisit both the definition and measurement of PPD. Accordingly, there is 
accumulating evidence that suggests that a broader definition of the disorder and a 
more limited window of onset are warranted (Austin, 2004; Halbreich, 2005; 
Pfuhlman, et al. 1998; Reicher-Rossler & Fallahpour, 2003; Stowe, Hostetter & 
Newport, 2005). The case for expanding the definition of potential postpartum 
disorders is not difficult, particularly when one considers the prevalence and 
distribution of disorders in any given population and the high rates of co-morbidity 
within individual diagnoses (Rush et al., 2005). Indeed, one might expect a similar 
distribution and pattern of co-morbidity in pregnant women.
In recent years a number of studies have emerged indicating that puerperal 
psychiatric co-morbidity exists more often than not. Both epidemiological and 
empirical research, particularly with anxiety and obsessive compulsive disorders 
(OCD), show that the rate of co-morbid anxiety disorders with both syndromal and
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sub-syndromal major depression is consistently elevated in both community and 
hospital populations of perinatal women (Austin, 2004; Altsuler, Hendrick & Cohen 
2000; Brandes, Soares & Cohen, 2004; Britton, 2005; Kumar et ah, 2004; Reicher- 
Rossler & Fallahpour, 2003; Ross et ah, 2005). Moreover, some studies indicate that 
anxiety based disorders show greater perinatal incidence than do depressive disorders 
(Ross et ah, 2005), but the evidence here is limited.
Postpartum Anxiety
Although there is a vast body of literature on postpartum depression and baby 
blues, 760 articles from 1995-2002 (Brockington, 2004), there are relatively few on 
peripartal anxiety. Much of this research is based upon the co-occurrence of anxiety 
in women already diagnosed with depression and often assessed by post-hoc factor 
analysis of the few anxiety dimensions endorsed in the depression scale of choice. 
Nonetheless, the research that does exist argues very strongly for a significant 
relationship between the puerperium and the onset of anxiety disorders with or 
without major depression.
Ross et ah, (2002), assessed depression and anxiety using the EPDS and Brief 
Symptoms Inventory (BSI) in a community sample of 150 obstetric women, found 
clinically significant anxiety present in 50% of clinically depressed women across all 
test times (prenatal, 6 and 16 weeks postpartum). Moreover the three EPDS anxiety 
questions (3, 4, and 5) accounted for approximately 40% of the total EPDS score. The 
authors also noted significantly higher sub-clinical obsessive compulsive behaviors in 
pregnant women versus non-pregnant controls and versus postpartum.
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A large Norwegian study (n=2730) evaluated the relative distribution and 
prevalence of anxiety and depression in postpartum (n=416) and non-postpartum 
(n=l,794) women. Using the Hopkins Symptom Checklist-25 (SCL-25), a self-report 
tool that evaluates depressive and anxious symptoms, researchers found that anxiety 
was equally likely in each group of women but that the risk for depression was higher 
in the postpartum group (Eberhar-Gran et al., 2003). Of interest, researchers found 
that crying easily and often did not confer a risk for other depressive symptoms. 
Researchers speculated that crying, a symptom often attributed to depressive 
symptomatology, particularly in PPD when assessed using the EPDS, should not be 
considered an indicator of depression (Eberhar-Gran et al., 2003). These results 
appear to contradict the findings of Ross et al. (2003) but Eberhar-Gran and 
colleagues utilized different instruments and did not disclose test times relative to 
gestation or parturition.
Using the State-Trait Anxiety Inventory, Britton (2005) found moderate 
anxiety in 24% of 422 new mothers, 1% of whom experienced severe anxiety. The 
study was conducted prior to the patients’ release from a US maternity hospital, 
sometimes within hours of delivery. The mean length of hospital postnatal stay was 
listed at 49.9 +/- 1 hour but the mean delivery to test time was not given. Britton 
found that elevated anxiety was associated with lower maternal age, education and 
income. As might be expected, first time mothers experienced greater anxiety than 
multiparous women. Interestingly, mothers of male infants experienced more anxiety 
than mothers of female infants and previous psychiatric diagnosis had no bearing on 
anxiety levels except in women with pre-existing depression.
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Using a community based sample of 68 postpartum women, Wenzel, Haugen, 
Jackson and Robinson (2003) found the prevalence of generalized anxiety disorder 
(GAD) to be higher than major depression (4.4% versus 2.9%) at eight weeks 
postpartum. Moreover, 27% of the participants endorsed sub-syndromal levels of 
anxiety compared to 8.8% who endorsed mild non-clinical depression. In a similar 
study by the same authors, the prevalence of GAD was found to be higher in 
postpartum women than in a representative sample of other women (Wenzel et al., 
2005). Interestingly, in a previous study by Wenzel and colleagues (2001), it was 
noted that the most common complaint of postpartum anxiety was autonomic 
hyperactivity. This is similar to non-puerperal patients, except that postpartum 
women did not associate those symptoms with fear of death.
Postpartum Obsessive-Compulsive Disorder
Over the last 15 years multiple retrospective studies have delineated the 
prevalence of obsessive compulsive disorder (OCD) onset during pregnancy and 
childbirth (for a review see Abramowitz et ah, 2003). OCD is an anxiety disorder 
marked by recurrent distressing thoughts, ideas, or doubts (obsessions) combined 
with urges to neutralize those thoughts via compulsive rituals (compulsions). In non- 
postpartum OCD, the content of the obsessions varies across patients but typically 
revolves around concerns of accidentally causing harm to oneself or others 
(Abramowitz, et al. 2003; Brandes, Soares & Cohen, 2004). The primary 
characteristic of perinatal OCD is uncontrollable and often violently aggressive 
intrusive thoughts and images about harming one’s child (Wisner et ah, 1999). 
Thoughts of harming one’s child are a common but relatively under-recognized
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component of postpartum psychological distress. In the only study of its kind, 
Jennings, Ross, Popper and Elmore, (1999) measured the prevalence of intrusive 
thoughts in recently delivered women and found that upwards of 41% of all depressed 
mothers experienced intrusive thoughts while only 7% of non-depressed mothers 
reported intrusive thoughts. Likewise Wisner et al. (1999) and Wenzel, Gorman and 
Stuart (2001) found thoughts of harming one’s infant and fears of imminent danger to 
be the most common obsessional content in postpartum women. This suggests that 
intrusive thoughts may be in part engendered by the postpartum period.
In a comprehensive review of peripartal OCD symptomatology, Abramowitz 
et al. (2003) speculated that pregnancy and postpartum confer a unique vulnerability 
to the onset of OCD for some women. This is supported by numerous 
epidemiological studies indicating that the women’s age of onset of OCD is bi- 
modally distributed and temporally related to childbirth. Several studies show that the 
number of new cases of OCD increases in females who have had children between 
the ages of 22-24 and 29-32 versus those who have not. Estimates of peripartal onset 
are approximately 39% (Neziroglu et al., 1992). Conversely, for women who have 
never had children age of onset is typically much earlier and between the ages of 13- 
16 years (Neziroglu et al., 1992). Although these data are impressive, the studies 
listed are based upon retrospective self-report. Very few studies have actually 
prospectively measured perinatal OCD.
Postpartum Psychosis and Bipolar Disorder
The nosological status of postpartum psychosis has vacillated widely over the 
last 60 years. Prior to the emergence of formal classification systems and since
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antiquity, psychotic episodes temporally associated with parturition were recognized 
as discrete nosological entities (Kumar, 2001). With the advent of modem operational 
criteria the existence of this disorder has been called into question, presenting obvious 
difficulties for clinicians and researchers alike. This is particularly so because most 
research in this area has been retrospective, relying solely on the diagnostic 
information ascribed in medical records.
Nevertheless, buried deep within this research, there are data suggesting that 
postpartum psychosis is a distinct nosological entity. What comes to mind here are 
the atypical symptom presentation and the research showing that 10-14% of cases of 
puerperal psychosis occur in women with no previous or familial psychiatric histories 
and no subsequent non-puerperal episodes (McGorry & Connolly 1990). For these 
women, puerperal psychosis seems to be a discrete entity. Unfortunately, new onset 
puerperal psychosis has not been investigated thoroughly.
When reading the case literature and research on postpartum psychosis one is 
left with a nagging sense of discordance between the disorder that supposedly does 
not exist and subsequent diagnostic criteria assigned thereto. Indeed, many 
professionals in the field argue postpartum psychosis is easily and blindly identified 
by its atypical presentation (Brockington, 2004; Hays & Douglas, 1984). That 
notwithstanding, the symptoms of postpartum psychosis are marked by several 
factors that differentiate it from its non-puerperal counterparts.
First, postpartum psychosis is marked by rapid onset of symptoms following 
parturition (Klompenhouwer, 1991). The rapidity of onset makes classification 
difficult, especially in the early stages of the syndrome when its duration has not yet
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met specified temporal criteria required for making particular diagnoses. Some 
speculate that there is a prodromal period beginning in late pregnancy but this 
supposition has not been established empirically (Dalton, 1994: Miller, 1999). 
Moreover, the putative prodrome appears to include restlessness, insomnia and mood 
lability, symptoms with striking similarity to the normal physiological changes 
associated with late pregnancy and postpartum (Hays & Doulgas, 1984). Frank 
symptoms are reported to begin within two weeks of parturition with some 
investigators reporting onset within days of delivery (Kumar et ah, 1995). 
Unfortunately, researchers have variously identified postpartum psychosis as 
beginning up through the first three months (Mowery & Lennon, 2001; Wisner,
Peindl & Hanusa, 1993; Wisner, Peindl & Hanusa, 1995), the first six months 
(Pfixhlmann et ah, 1998; Sing & Kauer, 1999), and even a year postpartum making 
arguments either for or against a separate disorder considerably weaker. If 
postpartum disorders are truly nosologically distinct from other psychopathologies, 
then their onset should be temporally related to the puerperium and should occur only 
during subsequent pregnancies or hormonally similar events.
Symptoms of postpartum psychosis include confusion, perplexity, irrational 
ideation and disorientation, instability or rapidly changing sensorium and psychotic 
hallucinations, extreme mood lability, restlessness, and insomnia (Brockington & 
Meakin, 1994; Hays & Doulgas, 1984; Klomenphauer, McCory & Connell 1990; 
1991; Miller, 1999). The severe confusion and disorientation and rapidity of onset are 
what have led many to argue for a separate disorder (Hays & Douglas, 1984; 
Videbech & Gouliacv, 1995), while the apparent cycling of moods and restlessness
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(and perhaps the lack of other suitable diagnostic criteria) have lead many researchers 
to associate postpartum psychosis with bipolar 1 disorder. This even though there 
does not appear to be the concomitant grandiosity or focused attention typically 
associated with the bipolar disorders and the postpartum mood cycling looks to be 
extremely rapid, consistent with extreme mood lability rather than the temporal 
cyclicity evident in the bipolar disorders.
Bipolar Disorder and Affective Psychosis
A contingent of investigators and clinicians hold that postpartum psychosis is 
a functional psychosis that can be sufficiently categorized under the diagnosis of 
unipolar affective psychosis (major depressive disorder with psychotic features) or 
bipolar disorder, presumably a bipolar 1, mixed episode. However, neither exact 
classifications are given in the literature nor is justification for inclusion in or 
exclusion from a particular diagnostic category elucidated.
The most consistent argument for the classification of postpartum psychosis 
under the rubric of bipolar disorders comes from epidemiological studies that suggest 
women with histories of bipolar disorder have a 1 in 5 chance of having a psychotic 
episode postpartum compared to the 1 in 500 chance of women without such histories 
(Stewart et a l, 1991). In addition, approximately 39%, but upwards of 60%, of 
women have their first manic episode after childbirth (Mowery & Lennon, 2001) with 
a family history of bipolar disorder increasing that risk substantially.
Most of this research has been done retrospectively on data collected from 
medical records in Scandinavian and Norwegian countries (Dean, Williams & 
Brockington, 1989; Klompenhouwer, 1991; Kumar et a l, 1995; Mower & Lennon,
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2001; Singh & Kauer, 1999; Wisner, Peindl & Hanusa, 1993; Wisner Peindl & 
Hanusa, 1995). As discussed earlier, the ICD has not continuously provided for the 
designation for either a discrete postpartum entity or even a postpartum specifier 
(Kumar, 2001) so researchers must compare delivery records with psychiatric 
admissions within a given period of time and cull together diagnostic and historical 
information based upon those records (Dean, Williams & Brockington, 1989; 
Klompenhouwer, 1991; Kumar et al., 1995; Mower & Lennon, 2001; Singh & Kauer, 
1999; Wisner, Peindl & Hanusa, 1993; Wisner Peindl & Hanusa, 1995). Because the 
prevalence of this disorder is small, psychiatric admissions within six months and 
even 12 months of delivery are commonly included within the research criteria 
(Dean, Williams & Brockington, 1989; Klompenhouwer, 1991; Kumar et al., 1995; 
Mower and Lennon, 2001; Singh & Kauer, 1999; Wisner, Peindl & Hanusa, 1993; 
Wisner Peindl & Hanusa, 1995). This methodological decision, while understandable 
in light of the limited prevalence rate, necessarily compromises arguments either for 
or against discrete nosological status. It is very difficult to make an argument that 
postpartum psychosis is distinct from other psychoses when the criteria for inclusion 
into a particular study or diagnostic group is so broad and allows women with 
potentially non-childbirth related psychoses into the mix. Moreover, women with 
previous histories of psychiatric disorder, either puerperal or non-puerperal, are 
routinely included in analyses (Brockington & Meakin, 1994; Brockington, Oates & 
Rose, 1990; Dean, Williams & Brockington, 1989; Sing & Kauer, 1999; Wisner, 
Peindl & Hanusa, 1995). This is true of the few prospective projects as well 
(McGorry & Connell, 1990). Again, without clear distinction between those with
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previous histories of serious psychiatric disorders and those without such histories, it 
is difficult to distinguish this syndrome from its non-puerperal counterparts.
In addition to methodological problems in the research, there are logical errors 
in the conclusions reached. Namely, the increased incidence in onset and recurrence 
of bipolar disorder, particularly in women with familial or personal histories of the 
disorder, does not demonstrate a nosological linkage between the two disorders. 
Rather, it indicates that pregnancy is a significant stressor that brings with it a risk of 
relapse or onset in women so disposed.
The research on prognosis or risk of relapse following a puerperal psychotic 
episode, though no more consistent than the aforementioned research, provides some 
evidence for separate disorders. It must be noted, however, that many of the studies 
cited in the following section do not always distinguish between new onset or 
recurrence, neither do they clearly elucidate symptom criteria. Thus, the numbers 
presented below are merely estimates culled together from the various projects for the 
purpose of discussion herein.
In women with histories of non-puerperal psychiatric affective psychosis there 
is an increased risk of both puerperal and non-puerperal psychotic episodes and 
functional prognosis is poor. The risks are consistent with those in the general 
population except in the immediate puerperium where the risk of major psychiatric 
illness increases several fold (McGorry & Connell, 1990). In women with family 
histories (first degree relatives) of psychiatric disorder and a puerperal psychotic 
episode there is an increased risk of future non-puerperal and puerperal episode.
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Prognosis is mixed. Moreover, there is a ten-fold increase in puerperal psychosis for 
first degree relatives (McGorry & Connell, 1990).
In women who have had puerperal psychotic episodes with no personal or 
familial history of psychiatric disorder, the risk of non-puerperal episodes is 
increased, compared to women without puerperal psychosis, but the risk appears to 
decrease over time (Hays & Douglas, 1984; Ramsey, 1994). However, the risk of 
subsequent puerperal psychotic episodes has variously been found equal to or greater 
than women without such histories with estimates of 20-60% recurrence of post- 
puerperal episode (Brockington & Roper, 1987; Davidson & Robertson, 1989; 
Videbech & Gouliacv, 1995). Prognosis and post-episode functional ability in these 
women is good, if there are no non-puerperal breaks, with estimates of upwards 96% 
achieving full functioning compared to 47% of women with personal or family 
histories (Dean, Williams & Brockington, 1989). The risk for subsequent puerperal 
episodes is high with more than one third of women across studies having subsequent 
episodes following parturition (McGorry & Connell, 1990).
Lacking from the above data are clear diagnostic criteria, delineation between 
first onset versus previous history, and between subsequent puerperal versus non- 
puerperal recurrences. What should be investigated is whether or not there are 
women, for whom the puerperium only, confers a risk of psychosis.
Epidemiology and Psychiatric Admissions in Postpartum
Epidemiological studies on postpartum mental illness are focused largely on 
postpartum depression and postpartum psychosis. There are very few studies that 
address other psychological disturbances. Of those studies, most fit into one of two
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categories, the prevalence of presenting disorder in inpatient populations relative to 
childbirth or the prevalence in outpatient referrals relative to childbirth. Very few data 
exist regarding prospective prevalence of disorder in community samples.
Wisner and colleagues (1993) reviewed medical records for a large cohort 
(n=1172) of women with both inpatient and outpatient psychiatric referrals relative to 
childbearing status. The data were divided into two groups, childbirth related onset of 
illness (CBROI) (n=168) and non-childbirth related onset of illness (NCBROI) 
(n=1004). Pre-index episodes of psychiatric disorders were not identified. 
Investigators found several significant demographic differences between the two 
groups. The CBROI group was an average of five years younger and had fewer 
children than the NCBROI group. The onset of illness in the CBROI group was 
earlier, particularly for affective and non-affective psychosis, but nonetheless similar 
to the NCBROI group with similar rates of prevalence in both groups for affective, 
anxiety and psychotic disorders.
The women in the CBROI group were, however, more frequently diagnosed 
with an adjustment disorder than the NCBROI group. The prevalence of adjustment 
disorder in the CBROI group may represent a catch-all diagnosis insofar as these 
women may not have met criteria for other disorders and might simply have been 
diagnosed with the adjustment disorder for lack of a more appropriate category. 
Wisner et al. (1993) also reported that of women who have ever had a child, the 
prevalence of psychological disorders was somewhat higher than expected at 14%. 
Based upon these findings the authors argued that postpartum women are as likely as 
nulligravid women to experience a range of psychiatric difficulties, not simply
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depression, and may be at a higher risk for these disturbances following parturition, 
particularly in the case of younger primigravid women.
In a study looking at both onset and co-morbidity, Kumar, Marks, Platz and 
Yoshida (1995) found 56 out of 100 consecutive admissions to a mother-baby 
psychiatric ward occurred within two weeks of delivery with a diagnosis of affective 
psychosis. Twenty-four were diagnosed with non-psychotic disorders and 20 with 
pre-existing schizophrenia. Of the 56 women diagnosed with affective psychosis, 26 
were experiencing an acute, first onset of mental illness. As was observed by other 
investigators, a consistent theme across disorders was the presence of intrusive 
thoughts or delusions about harming their infants.
In'one of the very few prospective studies on perinatal mental illness, Wenzel 
et al. (2001) reported prevalence rates for anxiety disorders in a community sample of 
788 postpartum women. Approximately 11% of study participants reported having 
had at least one panic attack in the previous 30 days. Eight and 9% reported having 
obsessions and compulsions, respectively. Co-morbid depression and panic disorder 
was reported in 1% of the population while co-morbid depression and OCD was 
present in 2.4% of the participants. No data were listed regarding the prevalence of 
depression alone. However, dysphoria was reported in all but 200 of the participants. 
The definition of dysphoria was not elucidated.
Time Course o f  Perinatal Psychiatric Disorders
Over the last 20 years numerous studies have addressed the prevalence and 
time course of perinatal depression (for a review see Gavin et al., 2005). The 
consensus appears to be that antenatal depression is highly associated with postnatal
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depression and that symptoms from pre-existing conditions remain stable 
longitudinally (Beeghly et ah, 2002; Gavin et ah, 2005). What has not been addressed 
is whether there is stability in symptoms for new onset antenatal or postnatal 
depression cases. However, there are some indications that the time course is quicker 
and the prognosis is better for new onset puerperal psychosis versus non-puerperal 
psychosis or mania. Moreover, the incidence of a non-puerperally based relapse is 
significantly less following puerperal psychosis than it is following non-puerperal 
psychosis (Williams & Brockington, 1989).
For other psychiatric disorders, such as panic disorder and OCD, there are a 
few reports suggesting that symptoms follow a similar pattern as has been found in 
perinatal depression, although there has been speculation that pregnancy provides a 
protective effect. That is, pregnancy hormones (presumably, progesterone because of 
its anxiolytic capacity, although not ever tested) are believed to prevent the onset or 
recurrence of anxiety. Cohen et al. (1996) investigated this hypothesis in a small 
sample (n=10) of pregnant women with a pre-existing diagnosis of panic disorder and 
found that pregnancy was not protective. Symptoms remained stable in each of the 
trimesters for seven of the ten women tested. The group was followed through the 
first three months postpartum. At the postpartum evaluation, 9 of 10 women met 
diagnostic criteria for panic disorder and 7 of 10 had to increase medication over 
previous levels.
Consistent with his previous work Cohen and associates (2005) found that the 
state of pregnancy did not protect women with long standing histories of depression 
from relapse. In this study, 201 women (mean age 34.1 years) with lifetime histories
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of major depression ranging from five years to over 20 years were tracked through 
pregnancy. Criteria for entry into the study included; that these women had a history 
of major depression; were less than 16 weeks pregnant; were euthymie from the last 
menstrual period through the proceeding three months; and were currently receiving, 
or had within the last 12 months received antidepressant medication.
Approximately 92% of the participants entered the study while taking a 
variety of serotonin reuptake inhibitors. The remaining participants were on tricyclics 
or a combination of medications. During the course of the study 43 women were able 
to decrease or discontinue medication without relapse. Seventy-two women prevented 
relapse by maintaining or increasing current dosages. Eighty-six women relapsed 
during the course of the study, of those 56 had either decreased or discontinued 
medication. The remaining 30 women either maintained or increased their 
medication dosages and still relapsed. These data suggest that in women with lifetime 
histories of major depression, pregnancy does not confer protection against an 
episode of major depression.
The authors argue that in light of the risk of relapse, antidepressant medication 
should be maintained throughout the pregnancy. There were, however, several 
limitations to this study. First, although standardized diagnostic and measurement 
instruments were used for assessment, namely the Structured Clinical Interview (I/P) 
(SCID-I/P) and the Hamilton Depression Rating Scale for Depression (HAM-D), 
there were no data given on baseline scores compared to relapse, severity of relapse, 
time from discontinuation to relapse, time to re-medication, pattern of discontinuation 
(abrupt or tapered). Nor was information given regarding which medications
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generated higher rates of relapse or whether or not chronicity and/or severity of 
disorder predicted relapse.
Using a prospective/retrospective mixed design, Wisner and colleagues (1996) 
evaluated the relationship between panic attacks and childbearing using psychiatric 
records of 22 women over the course of five years and 45 combined pregnancies. In 
each of these cases, the onset of panic disorder predated the pregnancy. As was the 
case in Cohen et al. (1996), neither panic intensity nor frequency changed during 
pregnancy for the majority of women (69%). But contrary to Cohen’s findings, if 
there was a change, symptoms typically improved during pregnancy (27%). For most 
patients (69%), assessed at un-specified times postpartum, there was no change in 
symptom intensity or frequency. However, approximately 31% experienced an 
increase in panic attacks postpartum. But again, at what point participants were 
assessed was not disclosed, nor was the absolute difference in intensity, frequency or 
quality of the panic during the puerperium.
In perhaps the largest study to date. Heron et al. (2004) prospectively tracked 
the prevalence and course of anxiety and depression from pregnancy to eight months 
postpartum in 8323 English women. The study, part of the Avon Longitudinal Study 
of Parents and Children (ALSPAC), was conducted via self-report questionnaire. 
Eighty-five percent of eligible women completed the survey at all test times. 
Depression was estimated based upon a score of >10 on the EPDS while anxiety was 
measured by the Crown-Crisp Experiential Index (CCEI) and indicated by a score of 
9 out of 16 points. Over the course of the study, antenatal and postnatal depression 
scores were moderately correlated at each test time. At 8 weeks postpartum only
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8.9% of the women exhibited depression and a third of those women were new cases. 
Additionally, 11% of the participants experienced depression only during pregnancy.
The prevalence of anxiety followed a pattern similar to that of depression, 
with correlations between antenatal and postnatal test times. Seventy-three percent of 
the total population reported no elevation in anxiety at any test time. However, at 
eight weeks postpartum, 8.1% reported elevated anxiety, of which approximately one 
fourth of the cases were new. In each instance antenatal psychological distress 
predicted postnatal distress.
Cognitive Sequelae o f  Pregnancy and Childbirth
Similar to the research on puerperal mood changes, the research on puerperal 
cognitive changes is plagued by methodological inconsistencies. With few 
exceptions, research in this area focuses upon subjective perceptions of memory 
impairment, usually during pregnancy and the immediate postpartum. Of the few 
studies utilizing objective measures, most have not measured concurrent hormone 
values and none have been able to substantiate what is commonly referred to as the 
“pregnancy brain drain” (Brett & Baxendale, 2001) or “maternal amnesia” (Brett & 
Baxendale, 2001) or the more technical term “benign encephalopathy of pregnancy” 
(Poser, Kassierer & Peyser, 1986).
Jarrahi-Zadeh et al. (1969) measured both subjective and objective cognitive 
and affective modalities in 86 women at various times during their last trimester and 
on the 3‘^‘^ day postpartum. These data were compared to data obtained from a group 
of 21 controls. The cognitive measures included Trails B and the Porteus Maze test. 
Both are tests of executive function and processing speed. Investigators found a
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significant difference between pregnant and non-pregnant controls and between 
postpartum and non-pregnant controls in Porteus Maze completion times and 
concluded that pregnant and postpartum women showed difficulties in concentration 
and planning compared to non-pregnant controls. The authors also noted a high 
prevalence of memory complaints amongst pregnant and postpartum women.
Brindle et al. (1991) found that pregnant women showed significant deficits in 
implicit but not explicit memory at 36 weeks compared to controls and reported a 
significantly higher subjective rating of impairment (59% vs. 11%). In 1993, Sharp 
and colleagues found similar results reporting that pregnant women were significantly 
impaired in incidental learning tasks, in word list recall, and word-stem completion 
when compared to controls. Sharp et al., (1993) Jarrehi-Zaddeh et al. (1969) and 
Brindle et al., (1991) also collected subjective reports of memory which revealed that 
81% of the pregnant women rated their memory as impaired compared to 16% of the 
control subjects.
Eidelmen, Hoffinan and Kaitz (1993), using a between subjects design, looked 
at memory deficits in 100 postpartum (days 1-3) women using the Weschler Logical 
Memory Test and the Weschler Visual Reproduction Test. They found that though 
significant memory deficits on both scales appeared on day one they resolved by day 
three. Interestingly, they tested fathers and found that they too showed impaired 
performance on the logical memory test but not on the visual reproduction test on day 
one, perhaps indicating that stress, exhaustion and all of the other overwhelming 
emotions that occur immediately after delivery may influence memory function.
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In a longitudinal case-control study assessing memory in 10 pregnant and 10 
non-pregnant women, Keenen et a l, (1998) found that pregnant women performed 
significantly worse during the third trimester as compared to controls in the paragraph 
recall task. The investigators noted no other differences in performance at either the 
first or second trimester or postpartum test times. Moreover, although the control 
group demonstrated significant practice effects across time, the performance of the 
pregnant women declined from the first until the third trimester, but improved 
somewhat during the second trimester. Recall scores improved between the third 
trimester and postpartum, returning to first trimester scores. The authors failed to note 
when postpartum testing occurred.
Deficits in selective attention were noted by de Groot, Adam and Homstra 
(2003) at 36 weeks pregnancy but had resolved by 32 weeks postpartum. The data 
demonstrated that pregnant women performed significantly worse than did controls 
and showed little to no priming effect. Crawley, Dennison and Carter (2003) found no 
differences between pregnant and non-pregnant controls in three cognitive modalities 
tested during the second and third trimesters as well as at six weeks and one year 
postpartum.
The measures used by these investigators included the Stroop test. Trails A 
and a self-designed text memory task. In addition to these objective measures, 
Crawley et al. (2003) assessed subject perception of memory impairment and found 
that a significant portion of the women tested reported a higher incidence of 
perceived memory deficit during the third trimester than compared to other trimesters, 
non-pregnant controls and postpartum. A second study by the same authors and
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published within this manuscript confirmed the subjective assessment results. The 
authors concluded that perceptions of cognitive impairment are likely subtle and may 
be associated with either depressed mood or the expectation of cognitive decline.
In perhaps the largest and most comprehensive work to date, Vanston (2005) 
measured cognitive performance and salivary hormones in 45 pregnant and 45 non­
pregnant age- and education-matched controls five times, three during pregnancy (12 
weeks, 24 weeks and 37 weeks) and on two occasions postpartum (six weeks and at 
the resumption of menstruation). The cognitive tests included the WAIS III Symbol 
Search (perceptual speed and accuracy) and Digit Symbol Coding (visual motor 
coordination), Purdue Pegboard (motor processing speed), California Verbal Learning 
Test (CVLT) (verbal memory), Silverman Eals Object Location Memory Task (object 
location memory). Listening Span (verbal working memory). Computation Span 
(arithmetic working memory) and the Shepard-Metzler Mental Rotation Test (MRT) 
(spatial working memory). The results indicated no significant differences between 
the pregnant and non-pregnant group on any of the tests for cognitive performance 
and no significant correlations between any of the hormones measured (progesterone, 
DHEAS, testosterone estrone, estriol and estradiol) and any of the cognitive tests. In 
fact the mean scores for the pregnant participants were higher, though not 
significantly, than the non-pregnant controls during pregnancy and at both postpartum 
test times.
Determining whether the lack of difference between groups in cognitive 
performance demonstrated that both groups were equally proficient or equally 
impaired is difficult inasmuch as only partial sections of various cognitive tests were
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administered. However, comparison of the mean score for the first three CVLT trials 
administered in this study, show that both groups scored above the normative mean 
with an average of 12 of 16 words retained per list. Likewise performance on the 
WAIS III symbol search and symbol coding suggested slightly above average 
performance with percentile ranking in 58-60* percentile.
These performance levels are consistent with the 14 years of education 
averaged by both groups and seem to challenge the anecdotally accepted perception 
of pregnancy-related cognitive deficits. However, methodological issues may have 
limited the interpretive validity of these findings. The inclusion of multiparous 
women in both the experimental and control groups was particularly troubling. If 
some aspect of pregnancy were to have deleterious effects on cognitive ability, it 
would be expected during the initial pregnancy when the mother has yet to adapt to 
either her new physiological status or to the psychosocial stressors associated with 
motherhood that await her.
The researcher did find that when the gender of the child was assessed in 
relation to performance, women who had been pregnant with males performed better 
on tasks of working memory (the listening and computation span tasks and the MRT), 
than did women who had been pregnant with females. Interestingly, the researcher 
was unable to identify significant differences in the androgenic hormone 
concentrations between the groups and the improved performance for the mothers of 
male children persisted through the postpartum test sessions, long after the effects of 
puerperal hormone changes would have dissipated.
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The discrepancy between the perceived deficits and what is empirically 
measurable has led some researchers to speculate that either mood disruptions 
commonly associated with pregnancy and postpartum underlie the perceived memory 
deficits (Crawley, Dennison & Carter, 2003) or that the perinatal memory deficits are 
just not salient (Crawley, 2002). Crawley (2002) found that only 2% of a sample of 
198 pregnant women spontaneously reported memory deficits. Based upon this 
finding, the author argued that perinatal memory deficits must not be that important. 
This is contrary to accounts by professional women who report impaired job 
performance during the latter stages of pregnancy and early postpartum and suggest 
that “the maternal amnesia syndrome is a reality that most mothers are too frightened 
to admit.. .and yet will talk of with obvious relief when they realize it is common, 
normal and temporary” (Baildam, 1991). It is also contrary to findings of Buckwalter 
et al. (1999) and Marrs (2006), where significant decrements in cognitive ability 
were identified across multiple domains and perceptions of cognitive ability tended to 
overestimate performance postpartum (Marrs, 2006).
Buckwalter and associates (1999) measured cognitive performance, mood and 
serum cortisol, progesterone DHEA, testosterone and estradiol concentrations using a 
standard battery of neuropsychological instruments in 19 women at 36 weeks of 
pregnancy and at one month postpartum. They found that pregnant women performed 
significantly worse on several aspects of the CVLT compared to normative data for 
women of similar age and education. They were particularly impaired on trials 1 and 
5, scoring in only the 6* and 5* percentiles respectively and showed significantly 
lower learning slopes ranking only in the 32"*^  percentile. Accordingly, subjects
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performed significantly worse in both the short and long free recall tasks (17* 
percentile for both) indicating potential problems in either retention and/or attention. 
They also performed more poorly on short and long cued recall tasks (21®‘ and 16* 
percentiles, respectively) and had a higher than normal number of intrusions.
In addition to the deficits listed above, the pregnant women showed 
significant impairment on Trails A, 2U‘ percentile, but not Trails B. They also 
performed more poorly on Trails B , the Stroop test, the Boston naming test and 
Digit Span Backward when pregnant(46*, 47*, 16* percentiles respectively), but the 
change in performance levels from pregnancy to postpartum failed to reach statistical 
significance.
The Marrs (2006) study measured cognitive performance using a complete 
battery of neurocognitive instruments in a cohort of healthy primi gravid women at 37 
weeks of pregnancy and within 10 days postpartum and found cognitive deficits 
across multiple domains when compared to age, gender and IQ-matched normative 
data. In tests of verbal memory as measured by performance on the CVLT-II, 
participants scored below the 20* percentile on the immediate and long term recall 
tasks in late pregnancy and early postpartum. Spatial memory, as measured by the 
Rey Complex Figure Test (CFT), was similarly impaired for many of the participants 
with mean rankings for recall during pregnancy in the 29* percentile and in the 4U‘ 
percentile postpartum.
To put these scores in perspective, the scores observed by Marrs (2006) and 
also by Buckwalter et al. (1999) were similar to or below scores that have been 
observed in patients with moderate closed head injuries (Bigler, Rosa, Schultz, Hall
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& Harris, 1989), obsessive compulsive disorder (Roh et al., 2005), schizotypy 
(Gooding & Braun, 2004), and schizophrenia (Penning, Mottes, Ricter-Levin, Treves 
& Levkovitz, 2002) and were marked by a consistent failure to organize information 
appropriately. Marrs also noted mild decrements in attention, cognitive and motor 
processing speed. Although psychiatric disturbances were present in over half of the 
participants in the Marrs study, they were not consistently related to poor cognitive 
performance. In fact depression levels were positively correlated to verbal memory. 
These findings were in stark contrast to the research by Crawley and associates 
(2002; 2003) who claimed that because women did not readily offer concerns 
regarding cognitive impairment that the impairment was not salient or some how 
associated with either mood changes or the expectation of cognitive impairment 
rather than impairment itself.
Summary
Puerperal Mental Illness
It is evident that much work is still needed. There is a relative paucity of data 
that addresses puerperal psychiatric co-morbidity and even fewer studies that have 
investigated the onset and longitudinal course of these symptoms. Of the reports that 
do exist, all suggest that co-morbidity is the rule rather than the exception, but when 
these symptoms emerge and how they progress is unknown.
While the onset of postpartum psychosis is generally accepted as being rapid 
and the prognosis is typically viewed as being good, the research is flawed relying 
heavily on retrospective data gleaned from hospital or psychiatric referral records. 
Women with previous psychiatric illnesses were included in the analyses and
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diagnostic or inclusion criteria frequently varied from project to project making 
delineation between the strictly pregnancy-related disorders from the re-emergence of 
pre-existing disorders difficult at best. Finally, the research presented thus far does 
not address the possibility that endocrine factors might contribute to or precipitate 
these disorders.
Puerperal Cognitive Changes
Puerperal cognitive changes are anecdotally accepted but have thus far largely 
eluded consistent empirical measurement. Some investigators have identified deficits 
(Brindle et al. 1991; Buckwalter et al., 1999; de Groot, Adam & Homstra, 2003; 
Jarrahi-Zadeh et al., 1969; Marrs, 2006; Sharp, 1993) and others have not (Crawley, 
Dennison & Carter, 2003; Vanston, 2005). The discrepant findings are likely related 
to methodological differences between studies. Although puerperal cognitive deficits 
are commonly attributed to either mood and/or hormone changes associated with 
pregnancy and postpartum, only three studies to date have investigated the relatedness 
of these three variables (Buckwalter et al., 1999; Marrs, 2006; Vanston, 2005) and 
none was able to provide strong support either for or against those associations.
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The Endocrinology of Pregnancy and Parturition 
The temporal association between psychiatric disturbances, cognitive 
impairment and pregnancy and postpartum is clear and generally supported by the 
literature. What has not been addressed is how pregnancy might precipitate these 
changes. Some have argued that psychosocial factors adversely influence puerperal 
mental health (Andrews-Fike, 1999). Others have suggested that changes in the 
reproductive hormones such as progesterone and estradiol trigger pre-existing 
conditions (Bloch et al., 1999; 2000; 2005). While neither possibility can be disputed 
fully, the research has yet to account for the substantially increased risk for mental 
illness during the two years surrounding pregnancy and birth in otherwise healthy 
women or for the temporal proximity to the onset of these disorders with the vast 
changes in puerperal internal chemistry.
If the argument is to be made that puerperal endocrine changes somehow 
mediate puerperal psychiatric and even cognitive disturbances then the basic 
components of the endocrine and central nervous systems must be shown to interact 
with each other. Provided below is an overview of basic endocrinology relative to 
pregnancy and parturition. Emphasis is placed upon the hormones potentially 
associated with puerperal psychiatric and cognitive disturbances and their respective 
interactions with central nervous system activity.
Basic Endocrinology
The endocrine system utilizes hormones as chemical messengers for 
communication between cells to regulate metabolism, reproduction and growth. 
Together with the central nervous system, the endocrine system is responsible for
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maintaining biological homeostasis. Hormones are synthesized in the endocrine 
glands and secreted into the circulatory system where they then may bind with 
receptors located exterior or interior to the cell from which they were released 
(autocrine regulation), with receptors on adjacent cells (paracrine regulation) or they 
may travel great distances to interact with other endocrine glands and target tissues 
(endocrine regulation). The synthesis of individual hormones is dependant upon 
enzyme availability and, thus, other peripheral tissues including adipose can 
synthesize great quantities of some hormones. Both the peripheral and central 
nervous systems also synthesize hormones and in some cases produce larger 
quantities than those found in circulation (Baulieu & Robel, 1990).
The hypothalamus integrates signals from both the external and internal 
environment to control the stimulation and inhibition of the trophic hormones 
released by the pituitary gland. Together the hypothalamus and pituitary and other 
adrenal glands form three endocrine circuits that regulate homeostasis, reproduction 
and growth: the hypothalamus-pituitary-adrenal (HPA) axis, the hypothalamus- 
pituitary-gonadal (HPG) and the hypothalamus-pituitary-thyroid (HPT) axis 
respectively. The HPG sometimes called the HPO (ovarian) when referring to female 
physiology regulates reproduction and will be the focus of this discussion. 
Non-Conception Cycles
The HPO circuit regulates the female menstrual cycle and supports pregnancy 
through a series of positive and negative feedback loops. The hypothalamus 
stimulates the pituitary's release of luteinizing hormone (LH) and follicle stimulating 
hormone (FSH) by releasing the gonadotropin-releasing hormone (GnRH). The
45
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
release of hypothalamic GnRH elicits the pituitary release of FSH and LH. As the 
follicle development proceeds, FSH and LH stimulate the release o f estradiol which 
ultimately inhibits continued FSH secretion. Concurrently, the release of estradiol 
causes the increase of LH, which in turn causes the release of more estradiol.
Estradiol concentrations are thought to peak immediately before ovulation. The peak 
in estradiol then signals the decline of GnRH and LH following ovulation on about 
day 15 of the cycle (Kaplan, Pesce & Kazmierczak, 2003).
After ovulation, during the luteal phase, estradiol concentrations wane prior to 
reaching a second and ultimately higher peak (Kaplan, Pesce & Kazmierczak ,2003; 
Schultheiss, Dargel & Rohde, 2003). During this time, progesterone concentrations 
increase until day 21-23 when the corpus luteum forms. If fertilization did not occur 
at ovulation, within a few days of luteal formation, luteolysis occurs, the 
endometrium sheds and menstruation begins.
Hormone Changes from  Conception and Pregnancy through Parturition
After ovulation and fertilization, the 2-8 cell embryo travels through the 
fallopian tubes into the uterine cavity and within 3-6 days following conception, the 
blastocycst now floating within the uterine cavity, unattached to the endometrium, 
begins secreting chorionic gonadotropin hormone (p-hCG) to hasten endometrial 
maturation and strengthen its ultimate implantation. After implantation, the embryo 
continues to secret P-hCG to maintain the biosynthetic capacity of corpus luteum and 
endometrium. The corpus luteum produces progesterone, 17a-hydroxyprogesterone, 
(17a-0H progesterone) estradiol and androstenedione for the first 6-8 weeks of 
pregnancy. Between weeks six and eight, a period called the fetal-placental shift.
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corpus luteum function declines and placental and eventually fetal steroidogenesis 
take over.
Pregnancy steroidogenesis is a multi-compartment process (Figure 1). 
Cholesterol in the form of low density lipoproteins (LDL) and very low density 
lipoproteins (VLDL) from maternal circulation binds with placental receptors that are 
up-regulated by estradiol and cross into the placenta (Carr 2001). The side chains of 
the cholesterol molecule are cleaved by the enzyme CYPl 1A1 and converted into 
pregnenolone. Progesterone is derived from pregnenolone as are maternal and 
placental androgens and estrogens, glucocorticoids and mineralcorticoids.
From conception until parturition maternal plasma progesterone 
concentrations, derived primarily from placental steroidogenesis (90%), increase from 
less than l-2ng/mL at conception to 100-300 ng/mL at term (Braunstein, 2003; Carr, 
2001). The role of progesterone during pregnancy is to suppress myométrial 
contractions (Challis & Lye, 1998) although researchers are finding that testosterone 
may also be involved in this process (Perusquia, Navarrete, Jasso-Kamel & Montano, 
2005). Maternal ovaries are mostly quiescent from approximately eight weeks of 
pregnancy until menstruation begins following parturition but provide a major source 
of 17a-0H progesterone through-out the pregnancy, nevertheless. Concentrations of 
this hormone increase from approximately 1-2 ng/mL at conception to approximately 
7 ng/mL at term (Mooney & Giudice, 2002).
The placenta is the major source of estradiol and estrone but because it lacks 
the CYP 17 enzymes 17a-0H and 17, 20 lyase, placental estrogens are derived from 
both maternal and fetal adrenal androgens rather than progesterone (Challis & Lye,
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1998). Research suggests that maternal DHEA and fetal DHEA contribute equally to 
the production of estradiol and estrone (Challis & Lye, 1998; Rainey, Rehman & 
Carr, 2004). Estradiol and estrone concentrations increase throughout gestation with 
values for both hormones ranging from .1-.4 ng/mL at conception to 6-30 ng/mL at 
term (Mooney & Guidice, 2002).
Estriol, synthesized by hepatic and peripheral conversion of the adrenal 
androgens, typically circulates at very low concentrations during non-conception 
cycles (Carr, 2001). During pregnancy however, the fetal adrenals produce vast 
quantities of DHEA and DHEAS, from which 90% of estriol is derived (Challis & 
Lye, 1998; Rainey, Rehman & Carr, 2004). Since most of the estriol is released into 
circulation, maternal estriol concentrations increase from less than . 1 ng/mL at 
conception to 10-30 ng/mL at term (Mooney & Giudice, 2002). Estriol, because of 
its fetal origins, is often used as a marker of fetal health and survival (Challis & Lye, 
1998).
With fetal contributions to DHEA/DHEAS production, maternal circulating 
concentrations of those hormones are thought to increase in first two trimesters but 
plateau in the third (Milewich et al., 1978; Soldin et al., 2005; Tagawa et al., 2004). 
As a fimction of the increased DHEA, maternal testosterone concentrations are 
believed to increase throughout pregnancy (Bamman, Coulam & Jiang, 1980). It is 
postulated that as the pregnancy progresses more fetal DHEA is converted to 
testosterone and to the estrogens, to support the growing fetus and ultimately initiate 
parturition and thus lower circulating concentrations of DHEA are noted at term 
(Gant, Hutchinson, Siiteri & MacDonald, 1971). The control of human parturition is
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complex process involving multiple hormones and systems and is beyond the scope 
of this discussion (for a review see Challis, Matthews, Gibb & Lye, 2000), however, 
there are data suggesting that the withdrawal of progesterone, together with a surge in 
estradiol, estriol and cortisol initiates uterine contractility in animal models (Olson, 
Mijovik & Sadowsky, 1995). In human parturition the data are inconclusive (Challis, 
Matthews, Gibb & Lye, 2000).
With the delivery of the fetus and placenta, maternal sources of steroid 
production are lost and circulating concentrations of most steroid hormones drop to 
pre-pregnancy values within 2-4 days of parturition (Illingworth & McNeilly, 1998). 
Resumption of menstruation and the cyclical production of progesterone and estradiol 
is reported to occur within two months in non-lactating women and can occur in some 
women while lactating, but typically does not resume until lactation ceases or is 
diminished significantly (Bolaji, Talion, Meehan, O’Dwyer & Fottrell, 1992; 
Illingworth & McNeilly, 1998).
Hormone Synthesis and Protein Binding
All steroids are synthesized from cholesterol (Figure 2). Cholesterol can be 
synthesized from acetate in many tissues including the skin and the intestines but the 
main site of production is in the liver (Niewoehner, 1998). During pregnancy, neither 
the fetus nor the placenta contains sufficient enzyme activity to convert acetate to 
cholesterol and thus require maternal cholesterol for steroid synthesis (Challis & Lye, 
1998). From cholesterol, the CYP 450 see (side chain cleavage) also denoted as the 
CYPl 1 A l, 20,22-desmolase and/or 20,22 lyase cleave either part or all the carbon 
side-chain converting the 27-carbon cholesterol skeleton into the 21-carbon
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pregnenelone (C21 pregnane group, progestins and corticosteroids). Total removal of 
the side chain results in the androstane (androgens) group of hormones (Cl 9).
Pregnenelone is the precursor hormone for the ovarian production of 
estrogens, the testicular production of androgens and the adrenal production of 
glucocorticoids, mineralcorticoids, androgens and estrogens. Ovarian and testicular 
production of steroids is subject to control by pituitary LH, whereas adrenal activity is 
modulated by pituitary adenocorticiotropin hormone (ACTH) (Niewoehner, 1998). 
Conversion from pregnenelone to the respective pregnane and androstane hormones 
is dependant upon the presence or absence of four enzymes that are widely distributed 
through-out the periphery and within the central nervous system. These enzymes 
include desomalase (lyases) which catalyze cholesterol side chain cleavage; 
hydroxylase, which adds a hydroxyl group to the steroid; hydroxysteroid 
dehydrogenase which catalyze reversible oxidation/reduction reactions and 
aromatase, catalyzes a series of reactions that ultimately remove Cl 9 methyl group 
necessary for the conversion of androgens to estrogens (Kaplan, Pesce & 
Kazmierczak, 2003).
Steroid hormones synthesized in the various endocrine glands and secreted 
into circulation are highly lipophilic and can be metabolized and eliminated easily in 
the liver. As such, steroids circulate tightly bound to carrier proteins such as sex 
hormone binding globulin (SHBG), corticosteroid binding globulin (CBG) and 
albumin or they travel as conjugated hormones (sulfates or glucuronide derivatives) 
(Faigle & Schenkel, 1998). Only a small percentage of steroid hormone circulates 
free and unbound to proteins. The fraction of circulating free hormone is estimated to
50
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
range from 1-8% of the total concentration of hormone (Faigle & Schenkel, 1998). It 
is argued that only free hormone or that which is not bound to protein, is capable of 
binding to the hormone receptor and initiating a cellular response and/or being 
metabolized into constituent compounds. Recent discovery of a transporter protein 
that facilitates the endocytosis of bound hormone through the cell membrane may 
challenge this notion in the future (Hammes et al., 2005).
Consideration of free/bound ratio is important nevertheless. Much of the 
research involving hormones is conducted using plasma/serum. Hormone 
concentrations from plasma/serum represent the total amount of hormone in 
circulation, including that which is protein bound (Virming, McGinnley & Rice,
1983). Both procedural and mathematical manipulations have allowed investigators to 
estimate the ratio of free to bound hormone, but with inconsistent results (Vermeulen, 
Verdonck & Kaufrnan, 1999). Although the free versus bound ratio is tightly 
controlled, there are instances where the equilibrium is altered and/or difficult to 
assess such as in some disease states and potentially during pregnancy (Vermeulen, 
Verdonck & Kaufrnan, 1999).
Binding protein concentrations and functionality are suspected of changing 
significantly during pregnancy and presumably again following parturition 
(Vermeulen, Verdonck & Kaufinan, 1999; Margarson & Soni, 1998). These changes, 
if empirically supported (there is a woeful paucity of research of these factors in 
pregnant/postpartum women), would affect the ratio of free to bound hormone and 
could alter the interpretative validity of hormone data depending upon the method of 
measurement.
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To more accurately reflect the free fraction of steroid hormone and in fact to 
provide a less invasive means by which to measure steroid hormone values, assays 
were developed that quantify hormone concentration in saliva. Inasmuch as most 
steroids are small neutral molecules, they freely pass through the membranes of the 
salivary gland via passive diffusion and are not suspected of being affected by flow- 
rate. However, some reports indicate that progesterone values increase as a function 
of salivary flow-rate (Lequin, van den Boogaard, Vermeulen & Danhof, 1986). More 
polar molecules such as DHEAS move through the tight junctions of acinar cells into 
the oral cavity via ultrafiltration, a process that is flow-rate dependent (Vinning, 
McGinley & Rice, 1983). Salivary stimulation decreases DHEAS concentrations 
measured from saliva (Vinning, McGinley & Rice, 1983). Thus, care must be taken to 
minimize the potentially confounding variable of salivary stimulation when 
investigating this and other hormones, a factor minimally addressed in the literature.
Measurement of steroid hormones in saliva provides an accurate measure of 
the free fraction of the hormone, when proper controls are employed. Correlations 
between free and bound hormone are significant and range from .5- .9 depending 
upon methodology, the lab and the hormone being measured, but are not absolute 
(Hoffman, 2001). This may suggest that the equilibrium between free and bound 
hormone is more dynamic than currently accounted for and/or may reflect the lack of 
inter-laboratory procedural standardization.
Neuroactive Steroids and Neurosteroids
If an argument that peripheral changes in endocrine parameters due to 
pregnancy affect psychiatric well being is to be made, then peripherally synthesized
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steroid hormones must have access to and bind with central nervous system (CNS) 
receptors and elicit some cellular response in regions not associated directly with 
reproduction. Indeed, the highly lipophilic steroid hormones cross the blood brain 
barrier (BBB) easily and freely where they bind to both membrane and nuclear 
receptors dispersed throughout the brain. It is well established that the brain is both a 
major target for and source of steroid hormones (for a review see Baulieu, 1998).
Researchers have thus far identified progesterone, androgen and estrogen 
receptors in the hippocampus, amygdala, cerebellum, basal forebrain, locus ceruleus, 
raphe nucleus, hypothalamus and pituitary in the both central gray and glial cells 
(Stomati, Genzzani, Petraglia & Genzzani, 1998). Steroid hormone receptors have 
also been located in and shown to exert significant trophic affects when bound to their 
cognate ligand in peripheral myelinated nerve tissue (Baulieu, 1999). Accordingly, 
pharmacological and genetic manipulation of circulating hormone concentrations 
and/or central hormone binding capacities demonstrates significant hormone/behavior 
effects, particularly in rodent social behavior and learning (Birzniece et al., 2006; 
Chestler & Juraska, 2000; Frye & Sturgis, 1998; Johansen, Birzniece, Lindhlad,
Olson & Backstrom, 2002) but also in human models (Hampson, 1990; Kampen & 
Sherwin, 1994; Maki, Zonderman & Resnick, 2001).
In addition to the neuroactive actions of peripherally synthesized steroids, 
many steroids are synthesized in the brain itself and act locally within the brain or 
efflux into circulation to modulate peripheral events (Asaba et al., 2000;
Steckelbroeck et al., 2004). The concept of neurosteroids, postulated by Baulieu and 
colleagues in the early eighties, was developed in recognition of the fact that brain
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concentrations of some steroids, such as DHEA would remain elevated weeks after 
peripheral sources were removed. Researchers have since identified most of the 
enzymes required for de novo steroidogenesis within the central nervous system 
suggesting that the brain is a major source of steroid production (Martini, Melcangi & 
Maggi, 1993; Steckelbroek et al., 2004).
Neurosteroids, Neurotransmitters and Behavior
The effects of steroid hormones are mediated through a variety of extra­
cellular and intracellular mechanisms. Original theories of endocrine mediated 
behavior change stressed the long term changes in cellular function generated by 
transcription. The recognition of rapid and quickly dissipating cellular change led to 
the discovery of extra-cellular steroid receptors. Finally, recent investigations have 
identified “ligand-independent” steroid receptor and intra-cellular signaling pathway 
activation whereby environmental factors stimulate receptor mediated protein 
transcription, up-regulating receptor expression in the absence of the cognate ligand 
binding (Braustein, 2004).
Because of their lipid status, unbound hormones easily diffuse through the cell 
membrane where it binds to heat shock proteins (Hsp) and is shuttled to the cell 
nucleus. After dissociating from the Hsp, the hormone binds with a nuclear receptor. 
The hormone-receptor complex then enters the nucleus, binds to hormone response 
elements on the DNA, activates or suppresses transcription factors and triggers RNA 
dependent protein synthesis to regulate changes in cell structure and function. 
Transcriptional effects develop over an extended course and as a consequence, the
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hormone/behavior relationship was thought to involve only long term changes in cell 
activity (Birzniece, 2006).
Among the steroid hormones estradiol is a particularly potent transcriptional 
regulator controlling the activity of 438 genes with 132 genes up-regulated in its 
presence and 306 down-regulated (Frasor et al., 2003). Estradiol, through its two 
receptors the ERa and ERP, with area specific distribution in the CNS (ERa: 
hypothalamus and amygdala; ERp: hippocampus, entorhinal cortex and thalamus) is 
thought to influence autonomic activity, reproduction (ERa) and memory and motor 
functions (ERP). Indeed rodent studies have demonstrated that estradiol 
administration induces female sexual receptivity through ERa (for a review see 
Osterlund & Hurd, 2001) but also hippocampal synaptogenesis through ERP 
(McEwen, et al., 2001) and learning (Chestler & Juraska, 2000; Frye & Sturgis, 1998; 
Johansen, Birzniece, Lindhlad, Olson & Backstrom, 2002; Shors & Leuner ,2003). 
Estradiol’s role in rodent learning involves, the enhancement of long term 
potentiation via n-methyl-d-aspartate (NMDA) binding (Shors, Falduto & Leuner, 
2004; Smith & McMahon, 2005) and/or aceytltransferase induction (McEwen, 1998). 
Similarly, studies in postmenopausal women show estrogen administration improves 
verbal memory and well-being (de Noaves-Suarez et al., 2001; Maki, Zonderman & 
Resnick, 2001; Hogervorst et al., 1999). In pre-menopausal women estradiol 
concentrations during the follicular phase of the cycle correlate with better verbal 
memory but poor spatial memory (Hampson, 1990).
Of note, the two estrogen receptors express similar binding domains but 
distinctly different activation patterns with ERP requiring 100-1000 greater
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concentrations of estradiol to activate transcription than ERa (Osterlund & Hurd, 
2001). Researchers propose that ERp binding suppresses ERa expression and 
transcriptional activation. Behaviorally, the relationship between receptor expression 
and binding has not been investigated, but poses some interesting possibilities 
regarding estradiol’s role in emotional learning. Continued activation of the ERa and 
the ensuing sexual receptivity ultimately activates the ERp in areas where learning is 
thought to occur and ultimately inhibits ERa mediated sexual receptivity. 
Pharmacological antagonism of ERa also blocks receptivity (Osterlund & Hurd, 
2001). In states of elevated estradiol such as pregnancy, the balance between these 
two receptors could have evolved to align reproductive proclivities with fertility 
(ovulation) and to limit reproductive behavior once pregnant with the cognitive 
consequences simply an artifact of this process.
In recent years ligand-dependent extra-cellular receptors that mediate rapid, 
short-term responses have been identified and are closely linked with mood states. 
Most notably are those associated with the y-aminobutryic acid (GABA) receptor 
complex, the NMDA glutamate receptors and dopamine (DA) receptors. 
Pregnenelone, pregnenelone sulfate, progesterone, allopregnanolone, DHEA and 
DHEAS all bind with and exert differential influence over the GABAa receptor 
complex (Charalampopoulos et al,. 2005; Gullinello & Smith, 2003; Sousa & Ticku, 
1997; Valle et al., 1997). Progesterone, estradiol, DHEA and DHEAS modulate 
glutamate and DA and estradiol and DHEA modulate serotonin (5HT) (Birzneice et 
al., 2006; Cabrera et al., 2002; Cabrera & Navarro ,1996; Charalampopoulos et al., 
2005; Compagnone & Mellon, 1998; Fink et al., 1999; Hou et al., 2003).
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Regulation of G ABA and glutamate activity because of their control over 
neuronal excitability may represent the most pervasive examples of the relationship 
between steroid hormones and brain function and subsequent changes in behavior. 
The GABAa receptor in particular exhibits distinctive binding/activity patterns with 
each of the aforementioned hormones based upon the chronicity of exposure and 
perhaps also the CNS location of the G ABA cells (Birzneiece et al., 2006). The 
GABAa receptor complex is composed of 18 subunits, currently divided into five 
functionally distinct families (Birzneiece et al., 2006). The conformation of these 
subunits alters the behavior of the G ABA cell by rendering the receptors more or less 
susceptible to endogenous G ABA and other endogenous or synthetic compounds 
(Birzniece 2006; Fuji & Mellon, 2001; Hsu & Smith, 2002; Gullinello & Smith,
2003).
Although multiple hormones bind to and exert influence with the GABAa 
receptors, the influence of progesterone, DHEAS and to a lesser degree DHEA are 
the most clearly elucidated and will be the focus of the discussion. Progesterone, 
either alone or via its metabolite allopregnenelone, like the benzodiazepines (BDZ) 
and alcohol, is a potent sedative-hypnotic and anxiolytic. Similar to BDZ and alcohol, 
acute administration of progesterone increases GABA chloride (CI-) channel open 
time to produce sedation, even anesthesia and respiratory failure (Arafat et al., 1988; 
Concas et al., 1998; Selye, 1941). These effects are mediated by binding with the a-1 
subunit (Gulinello & Smith, 2003; Gulinello, Gong & Smith, 2001). The anxiolytic 
effects of these compounds are believed to be mediated by a-2, a-3, a-4 subunits 
(Gulinello & Smith, 2003; Gulinello, Gong & Smith, 2001). Chronic exposure to
57
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
progesterone, its metabolites, BDZ or alcohol up-regulates the activity of a-4 and a-6 
subunits. When the a-4 and a-6 subunits are expressed in greater numbers than a-1 
through a-3 subunits and in combination with other subunits, BDZ and progesterone 
do not bind as effectively to the receptor and GABAa Cl- channel open time is 
reduced significantly (Concas et al., 1998; Costa, Spence, Smith & French-Mullen, 
1995). The net behavioral effect is CNS hyper-excitability and anxiogenesis.
Benzodiazepine research suggests that tolerance to chronic administration 
develops in phases with the gradual change in GABAa receptor confirmation and 
binding preferences. The sedative properties of the drug are lost initially (a-1) 
followed by the loss of anticonvulsant and anxiolytic subunits (a-2, a-3, a-4). 
Concomitantly, a-amino-3-hydroxy-5-methyl-4-isoazole proprionic acid (AMPA) 
receptor density increases and glutaminergic transmission is enhanced, particularly in 
the hippocampus and the frontal and occipital cortices (Izzo et al., 2000). It is 
reasonable to suspect that progesterone tolerance in pregnancy develops similarly.
Thus, based upon this research, chronic exposure to progesterone and its 
metabolites, as occurs during pregnancy would be expected elicit anxiety via 
conformational changes in the receptor, reduced GABA inhibition (Concas et al., 
1998; Costa et al., 1995; Gulinello & Smith, 2003; Gulinello, Gong & Smith, 2001) 
and enhanced glutaminergic transmission (Cabrera & Bregonzia, 1995; Cabrera & 
Navaro, 1996; Cyr, Ghribi, DiPaolo, 2000). Moreover, as is the case with BDZ and 
alcohol withdrawal, the cessation of progesterone exposure following parturition, 
should precipitate some degree of mood instability characterized by agitation and 
anxiety. The behavioral manifestations of these changes alone (absent other major
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endocrine mediated responses) could represent the commonly reported and transient 
postpartum mood lability. As will be discussed in the subsequent sections, there is 
some research to support this hypothesis.
However, pregnancy is marked by significant endocrine changes that when 
combined seem to exert disproportionate influence on the GABAergic and 
glutaminergic systems. Briefly, Marrs (2006) reported a marked increase in 
postpartum concentrations of DHEAS that was associated with increased psychiatric 
distress. DHEAS is a potent GABAa antagonist blocking GABA transmission with 
similar efficacy and from a proximally located receptor as that of picrotoxin, a potent 
convulsant (Sousa & Ticku, 1998). DHEAS also influences NMDA mediated release 
of norepinephrine (NE) and DA (Charalampopoulos et al., 2005). Against the 
backdrop of the expected rise and fall of progesterone and estradiol, large changes in 
DHEAS would fundamentally alter CNS excitability, particularly in the immediate 
puerperium when neither the compensatory enzymatic changes responsible for 
clearing the excess DHEAS will have occurred nor will the pre-progesterone 
exposure mediated conformational changes in the GABAa receptor have returned.
Finally, it appears that the expression of both genomic progesterone (PR) and 
estradiol and probably also androgen receptors (AR) can be controlled independently 
of cognate ligand binding (for a review see Braunstein, 2004). Environmental stimuli, 
especially those involved with sexual and parenting behaviors, activate a number of 
intracellular signaling pathways including protein kinases A, G and MAPK absent 
hormone-receptor binding. Dopamine, insulin and other growth factors have been 
investigated thus far and have been shown to up-regulate and mediate steroid
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hormone receptor regulated transcription in the absence of the cognate ligand without 
inducing the associated hormone synthesis. The D1/D5 DA receptor agonists, in 
particular, can substitute for progesterone in the facilitation sexual behavior in mice. 
Other examples include NE induced neural PR and ER up-regulation and muscarinic 
mediated ER up-regulation (Braunstein, 2004).
Puerperal Hormones and Psychiatric Symptoms
Based upon the supra-physiological concentrations of progesterone and 
estradiol during pregnancy, the chronicity of exposure to these hormones and their 
respective actions on individual neurotransmitter systems, but particularly 
progesterone’s actions on GABAa receptor, one might expect signs of tolerance 
towards the end of pregnancy, with withdrawal symptoms evident in the early 
puerperium. Based upon models of addiction and withdrawal to synthetic compounds 
that elicit similar changes in neurotransmitter and receptor availability, suggest these 
symptoms would likely be marked by agitation and/or anxiety type symptoms. 
Unfortunately, over the last 30 years relatively few investigators have explored the 
connection between these reproductive hormones and psychiatric disturbances and 
most have focused upon the measurement of depressive symptoms.
The results are equivocal but suggest a relationship between the magnitude of 
change from pre- to postpartum concentrations of progesterone, estradiol and/or 
estriol and the ambiguously defined baby blues. As was the case with the previously 
cited non-endocrine investigations of postpartum mood, methodological differences 
abound making direct comparison between individual projects difficult.
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In one of the earliest attempts to connect reproductive hormones and mood, 
Nott et al. (1976) measured serum estradiol and progesterone in 27 primiparous and 
multiparous women three times at weekly intervals from 2-6 weeks pre-delivery and 
intermittently through 5-10 post-delivery. Their results indicated that higher pre­
delivery estradiol was correlated with increased antenatal irritability and lower post­
delivery estradiol was correlated with increased postpartum sleep disturbances. The 
magnitude of change from pre-delivery progesterone to post-delivery progesterone 
correlated with depression at 10 days postpartum but was negatively correlated with 
postnatal sleep disturbances.
O'Hara, Schechle, Lewis and Wright, (1991) and Metz et al. (1983), measured 
plasma progesterone and estrogen concentrations at various times both pre- and 
postnatally. O'Hara and colleagues found a significant positive relationship between 
antepartum free and total estriol levels and postpartum blues. Metz, et al. found no 
direct correlation between ovarian hormones and mood, but did show that the 
magnitude of fall in hormones was positively correlated with a2-adrenoreceptor 
binding capacity, which was in turn correlated with measures of postpartum mood 
lability. The a-2 adrenoreceptors are inhibitory autoreceptors located on NE cells in 
the locus ceruleus. When bound to the ligand, a-2 limits the cell firing and 
neurotransmitter release. Increased binding capacity of these receptors would indicate 
a compensatory response by the cell to limit neurotransmitter release. The association 
observed by Metz et al. (1983) between increased a-2 binding capacity and hormone 
magnitude of change and mood lability suggests a connection between puerperal 
hormones and NE production.
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Kuevi, et al. (1983) reported a trend towards higher follicle stimulating 
hormone and lower estrogen and progesterone concentrations in women with the 
blues, particularly those women who showed a consistent state of 'blues' versus 
women who experienced brief periods of mood lability. Gard, Handley, Parsons and 
Waldron, (1986) reported a higher incidence of postpartum blues with the birth of a 
male child and/or a previous history of gynecological disorder.
The Cardiff study, (Harris et al. 1994) assessed salivary concentrations of 
progesterone and cortisol from 120 women over a period from two weeks pre­
delivery through four weeks post-delivery. With almost 10,000 salivary samples 
collected, Harris and colleagues demonstrated a positive relationship in the magnitude 
of change between antenatal and postnatal progesterone and depression scores 
measured by EPDS, the Stein Scale for Maternity Blues and the Beck Depression 
Inventory. They found no relationship between cortisol and depression. Nappi et al. 
(2001) identified a significant negative correlation between serum allopregnanolone 
(progesterone metabolite) and blues when measured three days postpartum but was 
unable to identify an association between progesterone and blues.
The research presented thus far suggests that there is some relationship 
between hormone change and baby blues. Which hormone contributes to which type 
of symptom is unclear because of the lack of specificity in the psychological 
measures that were administered as well as differences in test time and in hormone 
collection method. A more informative approach to characterizing the nature of 
puerperal psychiatric symptoms and subsequent associations with hormones would 
include assessment of a broader range of symptoms and a larger complement of
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hormones. This was accomplished by Buckwalter and associates (1999) who 
measured serum progesterone, estradiol, DHEA and testosterone concentrations at 36 
weeks of pregnancy (n=19) and at 1-2 months postpartum (n=15). They found that 
higher DHEA levels during pregnancy were correlated with better mood scores while 
elevated postpartum testosterone was associated with negative mood. DHEA, unlike 
DHEAS exerts only nominal influence over the GABAergic cells but is reported to 
attenuate glucocorticoid induced glutamate cytotoxicity in rodent models (Herbert, 
1998) suggesting that the balance between these DHEA and DHEAS is a factor in 
CNS excitability.
Hohlagswandter et al., (2001) also found elevated serum testosterone levels to 
be significantly associated with pre- and postpartum depression and with pre- and 
postpartum anger. More recently, Paoletti et al. (2006) measured serum DHEAS and 
cortisol levels in 14 healthy pregnant women across two menstrual cycles prior to 
pregnancy and throughout the pregnancy and compared those data to psychometric 
data from the SCL-90. They were unable to find any difference between non-pregnant 
and pregnant SCL-90 scores and thus concluded that puerperal mental illness does not 
exist,
Finally, Marrs (2006) measured salivary progesterone, DHEAS, testosterone, 
estrone, estradiol and estriol at 37 weeks pregnancy (n=32) and within 10 days 
postpartum (n-28) in a cohort of healthy primigravid women and found measurable 
psychiatric disturbances associated with androgenic steroid concentrations. Elevated 
prenatal DHEAS correlated positively with prenatal paranoia and psychoticism while 
prenatal testosterone correlated negatively with prenatal phohia, psychoticism.
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somatization and the GSI. Diminished prenatal testosterone also heralded the onset 
and exacerbation of postnatal symptoms and was correlated with increased postnatal 
anxiety, hostility, psychoticism, somatization, obsessive compulsive behavior, 
interpersonal sensitivity, depression and the GSI. Following parturition both DHEAS 
concentrations and the frequency and severity of psychiatric disturbances increased. 
Postnatal DHEAS correlated positively with postnatal anxiety, phobia, paranoia, 
psychoticism, somatization and the GSI. Progesterone, estrone and estriol were not 
associated with psychiatric disturbances and associations with estradiol were limited 
and inconsistent.
Both the Marrs and the Buckwalter findings are consistent with the putative 
neuromodulatory actions of DHEA and DHEAS. Because DHEA is more consistently 
associated with neuroprotection and stress reduction, positive correlations between 
DHEA and improved mood are expected. Conversely, the actions DHEAS on 
GABAa would predict CNS excitability producing a positive correlation between 
elevated DHEAS and symptoms of anxiety. The apparent disparity in testosterone 
findings are likely related to differences in matrix, serum versus saliva and the 
measurement of bound versus free hormone. While elevated total hormone 
concentrations may indeed be related to increased symptomatology, as was suggested 
by Buckwalter et al. (1999) and Hohlagswandter et al., (2001) the diminishment of 
free or bioactive testosterone observed by Marrs (2006), may be also be linked to 
psychiatric disturbances. These findings may suggest that changes in hormone 
binding rather than absolute circulating concentrations underlie these correlations.
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The pattern of high DHEAS and low testosterone, combined with postpartal 
increase in DHEAS values observed in the Marrs study could also point to altered 
patterns of hormone metabolism wherein prenatal testosterone is simply an early 
marker of the ensuing changes. Serum DHEAS values, investigated in relation to the 
onset of labor, are reported to increase in the first two trimesters, remain stable in the 
third and return to non-pregnant values following parturition (Milewich et al., 1978; 
Soldin et al., 2005; Tagawa et al., 2004). In the Marrs study, salivary DHEAS 
concentrations were high in late pregnancy and increased by an average of 34% 
following parturition, with those participants exhibiting the largest increases, also 
suffering the most severe psychiatric disturbances. Moreover, four participants of the 
28 who completed the testing, exceeded and many others approached the laboratory 
standards indicative adrenal pathology (>2500pg/mL) that typically merit further 
investigation.
With elevated DHEAS concentrations in general, testosterone concentrations 
are typically elevated as well. During pregnancy in particular, testosterone is 
presumed to increase significantly but fall to pre-pregnancy concentrations following 
parturition (Bammann, Coulam & Jiang, 1980). This appeared not to be the case in 
the Marrs study. Both pregnancy and postpartum testosterone concentrations were 
very low when compared to healthy non-pregnant women and were found to increase 
rather than decrease in five women following parturition, although as a group 
testosterone concentrations fell by 49%. In addition, low late pregnancy testosterone 
concentrations were associated with a myriad of psychiatric symptoms during
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pregnancy but more importantly heralded the onset and exacerbation of postpartal 
psychiatric disturbances.
This hormone pattern, high DHEAS and low testosterone, is unique insofar as 
it not only conflicts with the published trends expected for these hormones when 
measured in serum, but because it was so strongly associated with psychiatric 
disturbance. Had these values been observed without consistent association to 
psychiatric disturbances, one might question their accuracy, but when combined with 
the symptomatology, they become evidence for a putative endocrine role in 
postpartum psychiatric dysfunction. Thus, low late pregnancy testosterone combined 
with elevated pre- and postpartum DHEAS concentrations not only represented an 
atypical pattern in hormone metabolism but were linked with significant 
psychopathology. When these data are combined with those of Buckwalter et al. 
(1999) and Hohlagswandter et al. (2001), adrenal androgen regulation becomes a key 
factor in peripartal mental health.
Puerperal Hormones and Cognition
In as much as the vast hormone changes associated with pregnancy and 
parturition may elicit psychiatric distress, they may also alter cognitive function. 
Indeed, from the research presented earlier, pregnancy related cognitive impairment is 
widely expected and anecdotally accepted. Unfortunately, consistent empirical 
measurement and characterization of pregnancy related cognitive decline has thus far 
eluded investigators. Moreover, only three studies to date have actually measured 
puerperal hormones in conjunction with cognitive performance. The Vanston (2006)
66
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
study, which was discussed previously, found no evidence of impairment and no 
association between cognitive performance and hormones.
Both Buckwalter et al. (1999) and Marrs (2006) identified significant 
impairment in both pregnant and postpartum women across multiple cognitive 
domains but were unable to show consistent trends between individual hormones and 
specific cognitive modalities. However, the Marrs study did demonstrate a trend 
between higher hormone values in general and poorer cognitive performance overall. 
With so few investigations measuring puerperal hormones in conjunction with 
cognitive assessment, it is difficult to entirely discount the possibility of a hormone to 
cognition relationship, especially given the ample animal research that clearly 
demonstrates associations between hormones and learning (Chestler & Juraska, 2000; 
Frye & Sturgis, 1998; Johansen, Birzniece, Lindblad, Olson & Backstrom, 2002; 
Shors & Leuner 2003).
Summary
The general presumption about reproductive hormones is that they increase 
exponentially throughout the pregnancy and decrease rapidly following parturition. 
Accordingly, most postpartum research is based upon and supports this hypothesis 
(Dame, McGarigle & Lachelin, 1987; Harris, et al., 1993; Harris et al., 1994) 
including work by Marrs. The Marrs study found that progesterone estrone, estradiol 
and estriol were elevated in late pregnancy and generally declined following 
parturition. Estrone and estradiol concentrations increased in a few participants (one 
and three respectively) following parturition. Inasmuch as these changes are 
considered normal and have been associated, at least inconsistently, with the baby
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blues some argue that pregnancy hormone changes are not directly responsible for the 
more serious symptoms of puerperal mental illness, but merely provide the backdrop 
for the re-emergence of a pre-existing condition and/or trigger an aberrant 
psychosocial response (Bloch et a l, 2000). While it cannot be disputed that puerperal 
hormone changes might trigger the re-emergence of pre-existing conditions and might 
also elicit an ill-adapted stress response in some women, this hypothesis cannot 
explain the onset of serious psychiatric disturbances in previously healthy women 
immediately coincident with parturition.
A more accurate hypothesis, particularly in light of the unique pattern in 
adrenal androgen values reported by Marrs (2006), would be that the large changes in 
reproductive hormones either unmask a pre-existing endocrine condition and/or 
trigger an aberrant compensatory reaction in steroidogenesis. In either case, 
psychiatric symptoms might simply represent the outward manifestation of a 
disrupted internal chemistry. Of the questions that need to be addressed is whether 
either of those reactions is physiologically possible. Inasmuch as this pattern of 
circulating adrenal androgens has not been identified in other clinical disorders and 
adrenal androgens in general have not been considered to be a major determinant of 
pregnancy related psychiatric disturbances, a review of the literature pertaining to 
both the biological and pharmacological actions of these hormones is presented.
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Biological and Pharmacological Actions of DHEAS and Testosterone 
DHEAS and Testosterone Synthesis in Women
DHEA and its sulfated ester DHEAS, are synthesized primarily in the zona 
reticularis of the adrenal gland and, to a lesser extent, from ovarian granulosa and 
theca cells (Bonser et al., 2000; Burger, 2002). DHEAS is the most abundant adrenal 
androgen in human circulation (Hammer, et ah, Rainey et al. 2002; Roberts, 1999) 
followed by cortisol and DHEA (Herbert, 1998). DHEA/DHEAS concentrations are 
elevated at birth, surge during adrenarche and reach their peak in early adulthood, 
declining substantially through senescence (Kroboth, 1999).
DHEA is the precursor for other adrenal androgens such as androstenedione 
and testosterone and after aromatization estrone and estradiol (Hammer et ah, 2005; 
Roberts, 1999). During pregnancy, fetal adrenals produce vast quantities of DHEAS, 
from which estriol the most abundant estrogen of pregnancy, is derived (Challis & 
Lye, 1998). DHEA synthesized in the adrenal gland, is rapidly inactivated via 
conversion to its sulfate ester DHEAS (Bird et ah, 1978; Burger, 2002; Hammer et 
ah, 2005; Roberts, 1999).
Conversion of DHEA to DHEAS is dependant upon cytosolic enzymes called 
sulfotransferases, specifically identified as SULT2A1 (Hammer et ah, 2005; Mensah- 
Nyagan et ah, 1999). SULT2A1 are expressed in the adrenal glands, the intestines 
and the liver (Hammer et al,. 2005). Circulating DHEAS is converted back into 
DHEA via the microsomal sulfatase (STS) (Hammer et ah, 2005; Mensah-Nyagan et 
ah 1999). The sulfatase enzymes are widely distributed throughout the body and 
have been found in the testes, ovaries, adrenals, prostate, skin, central nervous system
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(CNS), fetal lungs, placenta, synovial fluid, endometrial tissue, peripheral blood 
lymphocytes, aorta, bone, kidneys and in breast cancer cells (Reed et a l, 2005). 
Interestingly, STS activity is negligible in the adult liver (Hammer et al., 2005).
Conversion of DHEA to DHEAS and back varies across the life span, disease 
states and reproductive states (Kroboth et a l, 1999; Salek, Bigos &Kroboth, 2002). 
Concomitant changes in androgen and estrogen production often follow suit. In non­
pregnant women, approximately 64% of DHEAS is converted to the biologically 
active DHEA whereas only 13% DHEA is converted to DHEAS (Kroboth et a l, 
1999; Salek, Bigos & Kroboth, 2002). During pregnancy DHEAS production is 
significantly up-regulated with both maternal and fetal adrenal glands contributing 
substantially to its synthesis (Challis & Lye, 1998). The rates of 
DHEA>DHEAS>DHEA conversion during pregnancy are not known, however, 
conversion of DHEAS to DHEA during pregnancy is facilitated by the abundant 
expression of placental STS (Dibbelt & Kuss, 1991).
The fraction of testosterone produced by placental conversion of DHEAS 
relative to maternal input is unknown. However, data based upon ratios of maternal 
circulating levels to umbilical cord levels indicate that placental testosterone (Troisi 
et al., 2003) and fetal adrenal contributions (Dharia et al., 2004) are minimal with 
most aromatased to the estrogens. Accordingly, fetal and placental conversion of 
DHEAS are responsible for 50%, 50% and 90% of estrone, estradiol and estriol 
respectively (Challis & Lye, 1998) with remaining portions synthesized in maternal 
adrenal and peripheral tissue. According to Kroboth et al. 1999, the DHEA/ DHEAS
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pathway accounts for up to 100% of active estrogens in menopausal women and 75% 
of estrogen synthesis in non-pregnant, pre-menopausal women.
Pharmacodynamics o f  DHEA and DHEAS
In addition to peripheral synthesis, DHEA and DHEAS are synthesized in the 
brain de novo and interact with each of the neurotransmitters (Baulieu, 1998).
DHEAS is both a GABAa antagonist and dopamine DA agonist (Hansen, Fjalland & 
Jackson 1999). Like many sulfated steroids, DHEAS inhibits GABAa chloride 
channels (Mehta & Ticku 2001). DHEAS is also involved in both NMDA associated 
release of NE and DA, as well as tyrosine hydroxylase induction, particularly with 
long-term administration (Charalampopoulos et al., 2005).
The research on DHEA is less clear but suggests that DHEA has some 
capacity to inhibit GABAa, and enhance NMDA mediated NE release, if only acutely 
(Charalampopoulos, et ah, 2005). This has lead researchers to postulate that DHEA 
requires conversion to DHEAS to exert its full neuromodulatory action 
(Charalampopoulous, et ah, 2005). Other research suggests that DHEA and DHEAS 
differentially modulate GABAa according to brain region and time course of 
administration (Mehta & Ticku, 2001; Hanson, Fjalland & Jackson, 1999). 
Accordingly, DHEAS but not DHEA binds to GABAa site proximal to the picrotoxin 
binding site (Sousa & Ticku, 1997) whereas, DHEA, reportedly attenuates 
glucocorticoid and glutamate cytotoxicity (Herbert, 1998). Lu and colleagues (2003) 
reported that DHEA works synergistically with testosterone to prevent neuronal and 
cell death in rodent models by up-regulating ARs. The putative mechanism of 
neuroprotection is the testosterone-AR complex activation of the mitogen-activated
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protein kinase / extracellular signal regulated kinase (MAPK/ERK) pathway 
(Nguyen, Yao & Pike, 2005). The MAPK/ERK is a signal transduction pathway 
responsible for cell growth and differentiation, inflammation and apoptosis. 
Conversely, DHEAS is not involved in AR receptor regulation (Mo, Lu & Simon,
2004).
If DHEA, but not DHEAS, offers neuroprotection against cytotoxicity and 
DHEAS but not DHEA chronically antagonizes the GABAa receptor, then the 
equilibrium between the two hormones becomes clinically relevant in both 
physiological and psychological disease states. Changes in enzyme availability, 
occurring during pregnancy, following parturition and perhaps even as breastfeeding 
begins or ceases, would necessarily alter the hormonal milieu and by association, 
central nervous system excitability. Although relevant evidence in the puerperium is 
limited, changes in the circulating concentrations of either DHEA or DHEAS 
observed in other endocrine pathologies reveal that both abnormally low and 
abnormally high circulating concentrations adversely impact both psychological and 
physiological well-being.
Adrenal Androgens and Mental Health
In conditions where DHEA/DHEAS are abnormally low such as in the 
elderly, individuals with Addison’s disease (Hunt et al., 2000), rheumatoid arthritis, 
systemic lupus erythematosus (Nordmark et ah, 2005), human immunodeficiency 
virus (Schfitto et ah, 2000) or adrenal insufficiency syndromes (Arlt, 2003; Arlt et ah,
2005), supplementation improves mood, cognitive function and general well-being 
(Bloch et ah, 1999; van Niekerk, Huppert & Herbert, 2001; Wolf, 2003; Wolf et ah.
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1998). Similarly, lower salivary DHEA levels have been noted in clinically depressed 
older adults (Michael, Jenaway, Paykel & Herbert, 2000).
In adrenal disease states where DHEAS levels are abnormally elevated 
(Dubrovsky, 2005) and in anabolic steroid use where excessive amounts of DHEA is 
taken as a supplement coneomitant psychological disturbances and autonomic 
hyperactivity have been reported (Cafri, et al., 2005; Trenton & Currier, 2005). 
Moreover, a number of clinical case reports indicate that abnormally elevated DHEA 
and/or DHEAS concentrations elicit symptoms of anxiety, mania and psychosis that 
are in some cases resistant to traditional therapeutic approaches and abate only when 
hormone concentrations are brought in check (Dean, 2000; Howard, 1992; Jacobs et 
al., 1999; Markowitz, Carson & Jackson, 1999)
In patients with treatment refractory depressed psychosis, defined as resistant 
to psychotropic medication and electroconvulsive therapy (ECT), both DHEA and 
DHEAS levels were elevated compared to controls and predictive of ECT non­
response (Maayan et al., 2000). Interestingly, the investigators found that neither pre- 
nor post-treatment DHEA and DHEAS changed significantly for either the responders 
or non-responders, perhaps suggesting a third factor associated with the behavioral 
outcome. It is also likely, that the substantial inter-individual variability commonly 
observed in hormone concentrations were concealed by comparison of mean data.
Individuals with treatment refractory anxiety disorder, associated with late- 
onset congenital adrenal hyperplasia exhibited elevated DHEAS values that were 
associated with increased anxiety scores on the Profile of Mood States questionnaire 
(Jacobs et al., 1999). Upon adrenal suppression treatment via either ketoconazole or
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low dose glucocorticoids, anxiety scores decreased by 55%, concurrent with a 10% 
reduction of DHEAS, returning DHEAS concentrations to within normal 
physiological parameters. Depression scores were inconsistent and not related to 
DHEAS in this study.
In the schizophrenic disorders, researchers have demonstrated aberrant 
patterns in adrenal androgen concentrations, marked by elevated DHEA and/or 
diminished DHEAS. Michele et al. (2005) found plasma DHEA concentrations 
significantly increased in 23 schizophrenic patients versus 23 healthy controls. The 
data remained significant even when the groups were divided by gender. Males 
reportedly have higher circulating concentrations of DHEA (Roberts, 1999).
Similarly, Ritsner and colleagues (2006) found significantly elevated DHEA 
concentrations in 21 male paranoid schizophrenics as compared to 14 healthy controls 
combined with significantly lower DHEAS and higher androstenedione 
concentrations in the patient group and normal coneentrations of progesterone and 
testosterone. The researchers speculated that these patterns may represent a trait-like 
marker of impaired HPA or HPG activity that is characterized by decreased 
sulfotransferase and/or 17p-hydroxylase activity combined with increased 3p- 
hydroxysteroid dehydrogenase activity (Ritsner, Gibel, Ram, Maayan & Weizman,
2006).
Alternatively, a polymorphism in the enzyme that is responsible for the 
metabolism of many mixed oxidase reactions in the human liver the CYP3 A4, yields 
a variation of the fetal enzyme CYP3A7 not normally present in adult livers that 
results in up to a 50% reduction in DHEAS concentrations (Smit et al., 2005). As
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many of the medications commonly prescribed to patients with schizophrenia utilize 
CYP3A4 metabolism (Dahl, 2002) individuals possessing this polymorphism might 
present with anomalous reactions to medication in addition to the reduction in 
DHEAS concentrations.
The data on DHEA/DHEAS role in depression is mixed. Fabian et al. (2001) 
found that measurable decreases in both DHEA and DHEAS were associated with 
remission of clinical depression in the elderly. Whereas Michael et al. (2000) found 
that depression in the elderly was linked to lower levels of DHEA and DHEAS. The 
disparity between these results is possibly explained by methodological differences 
and/or by the kinetics of these hormones. DHEA has a very short half-life, (1-3 hours) 
(Roberts, 1999), is susceptible to diurnal rhythms, food and medication intake and has 
been reported to fluctuate wildly from hour to hour (Kroboth et al., 1999).
Conversely, DHEAS has a longer half-life (10-20 hours) (Carlstrom, Karlsson & Von 
Schoultz, 2002) is more stable across time, but is susceptible to modulation by 
medication (Kroboth et al., 1999; Salek, Bigos & Kroboth, 2002), a common 
confounding variable in elderly populations.
Alternatively, the presence of depression in these populations could develop 
secondarily to a disrupted autonomic system, characterized by both somatic and 
psychiatric symptoms of anxiety. This was the case in Hsiao (2006) who measured 
DHEAS in a non-age restricted cohort of patients suffering an episode of clinical 
depression and found that DHEAS concentrations were significantly associated with 
the severity of co-morbid anxiety, but not associated with depression. Hsiao’s work 
is consistent with other studies, including Marrs (2006) and case reports that have
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shown elevated DHEAS is more closely associated the agitated states ranging from 
anxiety to mania and psychosis than with depressed states, even though depression 
may co-occur and may be significant. Likewise, the antagonistic actions of DHEAS 
at the GABAa receptor predict CNS hyper-excitability rather than depression.
Clinical Findings Associated with DHEA/DHEAS and Testosterone
In clinical disorders where DHEA/DHEAS concentrations are elevated, 
testosterone and estrogen concentrations are typically elevated as well. In women, 
elevated adrenal androgens result in a myriad of reproductive disorders often visually 
identified by hirsutism and viralization (Carr, 2001; Elsenbruch, 2003; Yildiz, 2004) 
with or without the concomitant diagnoses of polycystic ovarian syndrome (PCOS). 
PCOS, which is characterized chronic anovulation and variety of metabolic disorders, 
is thought to be caused by supra-physiological concentrations of DHEA/DHEAS, 
testosterone and estradiol and is commonly associated with both mild and severe 
psychiatric disturbances (Elsenbruch et al., 2003; Yildiz, 2004). Although it is not 
clear if the risk for psychiatric disturbance in women with PCOS is higher than that of 
the general population. Of note, there is a significantly higher incidence of PCOS in 
women with either bipolar disorder or epilepsy who are treated with valproic acid 
versus women treated with other compounds (Betts, Yarrow, Dutton, Greenhill & 
Rolfe 2003; Klipstein & Goldberg 2006). Whether valproic acid causes or simply 
triggers a pre-existing endocrine pathology remains to be elucidated. There are 
currently no endocrine evaluations reported for medication naïve patients.
In clinical disorders with low testosterone only, patients are noted to show 
decrements in mood and cognitive functioning (Arlt, 2003; Cherrier et ah, 2001;
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Wolf, 2003). It must be noted however, that research on low testosterone typically 
involves elderly males with hypogonadal function (Beuna et ah, 1993; Burris, Banks, 
Carter, Davidson & Sherins, 1992; Carani et ah, 1990). Of the research involving 
women, most is performed on postmenopausal women with reduced libido (Burger et 
ah, 1984; Sherwin, Gelfand & Brender 1985; Vermeulan, 1976). Research on military 
performance, again with males, demonstrates that testosterone concentrations 
decrease over the course of intense military training in relation to increased cortisol 
production suggesting that low testosterone is a marker of hypothalamic-pituitary 
activation (Lieberman et ah, 2005). Additionally, when under severe stress, elderly 
patients exhibit diminished testosterone levels concurrent to elevated cortisol (Dharia 
et ah, 2004).
Finally, Akhondzadeh et ah (2006), reported that significantly lower 
testosterone concentrations were associated with symptom severity in male patients 
with schizophrenia (n=54) either in general when compared to healthy controls (n= 
25) and significantly lower testosterone concentrations were noted in those patients 
with predominantly negative symptoms (n=27) when compared to those with 
predominantly positive symptoms (n=33). Moreover, testosterone was inversely 
correlated with negative symptom severity. The researchers also found other 
endocrine abnormalities including significantly lower concentrations of follicle 
stimulating hormone (required for sperm formation) and lutenizing hormone 
(augments testosterone production) combined with significantly elevated prolactin 
(associated with impotence and loss of libido) concentrations in the negative 
symptom group when compared to the positive symptom and control groups.
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Since dopamine inhibits prolactin, dopamine receptor blockade by 
neuroleptics often results in increased prolactin. However, all but three of the 
schizophrenia group were on the same medication, risperidone (n=51) and thus the 
difference in prolactin concentrations between the negative and positive symptom 
groups is not likely accounted for by differences in medication. Those changes could, 
however, be related to medication induced changes in other hormones that affect DA 
concentrations.
A study by Van den Berghe and colleagues (1995) found that DA suppresses 
DHEAS which in turn inhibits prolactin in critically ill patients. The complete circuit 
has yet to be elucidated, but lower DA as would be expected with neuroleptic 
treatment, could suggest higher DHEAS. If relatively less DHEAS is converted into 
DHEA and subsequently testosterone then this reaction could account for the lower 
testosterone concentrations in patients with negative schizophrenia. Additionally, 
lower DA would increase DHEAS concentrations while concomitantly increasing 
prolactin either via the relinquishment of the tonic inhibition the DA exerts over 
prolactin in the tuberoinfundibular pathway or via some other mechanism moderated 
by DHEA/DHEAS pathway. Alternatively, the decrease in FSH, LH combined with 
the increase in prolactin in patients with negative versus positive symptoms of 
schizophrenia could simply indicate a relative down-regulation of sexual/reproductive 
function consistent with diminishment of other behavioral capacities.
Physiological and Pharmacological Actions o f Testosterone
The role of increased testosterone in aggressive behavior has been thoroughly 
investigated in both human and animal models, but a definitive neuroendocrine
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mechanism has not been articulated (Albert, Walsh & Jonik, 1993; Archer 2004). 
Moreover, for as much as increased testosterone has been associated with aggression 
in criminal populations, clinically this is has not been the case (Pope, Kouri &
Hudson 2007). Hypogonadal males given testosterone supplements rarely show 
aggression even as testosterone concentrations increase to supra-physiological values 
(Albert, Walsh & Jonik 1993). Although female hyperandrogenism is often associated 
with psychiatric disturbances, concomitant elevations in testosterone are not 
correlated with aggression (Weiner, Primeau & Ehrlmann 2004). The lack of 
relationship between testosterone and aggression in non-criminal populations makes 
sense in light of testosterone’s mechanism of action at the cellular level.
In very recent research, testosterone has been found to be a fairly potent 
calcium channel blocker in the coronary artery and also in uterine myométrial cells 
(Jones, Pugh, Jones & Channer 2003; Perusquia, Navarret, Jasso-Kamel & Montano,
2005). Subsequently, and contrary to popular belief, researchers are finding that 
diminished rather than elevated testosterone confers a markedly increased rate of 
coronary artery disease in men (Jones, et al., 2003). Further investigation suggests 
testosterone decreases myocardial ischemia via vasodilation specifically via L- 
channel calcium (Ca2+) blockade (Jones, English, Jones & Channer, 2004).
Similarly, in a study on uterine contractility, Perusquia and colleagues (2005) 
showed that testosterone and testosterone metabolites reduced uterine contractility in 
human pregnant and non-pregnant myométrial tissue (obtained via biopsy) even more 
so than progesterone. The purported mechanism of action was Ca2+ blockade but 
researchers also noted increased potassium influx causing cellular hyperpolarization
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as well as some cell membrane fluidity. Moreover, testosterone and its metabolites 
mediate these responses in the absence of identified nuclear androgen receptor 
binding (Jones et ah, 2004).
In rodents testosterone acts through arginine vasopressin (AVP) and 
corticotrophin releasing hormone (CRH) to mediate glucocorticoid effects on 
neuronal response (for a review see Williamson, Bingham & Viau, 2005). Arginine 
vasopressin is believed to enhance CRH responsivity to acute stress. Enhanced CRH 
activates the pituitary hormone, adrenocorticotropin (ACTH). ACTH initiates the 
release of corticoids. Increased corticoids then feedback to inhibit the continued 
CRH/A VP synthesis to bring the system back into equilibrium. Williams et al. (2005) 
found androgen receptors co-localized on A VP neurons. Binding of testosterone 
effectively inhibits the stress related A VP up-regulation and expression which then 
inhibits corticoid output. In the absence of testosterone or in states of diminished 
testosterone, the negative feedback loop normally associated with this system is 
altered, A VP expression increases, which in turn increases CRH and the downstream 
release of corticoids. This reaction may be mediated by DHEA concentrations 
inasmuch as DHEA not only provides the substrate for testosterone synthesis, but also 
upregulates AR expression (Lu et al., 2003). Similarly, clinical research has shown 
that DHEA and cortisol are inversely related across multiple populations (Genazzani 
et ah, 2003; Ueshiba et ah, 2004). DHEAS on the other hand, has no effect on AR 
receptors (Mo, Lu, Hu & Simon, 2004).
Testosterone, however, also upregulates it own receptors. Unlike other 
hormones whose receptors down-regulate in the presence of ligand, ARs up-regulate
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(Patchev, Schroeder, Goetz, Rhode & Patchev, 2004) and thus more testosterone 
elicits more ARs while lower testosterone reduce the expression of ARs. The 
uniqueness of this positive feedback mechanism may have role in the presumptive 
associations between male dominance and/or aggressive behavior and testosterone 
concentrations with environmental factors reinforcing testosterone and AR activity.
Unfortunately, because testosterone is aromatized to estradiol and/or 
converted to dihydrotestosteome via 5a-reductase (the same enzyme that catalyzes 
the conversion of progesterone to allopregnanolone and/or shifts progesterone toward 
the cortisol pathway), it is difficult to dissociate purely androgenic from estrogenic 
CNS activity. Additionally, ARs and ERs show similar regional CNS distribution 
patterns and sequence homology to other steroid receptors as well as multiple levels 
of promiscuous interaction and target gene cross-regulation (Patchev et ah, 2004). 
Moreover, both receptors demonstrate receptor-activated transcription in absence of 
hormone-receptor binding, but in the presence of either environmental stimuli and/or 
via binding with neurotransmitters (Braunstein, 2004). Nevertheless, when the 
molecular actions of testosterone are compared to those of estradiol, testosterone is 
generally inhibitory and estradiol is predominantly excitatory.
Summary
The research presented thus far provides clear evidence of an exceedingly 
complex relationship between neural and endocrine factors in the development of 
mental illness. Whether endocrine disturbances precede mental illness, develop 
concurrently or subsequently or are a result of medication remains to be elucidated. 
What is clear is that endocrine changes affect mental health.
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Pregnancy and parturition offer researchers a unique model from which to 
study those associations. The hormone changes are vast and in some cases extreme. 
The abrupt withdrawal from the supra-physiological concentrations of reproductive 
hormones often coincides with the onset of psychiatric disturbances in previously 
healthy women. With such significant changes in reproductive hormones, 
compensatory reactions in other endocrine circuits are likely. Findings from Marrs 
(2006) may support this hypothesis. The low late pregnancy testosterone followed by 
the unexpected postpartal increase in DHEAS, not only represented a unique and 
previously unidentified pattern in puerperal hormones, but also, provides the first 
clear evidence of association between puerperal endocrine changes and the 
development of psychiatric symptoms in previously healthy women. Since there are 
no disorders currently documented that include this pattern of hormone values it is 
worth determining whether the profile is physiologically possible and by what 
mechanisms it might develop. While such a review is beyond the scope of the present 
research, consideration of the potential mechanisms that might produce elevated 
DHEAS and diminished testosterone provides useful insight regarding the uniqueness 
of the Marrs pattern and is included in the following section of this literature review.
Elevated DHEAS and Diminished Testosterone: Potential Mechanisms
Ideally, to investigate hormone synthesis patterns one would measure the 
entire pathway between the precursor (DHEAS) and product (testosterone), as well as 
measure the specific enzymes suspected of dysregulation. Barring that, however, it is 
possible to surmise which enzymes might contribute to a specific hormone profile
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based upon the presenting pattern of hormones compared with other known disorders 
associated with those enzyme deficiencies. Discussed below is a review of each the 
enzymes involved in metabolic process from DHEA/DHEAS through testosterone. In 
the initial sections, it is presumed that DHEAS and DHEA are in dynamic 
equilibrium and thus show parallel increases or decreases in circulating values. The 
equilibrium between these hormones is often presumed and has been validated in a 
number of clinical studies (for a review see Kroboth et ah, 1999). There are a number 
of instances though where the equilibrium between these hormones is disrupted (Arlt 
et ah, 2006; Reed et ah, 2005) and thus in second part of this review those cases are 
considered.
Elevated or Normal DHEA Concurrent with Diminished Testosterone
Although, no disorders have been reported with high DHEAS and low 
testosterone, there are disorders marked by normal/high DHEA and low testosterone. 
Since DHEA and DHEAS concentrations are often highly correlated, the presumption 
is made that DHEA/DHEAS change uni-directionally. While that interpretation will 
be contended with regard to the Marrs (2006), it is worth investigating the disorders 
with high DHEA and low testosterone if only to remove them from the list of possible 
factors that could have contributed to the Marrs hormone profile and subsequent 
psychiatric disturbances. Listed below is a systematic review of enzymatic 
deficiencies potentially involved with high or normal DHEA and low testosterone. 
Please refer to Figure 2 for the following discussion.
83
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
17, 20 Lyase and 17a-Hydroxylase Activity
Two genetic variants of congenital adrenal hyperplasia (CAH) are associated 
with normal and/or elevated DHEA and diminished testosterone, each mediated 
through entirely different enzymes (Miller, 2005). Though not likely factors 
contributing to the hormone profile observed by Marrs (2006), these disorders 
provide a useful illustration of how enzymatic permutations fundamentally alter 
hormone metabolism. In the first variant of CAH, 17, 20 lyase activity is up-regulated 
while 17a-hydroxylase (17a-0H) activity is unchanged or diminished (Miller, 2005). 
This shifts the adrenal metabolic pathway away from the conversion of 17a-0H 
progesterone to androstenedione and towards the conversion of 17a-0H pregnenelone 
to DHEA (Miller, 2005). This shift initially produces less cortisol concurrent with 
increased DHEA. However, since DHEA is rapidly converted to DHEAS, rather than 
to downstream derivatives, the upregulation of 17, 20 lyase results in a reduction in 
testosterone concentrations. In this variant of CAH, called lipoid CAH, the primary 
mutation is not in the CYP450 17 but rather in the CYP450scc (side chain cleavage), 
steroidogenic acute regulatory protein (StAR), responsible cholesterol transport into 
the mitochondria where it is converted to pregnenelone and other steroid hormones 
(Miller, 2005). Males with this disorder are severely undervirilized, showing external 
female genitalia as well as life-threatening salt-wasting and cortisol deficiencies. 
Females, on the other hand, exhibit normal female anatomy and because the ovaries 
do not begin synthesizing steroids until puberty, StAR independent steroidogenesis 
remains functional until then (Miller, 2005). After puberty and with each subsequent
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menstrual cycle, cholesterol esters accumulate, the adrenal cells engorge, and become 
less functional (Miller, 2005).
Researchers have termed the time-delayed “onset” of this disorder in females, 
the “two-hit model”. The first hit, a genetic mutation that is present at birth does not 
become fully activated until later when the second hit-puberty occurs (Miller, 2005). 
It is conceivable that pregnancy may be a “second hit” for some women in a yet 
unidentified endocrine reaction whose manifestations include psychiatric 
disturbances.
S f- Hydroxysteroid Dehydrogenase Activity
Another enzyme involved in the conversion of DHEA to testosterone includes 
3P- hydroxysteroid dehydrogenase (3p-HSD). The 3P-HSD enzyme converts 17a-0H 
pregnenelone to 17a-OH-progesterone but also converts DHEA into testosterone. In 
another rare CAH variant, a mutation in the gene that encodes 3|3-HSD globally 
inhibits the conversion of precursor hormones to products within each zone of the 
adrenal gland. This CAH variant is associated with salt-wasting (because of the 
enzyme’s involvement in the aldosterone pathway), genital ambiguity (because of the 
low testosterone) and hypogonadism (Carbunaru et al., 2004). It too can be ruled-out 
as a contributing factor the hormone profile observed in the Marrs study insofar as it 
would have been identified at birth.
However, researchers have speculated that a non-classical, late-onset variant 
of the 3P-HSD deficiency is present in women with PCOS particularly in those cases 
where insulin resistance is present (Carbunaru et al., 2004). Although a genetic 
mutation has not been identified, a consistent phenotype has been presented that
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demonstrates compromised, but not totally inhibited 3P-HSD activity in the adrenal 
cortex with the concurrent hypersecretion of lutenizing hormone and increased 
ovarian production of testosterone. Thus, while hyperandrogenism is present in both 
the non-compromised 3P-HSD and compromised 3P-HSD versions of PCOS, 
testosterone concentrations in the compromised group were significantly lower 
(similar to those in the CAH variant discussed previously) and were thought to reflect 
up-regulated ovarian production rather than adrenal synthesis. Although this late- 
onset version of CAH can not be entirely ruled-out, the odds of this having been a 
factor in the Marrs (2006) study are low. Inasmuch as compromised 3P-HSD is 
associated with PCOS which is in turn associated with infertility and insulin 
resistance, it is unlikely that even undiagnosed participants would have been included 
in the study. However, this research illustrates that an enzyme need not be totally or 
globally deficient to elicit aberrant hormone synthesis patterns. Sometimes subtle 
changes in enzyme functionality produce clinical disruption.
17f-Hydroxysteroid Dehydrogenase Activity
The final enzyme involved in the conversion of DHEA to testosterone is 1?P- 
HSD. The 17P-HSD enzyme conversts DHEA to androstendiol and androstendiol to 
estrone. Since 17p-HSD deficiencies are typically associated with male 
pseudohermaphroditism, this enzyme deficiency can be ruled-out as having caused 
the low testosterone in the presence of high DHEA or DHEAS.
Whereas the complete abolition of a particular enzyme is not likely to have 
been a factor in the Marrs hormone profile, transient changes in enzyme activity
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mediated by pregnancy or parturition and/or congenital deficits that only partially 
compromise enzyme function, cannot be ruled out.
The relationship between DHEA and enzyme function is not fully understood 
but suggests that DHEA regulates its own bioconversion and that of other hormones 
both acutely and chronically via control of the local enzyme production (Labrie, 
1997). For example, DHEA supplementation in both postmenopausal women and 
elderly men increases testosterone and estradiol production while simultaneously 
decreasing cortisol concentrations (Genzzani et al., 2006). It also influences the 
production of other hormones through enzymatic up-regulation, such as 
allopregnanolone (a progesterone derivative requiring 5a-reductase, the enzyme that 
catalyzes the testosterone to dihydrotestosteome reaction) and 17a- 
hydroxyprogesterone (17a -OHP) through the DHEA> 17, 20 lyase modulation 
(Genzzani, et al. 2006; Roberts 1999). In the case of postmenopausal women, 
researchers speculate that DHEA supplementation likely attenuates the age-related 
declines in 17, 20 lyase activity (Genzanni et a l, 2006)
Interestingly, the exact opposite pattern with regard to DHEA and cortisol is 
observed in both male and female patients with type 2 diabetes. In diabetics, 
decreased 17, 20 lyase and increased 17a-0H expression are associated with 
diminished DHEA and DHEAS concurrent with elevated ACTH and cortisol, 
suggesting that 17a-0H expression is a key enzyme shifting DHEA synthesis either 
towards (increased 17a-0H) or away from (decreased 17a-0H) cortisol production. 
This pattern was reversed with diet, as was the insulin resistance (Ueshiba et al, 
2002).
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From the research presented thus far it is evident that adrenal steroidogenesis 
is modulated both by substrate and enzyme availability, and both factors are 
intimately tied to DHEA concentrations. In the CAH variants discussed previously, 
DHEA concentrations were elevated or left unchanged but mutations in genes 
encoding the enzymes responsible for the conversion of DHEA into other metabolites 
drastically reduced the circulating androgen and estrogen concentrations. In 
postmenopausal women and elderly men, age related declines in 17, 20 lyase activity 
correspond to age related declines in DHEA production as well as in androgen and 
estrogen synthesis. In diabetic patients these factors are compounded by 
increased 17a-0H expression and consequent cortisol up-regulation. Each of these 
factors is ameliorated with DHEA supplementation indicating that DHEA plays a 
prominent role in multiple metabolic pathways.
More importantly however, this research demonstrates that the onset of some 
endocrine disorders is delayed and may only come to fruition under certain 
circumstances. The two-hit model, similar to diathesis-stress model of mental illness, 
suggests that the phenotypic expression of some endocrine disorders requires both 
genetic and environmental contributions.
DHEA, DHEAS Disequilibrium 
In the Marrs study (2006) DHEA concentrations were not measured but 
DHEAS and testosterone concentrations were. Barring disruptions in the Sp-HSD, 
17,20 lyase and/or 17a-0H enzymes, the only remaining enzymes capable of creating 
high DHEAS and low testosterone are those involved with the bioconversion of
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DHEA>DHEAS>DHEA, the SULT2A1 and STS enzymes. Disequilibrium between 
DHEA and DHEAS, where more DHEA is converted to DHEAS either by the up- 
regulation of SULT2A1 activity or down-regulation of STS activity would reduce the 
substrate availability needed for the conversion of downstream androgens and 
estrogens, but as was evidenced by the aforementioned research, might also alter the 
expression of other enzymes. Since there are no reports of SULT2A1 up-regulation 
(only down-regulation) the focus of this discussion will be on STS manipulation. 
Congenital Sulfatase Disorders
The STS enzyme catalyzes the hydrolysis of the sulfate ester bond for 
multiple steroids including cholesterol sulfate, pregnenelone sulfate, DHEAS and 
estrone sulfate. The enzyme is encoded by a single gene located on the distal arm of 
the X-chromosome (Hemandez-Martin, Gonzalez-Sarmiento & Unamuno, 1999). 
Eighty to ninety percent of the mutations involve complete deletions whereas 
approximately 10-20% of cases involve partial or point mutations (Reed et al., 2005). 
Because the mutation is X-linked, the associated disorders develop only in male 
children of female carriers. The most common of these disorders is X-linked 
ichthyosis (X-LI) which develops in approximately 1-6000 male children (Bradshaw 
& Carr, 1986). The gestational signs of X-LI are elevated DHEAS and diminished 
estriol caused by placental a STS deficiency (Bradshaw & Carr, 1986). Androgen 
concentrations are not typically measured.
Mothers of male infants with this disorder typically have longer pregnancies 
as well as difficult and/or non-progressive labor related to the limited estradiol 
conversion from estrone sulfate. Males bom with X-LI develop dark scaly patches of
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skin due to diminished cholesterol sulfate to cholesterol conversion in the skin. 
Cryptorchidism, which is marked by testicular mal-descent, is not considered a 
congenital disorder related to STS activity, but appears to be more prevalent in male 
X-LI babies (20-30%) than would be expected in the general population (Reed et al., 
2005). The prevalence of crytorchidism is also 1-6000 and is thought to develop 
because of diminished testosterone synthesis or androgen receptor insensitivity during 
gestation (Bradshaw & Carr, 1986). Since diminished STS limits the substrate 
availability required for testosterone biosynthesis, researchers have begun to 
investigate partial or point mutations on STS gene that may be linked to 
cryptochidism (Reed et al., 2005).
Although no male infants were reported by Marrs (2006) to have had these 
disorders at 10 days postpartum, it can not be ruled out that the participants in this 
study were not carriers of this particular genetic mutation and that elevated DHEAS 
was not some how related to diminished sulfatase activity. Female carriers of this 
genetic mutation, depending upon the degree and location of the mutation may or 
may not develop the ichythosis skin condition themselves. It was previously believed 
that acquired ichthyosis resulted from a de novo mutation in the STS gene. Re­
examination of the mothers and grandmothers of male children with this disorder 
suggests the presence of mutation is correlated with the degree and severity of female 
symptom development (Cuevas-Coverrubias, Valdes-Flores, Orozco & Diaz-Zagoya, 
1999). Researchers believed that the STS activity in female carriers of this mutation is 
not impaired. When it was actually measured however, STS activity in female carriers 
was significantly less than in normal females (Epstein & Leventhal, 1981). But only
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one such comparison of STS activity in carriers versus non-carriers has been 
published to date with only five participants.
It has also been suggested that female carriers of this genetic mutation exhibit 
an increased incidence of “psychoreactive” disorders (Hemandez-Martin, Gonzalez- 
Sarmiento & Unamuno, 1999). Unfortunately, the original article claiming the 
psychoreactive responses was unavailable for review and there is very little data on 
the health status of female carriers. The extant research is focused entirely upon the 
identification and classification of male patients. The possibility exists, however, that 
female carriers of this mutation, likely exhibit diminished STS when compared to 
their non-carrier counterparts and that up-regulation in pregnancy related DHEAS 
production saturates the enzymes capacity catalyze hydrolysis thus un-masking a 
previously latent disorder.
Endogenous Factors Regulating Sulfatase Activity
In addition to the congenital disorders associated with STS deficiency, recent 
investigations have identified a number of endogenous and exogenous factors that 
decrease STS activity and thus impair DHEAS>DHEA conversion. These include 
interleukin P, estradiol and/or estradiol withdrawal and some synthetic progestins. 
Progesterone, testosterone, estradiol, other synthetic progestins, retinoids, vitamin D3, 
tumor necrosis factor a  and interleukin 6 (IL-6), on the other hand, have all been 
found to increase STS expression (Reed et al., 2005). Because of its potential to 
diminish the circulating concentrations of androgens and estrogens, STS activity in 
hormone dependant cancers has been explored extensively in recent years. Data from 
this line research, although potentially confounded by oncogenesis, provide important
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clues regarding mechanisms of STS inhibition as well as the subsequent hormone and 
psychological changes associated therewith.
Cancer Research
Using human corticoadrenal carcinoma cells, Gell and colleagues (1998) 
investigated the role of estradiol in DHEAS production in cell culture and found that 
estradiol increased DHEAS production in a dose-dependant manner while 
simultaneously decreasing 3P-HSD activity and cortisol production. Moreover, 
estrogen receptor antagonism did not impede DHEAS production. Researchers 
speculated that because of the increase in DHEAS and concomitant decrease in 3P- 
HSD activity and cortisol, estradiol mediated the hormone concentrations through the 
3P-HSD enzyme. However, they did not measure DHEA or androstenedione, the two 
hormones most likely to be altered by increased DHEAS concentrations and 
concomitant changes in enzyme activity.
An alternative and more parsimonious explanation might be that estradiol 
inhibits STS activity as part of a local negative feedback loop. By inhibiting STS 
activity estradiol would limit the concentration estrone available for synthesis to 
estradiol and also limit the amount of DHEA, androstenedione and testosterone. The 
reduction in 3p-HSD activity might simply reflect a natural downregulation in 
activity based upon the diminished availability of precursor or it could be mediated 
by a third factor linked to cancer steroidogenesis. This hypothesis was partially 
supported by Pasqualini and Chetrie (2001), who found estradiol inhibited estrone 
sulfatase activity in breast cancer cells. In addition, multiple labs that have since 
developed dozens of potent synthetic STS inhibitors by modifying the basic structure
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of the estradiol molecule (for a review see Nussbaumer & Billich, 2004). 
Unfortunately, many of these compounds irreversibly inhibited STS and had very low 
ED50 (4) and were thus not acceptable for human use. Dozens of molecular 
manipulations yielded many reversible STS inhibitors that were safer but far less 
effective (Nussbaumer & Billich, 2004).
The first STS inhibitor to reach phase 1 clinical trials was STX 64 (667 
Coumate) (Stanway et al., 2006). Prior to clinical trials, Coumate administration in 
male rodents demonstrated that STS inhibition resulted in increased DHEAS which 
was associated with unprovoked aggression (Nicholas et al., 2001). STS inhibition 
also enhanced long term learning in rodent models (Flood, Farr, Johnson, Li & 
Morley, 1999).
In the phase 1 clinical trial, Coumate (5mg and 20mg) was administered to 13 
postmenopausal women with either locally advanced or metastatic breast cancer in a 
non-random, open-label, dose-escalation study over a period of six weeks. The 
outcome measures included serum concentrations of DHEAS, DHEA, 
androstenedione, androstendiol, testosterone, estrone, estrone sulfate, estradiol as well 
as STS presence in peripheral blood lymphocytes (PBL) and in the tumor cell. With 
STS inhibition, DHEAS concentrations increased significantly while DHEA, 
testosterone and estradiol concentrations decreased. These changes paralleled drug 
dosage with higher doses linked to larger changes in circulating hormone 
concentrations (Stanway et a l, 2006).
As expected, the ratio of DHEAS/DHEA increased substantially (320%) 
following drug administration. Estrone sulfate and the ratio of estrone sulfate to
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estrone increased as well but not as dramatically as DHEAS. Sulfatase activity was 
dramatically inhibited in both the PBLs and within the tumors. Of interest the adverse 
events associated with drug administrations included Grade 2 or moderate (on scale 
of 0-none to 5-death) fatigue, hot flushes, mood alterations (details not listed), 
arthralgia (STS are found in synovial fluid) and headache. Since psychiatric 
disturbances were not measured as outcome variables, it is difficult to discern the 
exact nature and scope of the mood alterations experienced by participants in this 
trial, but it is important to note that psychiatric disturbances did occur. Thus, in 
addition to its potential efficacy as a cancer treatment, Coumate administration 
produced a hormone profile similar to the one observed in Marrs (2006) with high 
DHEAS and low testosterone that was associated with mood instability and/or 
negative behavioral changes (rodent) (Nicholas et al., 2001) providing preliminary 
evidence that compromised STS activity could be associated with puerperal 
psychiatric disturbances in some women.
Sulfatase and Pregnancy
This possibility was explored by Maayan and colleagues (2005) using a rodent 
model of pseudo-pregnancy/withdrawal. Investigators exposed three groups of rats to 
a period of hyper-physiological levels of estradiol or vehicle followed by an abrupt 
withdrawal in order to proximate the pregnancy/postpartum experience. The rats 
were ovariectomized to eliminate peripheral synthesis capabilities. Following 
withdrawal both peripheral serum and cortical concentrations of DHEA, DHEAS, 
pregnenolone, pregnenolone sulfate levels were assessed as was STS activity. There 
were no differences between the groups in peripheral serum DHEA or DHEAS, nor
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were there differences in serum pregnenolone or pregnenolone sulfate. This would be 
expected because ovariectomy removed all peripheral synthesis capabilities. There 
were however, significant differences in cortical DHEAS and STS concentrations 
between the experimental and control groups. DHEAS concentrations were 
substantially higher and STS concentrations were lower in the experimental group. 
The authors speculated that rapid estradiol withdrawal, as occurs following 
parturition, altered the equilibrium between cortical DHEA and DHEAS 
concentrations via decreased STS activity. However, since the investigators did not 
measure STS activity during the pseudo-pregnancy when the rodents were exposed to 
supra-physiological concentrations of estradiol, it is impossible to determine whether 
the STS impairment was mediated by elevated estradiol as was suggested by the 
aforementioned cancer research or by the subsequent of withdrawal of the 
reproductive hormone as was speculated by Maayan et al. (2005).
Based upon these cancer studies, it seems more likely that STS inhibition is 
tied to estradiol concentrations rather than to estradiol withdrawal. This would 
suggest that the compromised STS activity observed following parturition by Maayan 
et al. (2005) reflected the diminished STS of late pregnancy and not necessarily a 
postpartum decline. The time-course of systems re-regulation following parturition 
could be related to oft reported 3-4 day postpartal clearance of the estradiol and other 
reproductive hormones (Illingworth & McNeilly, 1998) and/or to the inherent time 
course of STS transcription. There are no data on cortical or peripheral STS 
transcription rates, but data from cultured human skin fibroblasts suggest that STS 
synthesis takes at least two days to complete and that the STS half-life is four days
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(Conary et a l, 1986). This time course, along with the extended clearance of 
puerperal hormones and the already limited STS activity in the adult human liver 
(Hammer et al., 2005), would suggest that maternal STS activity is probably low in 
late pregnancy, but is compensated for by placental contributions (Carr, 1998). 
Following parturition, however, when the placenta is removed and as estradiol and 
the other previously elevated hormones decline, there would likely be some delay 
before STS activity returned to pre-pregnancy levels. This could result in a postpartal 
increase in DHEAS and the degree to which DHEAS concentrations increased would 
correspond to the severity of psychiatric symptoms as was postulated by Marrs 
(2006).
Admittedly, the research is lacking and this hypothesis remains to be tested. 
However, in light of the hormone profile and associated psychiatric symptoms 
observed in the Marrs study, diminished STS activity provides a plausible hypothesis 
for the development of these symptoms. Whether the proposed changes in STS 
activity are merely reactions to the puerperal endocrine environment or represent 
some previously unidentified congenital deficiency is currently unknown and will 
remain so unless and until a proper genetic study is undertaken.
However, a longitudinal analysis of postpartum hormones and psychiatric 
disturbances could yield additional clues to the etiology and course of postpartum 
psychiatric disturbances and its association with endogenous endocrine factors. The 
degree to which these hormone factors change over time should correspond to 
improvements or decrements in psychiatric symptoms. More specifically, if  the 
observed endocrine patterns noted in the Marrs study represent a primary
96
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
endocrinopathy that is simply im-masked by pregnancy, further disturbances in 
endocrine regulation and continued psychiatric distress are expected. Whereas if the 
postpartal increase in DHEAS concentrations represent reaction to the abrupt changes 
in the reproductive hormones, DHEAS and other hormone values should return to 
normal and psychiatric symptoms are expected to diminish.
97
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTERS
METHODS
Participants
The twenty-eight healthy, primigravid women who completed the Marrs 
(2006) study were re-contacted and recruited for this longitudinal follow-up study. 
The Marrs (2006) study assessed cognitive, affective and hormonal variables 
associated with pregnancy and parturition at both 37 weeks of pregnancy and within 
10 days postpartum. The present study looked at those same variables at four, eight 
and twelve months postpartum.
Only healthy, primigravid women without histories or current evidence of 
drug or alcohol use or abuse or neurological or psychiatric disorders and who were 
not taking medications that would confound with either psychological or hormone 
measures were used as participants in Marrs (2006). In the present follow-up study, 
there were no exclusionary criteria and all of the women involved in the Marrs (2006) 
research who agreed to participate were included. Medications, illnesses, 
breastfeeding and subsequent pregnancies were documented at the four, eight and 
twelve month postpartum data collection times.
Of the 28 participants in the previous research, 14 women agreed to 
participate in this follow-up. However, participation across the study was inconsistent 
with different women being available for testing at each of the follow-up times.
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Twelve women were tested at four months, eight women were assessed at both eight 
and twelve months and only five women were tested at all three test times.
In order to equate the number of participants at each test time for purpose of 
data analysis, it was decided that participant data would be included in the final 
analyses for those women for whom there was no more than one set of missing 
variables (a single missed testing session). Nine participants met this requirement. For 
those nine participants, the single set of missing data were estimated using the series 
median of individual participant values. Data were estimated for one participant at 
four months, two participants at eight months and one participant at 12 months.
Enrollment and Testing 
Upon completion of the pregnancy and postpartum testing in Marrs (2006) 
study participants were appraised of the possibility of a follow-up study and asked if 
they would be interested in participating in the subsequent research. All 28 agreed to 
be contacted. Approximately two-weeks before each participant reached four, eight 
and twelve months postpartum, each participant was contacted by telephone. (Prior to 
study approval from the hormone laboratory, four participants had passed the four- 
month test date and were not contacted initially until their eight-month assessment). 
This study was approved by the University of Nevada, Las Vegas Institutional 
Review Board (Appendix A)
Upon agreement to participate, new informed consents were mailed and 
signed, salivary specimen collection kits and instructions (Appendix B) were mailed 
and testing appointments were set for the participants. Additional consent forms were
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signed in the presence of the researcher at the first appointment. Testing occurred at 
four, eight and twelve months postpartum +/- one week for each participant in the 
participant’s home. Data collection occurred over a 15 month period.
The morning of each testing session, pre-prandial, un-stimulated, salivary 
specimen were collected by the participant and stored at room temperature until the 
testing session. At each testing session, the following instruments were administered 
in order: the Symptom Checklist 90-Revised (SCL-90-R), the California Verbal 
Learning Test-II (CVLT-II) part one. Paced Auditory Serial Attention Test (PASAT), 
the CVLT-II-part two, the Rey Complex Figure Test (CFT)- copy, the Finger Tapping 
Test (FTT), the Purdue Pegboard, the Verbal Fluency Test, CFT-recall and the 
Design Fluency Test.
Breaks were given to the participant as requested and when needed to allot for 
down-time between tests. Testing at each session took approximately two hours. To 
compensate for practice effects on cognitive measures, alternate test forms were 
administered for the CVLT-II and the Rey CFT at each testing session.
Steroid Hormone Analysis and Neuropsychiatrie Measures 
Steroid Hormone Analysis
Non-stimulated saliva specimen were collected for the quantification of 
progesterone, DHEAS, testosterone, estradiol and estriol. Estrone, which was 
quantified in Marrs (2006), was not quantified in the present study due to laboratory 
financial considerations. However, since estrone did not appear to be a factor 
affecting dependent variables in Marrs (2006), its impact on the present study was
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expected to be minimal. The morning of each test session, before eating drinking or 
brushing her teeth, participant saliva was collected by expectoration over a 30-minute 
period between 8:30 and 9:00 AM. Participants who were breastfeeding were further 
instructed to avoid breastfeeding within two hours of the collection interval to prevent 
feeding-stimulated hormone release that might confound results. Specimen were 
shipped by two-day courier to the analytical facility (AllVia Diagnostic Laboratory, 
Phoenix, AZ) where they were stored at -20 C° for <24 hours, then thawed and 
analyzed for progesterone, DHEAS, estradiol and estriol concentrations by enzyme- 
linked immunosorbent assays. Testosterone was measured using luminescence 
immunoassay. The lower and upper bounds of quantification and inter-day variance 
for each hormone were established prior to analysis of participant samples. The lower 
and upper limits of quantification were as follows: Progesterone 10-3000 pg/mL; 
DHEAS 100-12,000 pg/mL; testosterone .3-760pg/mL; estradiol .1-100 pg/mL; 
estriol 1-4000 pg/mL.
Neuropsychiatrie Measures
Intelligence
Intelligence was estimated in Marrs (2006) using the Barona Index and those 
scores were utilized in this investigation as part of the demographic data and for 
comparison with appropriate age and IQ-matched normative data.
Psychiatric Symptoms
Nine clusters of psychiatric symptoms were assessed using the SCL-90-R.
The SCL-90-R is a 90-item psychiatric self-report inventory designed to measure the 
severity and intensity of psychiatric symptoms in both inpatient and outpatient
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populations (Derogatis, 1994). Participants rated the severity of distress experienced 
during the prior seven-day period using a 0-4 Likert-type scale (0=no distress-“not at 
all” to 4=extreme). Symptoms measured included: anxiety, hostility (aggression, 
irritability, etc.) phobic anxiety, paranoid ideation, psychoticism, somatization 
(perceptions of pain or other physical disturbances), obsessive-compulsive behavior, 
interpersonal sensitivity (feelings of personal inadequacy), depression and the global 
severity index (GSI), a composite score that reflects the overall symptom severity. 
The GSI is calculated as a sum of all responses divided by 90 (the total number of 
responses).
Cognitive Functioning
Marrs (2006) identified cognitive impairment across the puerperium that was 
marked by particularly low verbal and spatial memory performance. To assess 
changes in cognitive performance across the postpartum year, the present study 
utilized the same neurocognitive measures as were administered in Marrs (2006) at 
each test time. The tests administered included: the CVLT-II, PASAT, Rey CFT, the 
verbal and spatial fluency tests, the Purdue Pegboard test and the finger-tapping test.
The CVLT-II assessed short and long-term memory as well as learning 
strategy and conceptual organization using five trials of 16 words in four conceptual 
categories (Lezak, 1995; Spreen & Straus, 1998). Results were evaluated based upon 
total recall, short and long delay recall, proactive interference and semantic clustering 
(Lezak, 1995; Spreen & Straus, 1998). Both Marrs (2006) and Buckwalter et al. 
(1999) found significant verbal memory impairment in both pregnant and postpartum 
women. Activation studies show that the CVLT activates the left inferior prefi-ontal
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cortex, the left dorsal lateral prefrontal cortex, the orbitofrontal cortex and the left 
hippocampus (Savage et al., 2001).
The PASAT was used to assess the rate of information processing, sustained 
attention and vigilance. The PASAT consists of a taped presentation of randomly 
presented numbers. In each trial, the subject was asked to add pairs of numbers 
together in sequence with the second number added to the first, the third number 
added to the second, etc. There are four trials each with increasingly more difficult 
presentation rates (Lezak, 1995; Spreen & Straus, 1998). The PASAT is believed to 
be especially sensitive to subtle changes in attentional abilities. Marrs (2006) found 
mild to moderate impairment in attentional capacities which may have contributed to 
poor performance on the CVLT-II.
The CFT measured visual spatial and constructional ability as well as visual 
memory, planning, organizational and problem solving (Lezak, 1995; Spreen & 
Straus, 1998). Participants were asked to copy a complex figure and after a delay and 
without prior warning were asked to produce it again from memory. The figure was 
scored based upon accuracy and recall (Spreen & Straus, 1998). The CFT is argued 
to be adept at identifying frontal cortex dysflinction (Cummings & Trimble, 1995). 
CFT scores in Marrs (2006) were particularly low when compared to normative 
means.
The verbal and spatial fluency tests were designed to measure lateralized 
executive functioning. During the verbal fluency task subjects were asked to name as 
many words as they could in a particular category in one minute. They were also 
asked to name animals within a minute. Verbal fluency assesses left frontal cortex
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functioning. For the spatial fluency task subjects were asked to draw multiple novel 
figures within a certain time frame. The spatial fluency test assessed right frontal 
cortex functioning (Cummings & Trimble, 1995). Both tasks are difficult for 
individuals with dorsal lateral prefrontal cortex injuries.
The Purdue Pegboard assessed fine motor dexterity and motor processing 
speed as well as right-left dominance. Subjects were asked to take pegs from a cup 
and place them in the pegboard, first with the dominant hand, then the non-dominant 
hand, and finally with both hands. Each trial takes thirty seconds and is scored by 
number of pegs placed during each time period (Spreen & Straus, 1998).
The finger tapping test measured fine motor speed and right-left dominance. 
Subjects must tap a key with the index finger of each hand as quickly as possible for 
five trials of 10 seconds each. Scores were computed for each hand and a mean for 
the five trials was produced (Spreen & Straus, 1998).
Data Analysis
The primary goal of this study was to evaluate the longitudinal trends and 
relative associations between postpartum hormones, psychiatric symptoms and 
cognitive performance across the first postpartum year. To assess the trends in 
hormone concentrations, psychiatric symptoms and cognitive performance, data from 
each group of variables were compared at five test times: 3 7-weeks of pregnancy 
(Tl), <10 days postpartum (T2), four-months postpartum (T3), eight-months 
postpartum (T4) and one-year postpartum (T5) where data for T l and T2 were
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collected in Marrs (2006) and data for T3, T4, and T5 were collected in the present 
study.
Data were analyzed using a series of repeated measures within-subject 
univariate analyses of variance (ANOVA). Assumptions of spherieity for each 
symptom scale, hormone value and cognitive variable were assessed using Mauchly’s 
W statistic and when violated, significance levels were adjusted using the 
Greenhouse-Geisser method. Differences between test times were calculated using 
simple effects contrasts.
Performance on cognitive tests is susceptible to change over time due to both 
the imprecision of the instrument and/or practice effects (Wilson, Watson, Baddeley, 
Emslie & Evans, 2000). Thus, delineating functional change in individual scores 
requires the accommodation of those factors. A common procedure for dealing with 
this is to utilize reliable change indices (RCI). An RCI establishes the range of 
expected scores across time to determine the number of points on each cognitive test 
required in either direction for change scores to be considered to have not occurred by 
chance. Typically a confidence interval of either 90% or 95% is used. However, upon 
review of the RCIs established by Wood, Delis, Scott, Kramer & Holdnack (2006) for 
the CVLT-II in a healthy control group (there are no RCIs established for the other 
instruments used in this study) it was determined that the number of points required to 
merit the designation “improved” would exceed the total points possible for this 
instrument after a couple of trials and would not likely provide a useful reference. 
Thus, measures of change were based upon statistical difference and comparisons 
made to normative standards published for age, IQ and/or education-matched
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controls. Interpretation of change in these circumstances must be made cautiously and 
with the understanding that practice may have accounted for a large percentage of any 
observed improvement.
To assess the relatedness of hormones to psychiatric symptoms and cognitive 
performance Pearson’s bivariate correlations were calculated. Because of the small 
sample, data were not normally distributed and resisted transformation. It was 
decided in advance that if normality assumptions were not met, parametric statistics 
would still be used with the caveat that significance levels be interpreted cautiously. 
As was case with Marrs (2006), those participants with the most severe symptoms 
also typically exhibited the most extreme hormone values and, thus, represented the 
clinical cases of most interest. To have removed these cases from data analysis would 
have obfuscated the relational trends between non-normal hormone profiles and 
psychiatric symptoms.
In Marrs (2006) post-hoc analysis of data revealed two distinct groups of 
women, those who were considered symptomatic (T-score >60 on any one symptom 
cluster of the SCL-90-R) and those who were asymptomatic. Because of the small 
sample in the present study, statistical analysis of these two groups was not possible. 
However, descriptive analyses of symptomatic versus asymptomatic participants were 
conducted using the same criteria as Marrs (2006).
The large number of analyses performed necessarily increased the type 1 error 
rate which might or might not have been counterbalanced by the limited power 
associated with such a small sample size. Typically adjustments to the significance 
level are made. It was decided in advance not to do this, so that all symptom trends
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would be identified, again with the caveat that significance should be interpreted 
cautiously. It was also decided in advance, that while the complete battery of 
cognitive tests would be administered, only those factors found to be most impaired 
in Marrs (2006) and that continued to show impairment when pregnancy and 
postpartum data were re-analyzed for this subset of nine women, would be analyzed 
in the present study.
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CHAPTER 4
RESULTS 
Participant Data
The average age of study participants was 31.6 years (SD 3.1), education was 
15.8 years (SD 2.45) and the full scale IQ as estimated from the Barona index 
administered in Marrs (2006) was 112.4, (SD 5.7). Pregnancy and health related data 
for the nine participants who were followed across the postpartum year are given in 
Table 1. Mean gestational length for these participants was 278 days (SD 2.7) and 
each of the nine women had vaginal deliveries. Seven of these nine participants gave 
birth to boys, compared to 50% of the total group of participants in Marrs (2006).
At the four month postpartum test time seven participants were breastfeeding 
and four participants had begun menstruation. Three participants were taking oral 
contraceptives and two participants were taking anti-depressants. At this test time 
four participants were working part-time, three of whom worked in the home. 
Comparatively, of the nine women who declined to participate in the research, but 
who returned our calls, seven were working outside the home full-time.
At the eight month postpartum test time, two women were still breastfeeding. 
Six women had at least one menstrual cycle prior to this test session. The same four 
participants that were working at four months were continuing to work part-time at 
eight months and the same three participants who were previously taking oral
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contraceptives were still taking oral contraceptives. Both participants previously on 
anti-depressants had ceased taking the medications.
At 12 months postpartum, only one participant was known to be 
breastfeeding. Participant E was unavailable for testing and it was not known whether 
she was still breastfeeding. The same three participants were taking oral 
contraceptives and no other medications were reported. Each of the seven participants 
known not to be breastfeeding at this time reported having mostly regular menstrual 
cycles. Participant H was later found to be five weeks pregnant at this test time. Her 
progesterone, DHEAS, testosterone and estriol values did not differ significantly from 
those of the other eight participants. Her estradiol values were significantly greater 
than those of the other participants at the 12 month testing session, but were lower 
than either her own four month or eight month estradiol values, when she was known 
not be pregnant. Thus, her data were included in the analyses.
Psychological Data 
Longitudinal Trends in Postpartum Mental Health
Postpartum psychiatric distress has been described and investigated largely 
under the rubric of three popularly but loosely defined depressive disorders 
developing sometime within the first postpartum year. Accumulating evidence 
suggests that postpartum psychiatric symptoms are not limited to depression and 
develop in the immediate puerperium. The current research examined the breadth, 
onset time and time course of these disturbances over one year in a cohort of nine 
women. In order to characterize fully the spectrum of psychiatric symptoms across
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the postpartum year, the SCL-90-R was administered at four (T3), eight (T4) and 
twelve (T5) months postpartum as the primary outcome measure. SCL-90-R data 
previously collected during week 37 of pregnancy (Tl) and 10 days postpartum (T2) 
(Marrs 2006) for these nine women were included in the longitudinal trend analyses. 
Symptom Checklist 90-R
The SCL-90-R manual (Derogatis, 1994) provides normative T-scores for 
both psychiatric and non-patient populations. All data comparisons in this study were 
made to the normative scores for the female non-patient population. Each of the 
symptom domains has a mean T-score of 50 with a standard deviation of 10. A T- 
score of 60 is equivalent to a percentile rank of 84, suggesting that scores one 
standard deviation above the mean are indicative of relatively high distress levels. 
Listed in Table 2 are mean T-scores, standard deviations and percentage of 
participants who were considered symptomatic for each of the symptom domains 
measured by the SCL-90-R at each of the five test times.
As can be seen in Table 2 mean participant scores were close to or slightly 
above normative means in each of the symptoms clusters at each test time suggesting 
that the participants as a whole experienced mild to moderate distress. However, 
obtained standard deviations and examination of individual scores belies this 
generalization by exhibiting a large range of individual scores and symptom severity. 
Looking at the percentage of women who were considered symptomatic (SCL-90-R 
T-score >60) at each test time demonstrates for some symptoms a larger percentage 
of participants suffered from psychiatric distress than was inferred from the mean 
scores. This is illustrated in Figure 3 which plots the percentage of symptomatic
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women at each test time. Conversely, at each test time there were women for whom 
pregnancy was a wonderful experience and who’s SCL-90-R T-scores remained 
below 50 across all test times.
During pregnancy symptoms of distress were present in at least half of the 
women tested. The depression, somatization and obsessive compulsive scales showed 
the highest percentage of symptomatic women at this test time. Ten days following 
parturition, the percentage of symptomatic women increased for all but the paranoia, 
somatization and obsessive compulsive scales. Four participants demonstrated 
symptoms of obsessive compulsive behavior at both test times. Additionally, in the 
immediate postpartum, one-third to over one-half of the women tested were 
symptomatic in each of the anxiety symptom clusters (anxiety, phobia, obsessive 
compulsive behavior and somatization). Four women showed evidence of sub­
threshold psychotic disturbances absent concurrent elevations in paranoia and eight of 
the nine women tested scored >60 in the depression scale, representing the largest 
measure of psychiatric distress. Overall, five women were significantly distressed in 
enough clusters to merit GSI scores >60.
At four months postpartum, both the frequency and severity of psychiatric 
symptoms diminished with only one participant exhibiting a GSI score > 60 and two 
additional participants showing signs of mild distress with intermittent elevations in 
individual symptoms scales. Psychiatric distress increased again at eight months 
postpartum with four participants exhibiting signs of depression, three participants 
exhibiting obsessive compulsive behavior, two participants showing elevated 
psychoticism scores and two participants showing elevated GSI scores. Depression
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scores wane again at one-year, but the GSI remains consistent with two participants 
reaching the cutoff of >60. It is interesting to note that by eight months postpartum 
only two participants were still breastfeeding and seven participants had resumed 
menstruation.
In order to determine if the symptom changes described above were 
statistically significant a series of repeated measures ANOVAs were run. As shown in 
the top row of Table 3 all of the symptoms showed significant improvement across 
time except for anxiety, paranoia and interpersonal sensitivity which showed no 
change. It should be noted, however, that paranoia was not a significant contributor to 
psychiatric distress at any test time.
A trend analysis was performed to detect the direction and shape of these 
trends in postpartum symptom change. Significant linear and cubic trends were 
identified for a number of symptom clusters. With the exception of somatization, 
which followed a consistent downward trend from pregnancy through the postpartum 
year, each of the other symptom clusters exhibited some degree of curve in the trend 
line, typically denoted by spikes in symptom severity both at 10 days postpartum and 
again at four months postpartum, although symptoms increased to a much lesser 
degree at the four month test time. The second and third rows of Table 3 show which 
of these obtained trends reach statistical significance.
To determine when the largest change in symptom severity took place, paired 
comparisons were made between each test time. These results are reported in Table 3 
as well and illustrated in Figure 3. The largest number of significant changes in 
symptom severity and frequency occurred between the immediate postpartum and
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four month test times with statistically significant differences occurring in all 
symptom clusters except anxiety, paranoia and interpersonal sensitivity, which 
improved but did not meet statistical significance. Thereafter, few statistical 
differences are obtained between successive test times. This indicates that recovery 
from symptoms experienced during pregnancy and immediately postpartum is largely 
resolved by four months postpartum. Similarly, it suggests that symptoms appear to 
peak in the immediate postpartum.
Summary
By way of overview it would appear that postpartum psychiatric disturbances 
develop in late pregnancy, escalate in the immediate postpartum and diminish greatly 
by four months postpartum. Symptoms may wax and wane over the course of the 
postpartum year, and may develop in association with other life events, but 
postpartum symptoms appear to be temporally related to childbirth. Thus, the 
investigation postpartum symptoms in childbearing women should be conducted in 
proximity to the precipitating event rather in the months and year that follows. 
Moreover, in contrast to the current nomenclature and nosological distinctions that 
are rather narrowly focused upon depression, postpartum psychiatric disturbances 
seem to be characterized by a range of symptoms.
Cognitive Performance
Previously, Marrs (2006) observed moderate cognitive impairment across 
multiple domains both during pregnancy and in the immediate postpartum. Cognitive 
performance was particularly poor in both verbal and spatial memory with percentile
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rankings from only the single digits to the low double digits when compared to age 
and IQ-matched normative data. The purpose of this study was to determine if and 
when during the first postpartum year, cognitive performance returned to normal and 
to track these potential longitudinal trends across the first postpartum year. 
Longitudinal Trends in Cognitive Performance
Evaluation of Tl and T2 cognitive tests for this group of nine women showed 
significant impairment in verbal memory at both test times. However, spatial memory 
did not appear to be impaired at 10 days postpartum as had been the case in Marrs 
(2006). Similarly, performance on other cognitive tests such as the PASAT, the 
verbal and spatial fluency tests were not impaired at either the pre- or postpartum 
testing session for the current participants. Performance on the Purdue pegboard, 
however, was below average at both of these test times whereas the finger tapping 
test was not suggesting that manual dexterity may have been an issue during 
pregnancy and in the immediate postpartum.
So as to minimize Type I error and maximize statistical power only verbal 
memory performance was analyzed across the three postpartum testing sessions 
carried out in this research. However, a descriptive overview of each of the cognitive 
test results obtained across the first postpartum year is provided next.
As demonstrated by Table 4, and illustrated in Figure 4, performance on most 
of the cognitive tests administered in this research showed a slight upward trend from 
the end of pregnancy to the postpartum period which, for the most part, was 
characterized by stable above average performance across all postpartum test times. 
One exception was spatial memory, as measured by the recall portion of the CFT,
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spatial memory showed substantial improvement from pregnancy to postpartum but 
declined again at four months and again at twelve months. The apparent 
improvements in spatial memory correspond to the administration of Taylor’s 
alternate CFT form. Comparability studies have found that while the copy scores of 
each of the CFT forms is equal in healthy young adults, the Rey CFT standard form is 
more difficult and typically merits a five point difference in scores (Spreen & Strauss 
1998). When those points are accounted for, the data reveal that there was no 
substantial improvement in the recall portion of the spatial memory task. Considering 
that each woman was exposed to the Rey CFT standard form on three different 
occasions, practice effects would have been expected. Indeed, in healthy young adults 
an improvement of 10% or more per trial is expected (Spreen & Straus, 1998). In the 
present research the overall improvement across the three administrations of the 
standard form was less than 10%.
Unlike CFT scores from Marrs (2006) where the copy portion of the CFT was 
equally as impaired as the recall portion, copy scores in the present study were 
generally above the mean at each test time but did show slight downward trend across 
test times. The difference in copy scores may be related to the small sample size in 
the current study.
Performance on the Purdue pegboard was below average both during 
pregnancy and following parturition but showed improvement across the remaining 
test times. If both the finger tapping test and the pegboard had been impaired, motor 
slowing would have been suspected. Since the Purdue pegboard demands significant
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fine motor dexterity it is possible the pregnancy related swelling contributed to the 
poor performance.
As noted above, verbal memory was impaired at 37 weeks of pregnancy and 
in the immediate postpartum period. Table 5 and Figure 5 show that when compared 
to age and IQ-matched (based upon an estimated full-scale IQ of 112) normative data, 
immediate, short and long delay verbal memory scores ranged from the <1®' to the 
25* percentile during pregnancy and < F ‘ to the 32"'* percentile in the immediate 
postpartum (Spreen & Strauss 1998). Normative data by age and IQ were not 
available for the semantic clustering or learning slope variables. Accordingly, the 
percentile ratings reported here for these measures may be higher than what have 
been expected for this group based upon their performance on the recall scales. 
Semantic clustering, the degree that words were categorized by meaning in the recall 
measures, was above average at both Tl and T2, whereas the learning curve scores 
fell considerable below average at both of these test times. Scores for this subset of 
women were consistent with those for the entire group in Marrs (2006).
For the most part verbal memory improved across the postpartum year with 
percentile rankings approaching or exceeding normative means. The lower scores 
sometimes observed at 10 days postpartum and again at eight months postpartum 
corresponded to the administration of the alternate test form although test designers 
posit high correspondence between performance on the standard and alternate forms 
(Dellis et al., 2000).
Irrespective any potential performance discrepancies between the standard and 
alternate forms, verbal memory scores improved in each of the dimensions measured
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except for proactive interference, Trial B, which remained below 15% throughout the 
postpartum. Trial B is a distracter list of words administered after the fifth trial of the 
primary list, in the immediate recall portion of the exam and before either of the 
delayed recall trials begins. It measures the degree to which previously learned 
information hinders the acquisition of new information. While some proactive 
interference is expected in non-clinical populations, the consistently low scores for 
trial B observed across pregnancy and postpartum indicate a potential deficit in 
working memory (Jonides & Nee, 2006). Consistent with that possibility, the 
obtained learning slope scores, which measure the number of new words learned per 
trial were relatively low and stable across most postpartum test times.
Deficits in working memory are suspected when the number of words learned 
in Trial 1 is greater than the number of words learned in Trial B as measured by a 
difference in z-score of >1.5 points (Bonders, 2006). This criterion was met at three 
test times and just missed the cutoff at four months and at eight months where the 
difference between the scores was 1.49 and 1.32 points, respectively. Interestingly, in 
comparison to other individuals with similar difficulties in proactive interference, 
overall recall scores (CVLT-II, Trial 1-5 total) were significantly better for 
participants in the present study whose scores ranged from 52-62 total words recalled 
across all test times versus a mean of 49 total words recalled (n=955) (Bonders, 
2006). Similarly, mean semantic memory z-scores for this participant group were 
very high, ranging from 0-3.59 across all test times and likely contributed to the 
greater number of words recalled.
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Repeated measures analyses (Table 6), revealed significant main effects for 
time for each of the primary measures of verbal memory except for Trial B which 
was not significant and long delay recall which approached significance at p>.056. 
Semantic clustering also improved significantly over time but the learning curve did 
not. The trend analysis indicated significant linear trends for each of the primary 
measures except long delay recall.
Change between test times was analyzed further using a series of repeated 
measures ANOVA contrast tests. As is exhibited by Tables 6, verbal memory scores 
improved in a mostly linear fashion across time. Improvement between test times was 
not always statistically significant. However, improvement between T1 and T5 was 
significant in most of the verbal memory measures, excluding Trial B, the learning 
curve and long delay recall.
Inasmuch as neither a control group nor a reliable change index was used to 
counter the effects of practice in short and long term verbal memory test performance, 
these results must be interpreted cautiously. It is impossible to discern whether true 
improvement or improvement mediated by repeated exposure was observed in the 
present study. However, the lack of improvement in both the learning slope and in 
performance on trial B suggests the possibility that improvement in the other aspects 
of verbal memory may have come from practice.
Associations between Verbal Memory and Psychological Distress
Unlike in Marrs (2006) where psychiatric symptoms were inconsistently and 
sometimes positively associated with cognitive performance, in the present study 
several scales on the CVLT-II were consistently and negatively associated with SCL-
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90-R symptoms, predominantly at T l, T2 and T3. For example, anxiety was 
negatively correlated with immediate recall trial 1 and recall total at one year 
postpartum (r=-.716, p<.05; r=-.688, p<.05, respectively). It had previously been 
associated with poor delayed recall during pregnancy (r=-.669, p<.05). Hostility was 
associated with poorer immediate recall trial 1 and trial B during pregnancy but not in 
subsequent testing session (r=-.713, p<.05; r=-.913 p<.001, respectively).
Somatization was a factor in both the long delay recall trial at T2 (r=-.671, 
p<.05), T3 (r=-.730, p<.05) and on semantic clustering ability during pregnancy only 
(r=-.709 p<.05). Obsessive compulsive behavior was related to poor performance on 
the immediate recall total (r=-.679, p<.05), short delay free recall (r=-.666, p<.05) and 
the long delay recall trial (r=-.723, p<.05) at four months postpartum. Increased 
interpersonal sensitivity was also associated with performance on the long delay trial 
(r=-.691, p<.05) at T3 as was depression at T2 and T3 (r=-.753, p<.05; r=-.691, 
p<.05, respectively). Finally, the GSI was associated with poor long delay recall 
abilities at T2 (r=-.682, p<.05) and T3 (r=-.813, p<.01).
Summary
The most robust findings concerning cognitive performance during pregnancy 
and postpartum obtained herein were that deficits in spatial and verbal working 
memory originally identified during pregnancy persist through the first postpartum 
year. Moreover, psychiatric distress impaired verbal memory performance. At least it 
was the case that each of the significant associations obtained between verbal 
memory and distress were negative and most prominent during pregnancy, the 
immediate postpartum and four-months postpartum. As verbal memory improved.
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whether by practice or not, and psychiatric distress was ameliorated, the correlations 
between the two dissipated.
Hormone Data
Results from Marrs (2006) demonstrated a strong relationship between the 
adrenal androgens DHEAS and testosterone and psychiatric disturbances. Prenatal 
testosterone was associated negatively with prenatal psychiatric distress, but also 
heralded the onset and exacerbation of symptoms following parturition. Concurrently, 
elevated DHEAS was associated positively with both pre- and postpartum distress. 
Following parturition as DHEAS concentrations increased so too did the severity of 
psychiatric distress. The current study investigated the time related trends in these 
hormones relative to psychiatric distress and cognitive function.
Patterns o f Change
The inter-individual variance in hormone values observed in this study was 
enormous, with standard deviations as large as or greater than mean values for some 
hormones. These mean values and standard deviations are shown for each hormone 
measured at each test time in Table 7 along with reference ranges for non-pregnant, 
non-postpartum women. It should be noted that reference ranges for salivary hormone 
values have not been established for either pregnant or postpartum women and these 
reference ranges should be interpreted with caution. Mean data for each hormone are 
plotted against test time in Figure 6.
Immediately following parturition mean progesterone, estradiol and estriol 
decreased by 95%, 46% and 97% respectively. Mean DHEAS concentrations almost
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doubled following pregnancy showing a 99.24% increase at the first postpartum test 
time and testosterone values increased by 10%.
Between the immediate postpartum and the subsequent three testing sessions 
the pattern of hormone change varied among the hormones. As may be gleaned from 
Table 7 mean postpartum progesterone, estradiol estriol concentrations generally fell 
within the normal range of expected values for non-pregnant women, non-postpartum 
women and remained fairly consistent across the postpartum year.
Mean postpartum testosterone concentrations fell within the normal range of 
expected values, but skewed toward the lower end of the normal range at four months 
postpartum and then approached the median normative values for the remaining two 
test times. Inter-individual variability was particularly large for postpartum 
testosterone with concentrations ranging from as low as .4 pg/mL for Participant A at 
T2, to as high as 80 pg/mL for Participant E at T4. Individual hormone values and 
percent changes between successive test times are given for each participant in Table 
8 .
DHEAS showed the most unique pattern in that mean values increased from 
pregnancy to postpartum and showed no tendency to decrease across the postpartum 
year. Moreover mean DHEAS values were at the high end of the reported reference 
ranges. Mean DHEAS concentrations across the postpartum year ranged from 1725 
pg/mL to 2125 pg/mL compared to the 200-2500 pg/mL reference range. At each of 
the four postpartum test times, at least two participants approached or exceeded the 
clinical reference ranges. Overall four different women met or exceeded clinical 
cutoffs for this hormone at least once during the year. As may be seen by reference to
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Table 8, participant E exceeded the cutoff on four occasions and Participant G, 
exceeded the cutoff on two occasions. Participants D and H exceeded the clinical 
cutoff on one occasion each.
DHEAS concentrations >2500 pg/mL are clinically indicative of adrenal 
dysfunction and typically merit further diagnostic investigation. Moreover, elevated 
DHEAS values are generally co-associated with elevated testosterone (Bulun & 
Adashi, 2003) which did not occur in this research. Participants with supra- 
physiological concentrations of DHEAS were notified by the investigator and 
encouraged to seek further testing. Only Participant E whose DHEAS values reached 
>7200 pg/mL chose to do so.
Special note is taken that the mean postpartum estriol values, while relatively 
stable across the postpartum trended toward the high end of the non-pregnant, non­
postpartum reference ranges. Mean postpartum estriol concentrations observed in this 
study ranged from 12-14 pg/mL compared to the laboratory reference range of .5-16 
pg/mL (Table 7). Whereas individual postpartum values ranged from as low as 4.2 
pg/mL to as high as 26.6 pg/mL, five different women on nine different occasions 
exceeded the clinical cutoff (Table 8).
Estriol is the primary metabolite of fetal DHEAS during pregnancy. Fetal 
adrenals produce large quantities of DHEAS, which are then metabolized into estriol 
by the fetal liver via 16a-hydroxylation. With the occasional supra-physiological 
DHEAS values observed in the present study, one might expect increased conversion 
of DHEAS to estriol in the maternal liver. Correlations between hormones at each of
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the test times are given in Table 9. As can be seen therein a significant correlation 
between DHEAS and estriol occurs only at T4.
Further examination of the hormone to hormone correlations shown in Table 9 
reveals that while DHEAS was significantly correlated with testosterone at four, eight 
and twelve months postpartum, testosterone concentrations were not correlated with 
estradiol concentrations at any of the test times, but were correlated significantly with 
estriol during pregnancy and postpartum and again at T4. The lack of association 
between testosterone and estradiol is surprising insofar as testosterone and estradiol 
are thought to be highly correlated, particularly in hyperandrogénie conditions (Bulun 
& Adashi, 2003).
Longitudinal Trends in Postpartum Hormones
A series of repeated measures ANOVAs were performed to assess the 
statistical differences in mean hormone concentrations across test times. Multiple 
contrast measures were utilized to determine differences in mean hormone 
concentrations between each test time and polynomial trend analyses were performed 
to assess the shape and significance of trends across time.
As illustrated in Table 10 there were significant main effects for time for 
progesterone and estriol with most of the effect accounted for by the significant 
changes from pregnancy to the immediate postpartum (p<.000 for each). Neither 
DHEAS nor estradiol showed significant main effects but did follow significant linear 
and cubic trends, respectively, and showed some significant changes between 
individual test times, particularly at Tl and T5.
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Mean DHEAS values between test times did not show significant differences, 
probably because of the previously noted substantial inter-individual and intra­
individual (between test times) variability observed for this hormone. Nevertheless, 
the unique pattern obtained for this hormone merits its further consideration.
DHEAS values measured in serum, are reported to be high in early pregnancy 
diminish in late pregnancy and return to non-pregnant concentrations following 
parturition (Soldin et al., 2005; Tagawa et al., 2004). At one year postpartum, serum 
DHEAS concentrations are expected to be within non-pregnant reference ranges 
(Soldin et al., 2005). There are no published data on salivary DHEAS concentrations 
either during late pregnancy or at any time during the first postpartum year. However, 
the balance between serum values, which represent the fraction of hormone bound to 
protein (DHEAS is tightly bound to albumin) and the salivary concentrations, which 
represent the free fraction of hormone, that which is not bound to circulating proteins, 
are highly correlated and reportedly maintained in dynamic equilibrium (Bolaji, 1994; 
Lu et al., 1999; Meulenberg & Hofinan, 1989; Vinning & McGinley, 1987). Thus, it 
would be expected that the trends in salivary hormones observed in this study 
compared to others would be similar those obtained previously in serum. This 
appeared not to be the case. With the exception of a slight decrease at eight months 
postpartum, mean DHEAS concentrations increased from pregnancy through the first 
postpartum year. It has also been reported that elevated DHEAS concentrations are 
typically associated with elevated testosterone and estradiol (Kroboth et al., 1999). 
This appeared not to be the case in the present study.
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Hormone to Symptom Associations
In Marrs (2006), the adrenal androgens DHEAS and testosterone were 
uniquely and significantly associated with the full spectrum of psychiatric 
disturbances measured by the SCL-90-R. Elevated puerperal DHEAS and diminished 
late pregnancy testosterone were associated with pre- and postpartum symptoms 
whereas progesterone and estriol were not associated with any symptoms and 
estradiol was only correlated with a few dimensions. To determine what role these 
hormones played in psychiatric symptomatology across the year, correlations between 
hormone values and psychiatric symptoms were calculated for the current participants 
at each test time.
Results from the correlation calculations are listed in Table 11. Correlations 
between hormones and psychiatric symptoms during pregnancy and postpartum were 
not significant. However, immediate postpartum DHEAS was significantly correlated 
with increased postpartum anxiety, paranoia, psychoticism and the GSI. Progesterone 
and estriol were not associated with symptoms at either of these two test times and 
estradiol was not correlated with any symptom at any test time.
At four months postpartum, progesterone, DHEAS and testosterone were all 
significantly and positively associated with a variety of psychiatric symptoms as 
shown in Table 11. Most notable were the hormone to mood correlations for anxiety, 
phobia, paranoia, psychoticism, obsessive compulsive behavior and depression.
Estriol was also significantly correlated with depression at this test time.
At eight months postpartum significant positive hormone to psychiatric 
symptom correlations were found only for DHEAS, testosterone and estriol. As
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shown in Table 11, DHEAS was correlated with phobia, paranoia and psychosis and 
testosterone was correlated with phobia. It is notable that the largest number of 
correlations at eight months postpartum was found for estriol which was correlated 
positively with anxiety, phobia, paranoia, psychoticism, obsessive compulsive 
behavior and depression.
Finally, at twelve months postpartum, only progesterone was associated with 
psychiatric symptoms. Progesterone was correlated with phobia, paranoia, 
psychoticism and somatization as again shown in Table l l . l t  must be noted that 
hormone values and SCL-90-R scores for participant E were estimated for this test 
time using the median value of her hormone values and scores from previous sessions 
and thus correlations presented here must be interpreted with caution.
Hormone to Verbal Memory Associations
In Marrs (2006) the relationship between individual hormones and tests of 
cognitive performance was inconsistent but did indicate that elevated hormone 
concentrations were associated generally with poorer performance across multiple 
measures. In the present study, no statistically significant associations were identified 
between measures of verbal memory and any hormone at any of the three postpartum 
test times.
Summary
The hormone data presented herein suggest that inter-individual variability is 
considerable and that trends changes in hormones across the postpartum period can be 
concealed by analysis of mean data alone. Nevertheless, the obtained mean data do 
demonstrate that progesterone, testosterone, estradiol and estriol are elevated during
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late pregnancy, decline after parturition, and stabilize across the postpartum year. On 
the other hand, mean DHEAS values trended upward across the postpartum year.
Each of the hormones measured was correlated positively with psychiatric 
symptoms at some time during the postpartum year except for estradiol, which was 
not correlated with any symptoms at any test time. DHEAS was significantly 
correlated with symptoms at T2, T3 and T4 showing the largest number of significant 
correlations of any of the hormones measured. This was followed by progesterone 
which was associated with symptoms at T3 and T5 while testosterone and estriol 
were associated with symptoms at T3 and T4. The present study obtained no 
significant hormone to cognitive performance correlations at any test time.
Case Histories
Two women within this cohort. Participants D and E, suffered significant 
psychiatric distress in the immediate postpartum to merit a more detailed description 
of their individual symptoms, hormone patterns and results from the 
neuropsychological assessments. Participant D was 29 years old at the time of the 
first testing session, married, pregnant with a male child, right-handed and employed 
professionally, with 16 years of education. Participant E was 26 years old, married, 
pregnant with a female child, left-handed, with 16 years of education. She had been 
employed professionally until five months of pregnancy when persistent nausea had 
precluded her continued employment.
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Participant D
Participant D reported a normal but extended pregnancy. She delivered 
approximately two weeks after her scheduled due date with labor induction required. 
Her labor was approximately 18 hours. At T l, she showed some signs of 
psychological disturbance with elevated SCL-90-R T-scores in the following 
symptom clusters: somatization, 62; obsessive compulsive, 72; depression, 62; and 
GSI, 63. It was noted that during this testing session, her affect was unusually flat, 
with little to no expression of either positive or negative emotion.
Performance on the battery of neuropsychological exams was marked by 
below average short and long term verbal recall (45^ and 32"‘* percentiles, 
respectively), very poor control of proactive interference (Trial B, l(f^ percentile) as 
measured by the CVLT-II and poor spatial memory (9^ '’ percentile) as measured by 
the CFT. Attentional capacity as measured by the PAS AT was at or just below the 
50^ percentile across all four trial speeds. Motor processing and fine motor skills as 
measured by the FTT and Purdue were within normal ranges and performance on 
both the verbal and design fluency tests was at or just below the 50* percentile.
Following parturition. Participant D experienced severe anxiety and panic 
attacks. She exhibited autonomic instability without concomitant thoughts of harming 
her child. Her SCL-90-R scores increased considerably. Her T-scores were as 
follows: anxiety, 76; hostility, 61; phobia, 66; psychoticism, 69; somatization, 78; 
obsessive compulsive behavior, 70; depression, 72; and her GSI was 70. Again, and 
even with such active psychiatric disturbances her affect was unusually flat. 
Concurrent with these symptoms DHEAS and testosterone concentrations went from
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640 pg/mL and 48 pg/mL respectively at Tl to 4555 pg/mL and 25 pg/mL 
respectively, following parturition. Postpartum cognitive performance improved 
minimally and/or remained consistent with performance during pregnancy, although 
her CVLT-II total immediate recall declined somewhat from the 45* percentile 
during pregnancy to the 42"^ percentile postpartum. Spatial memory remained poor at 
the 9* percentile.
At approximately three weeks postpartum she sought help from a physician 
and was prescribed escitalpram oxalate (Lexapro), a selective serotonin reuptake 
inhibitor (SSRI) commonly prescribed for depression but also for generalized anxiety 
disorder. By two months postpartum the participant reported feeling better and by 
four months postpartum had begun to taper her medication. At four months 
postpartum, her symptoms had subsided with only the somatization scale reaching T- 
score above 60 (T=62). Her DHEAS and testosterone concentrations returned to 
within normal ranges and her affect had returned to normal. Cognitive performance 
across all tests improved slightly or remained consistent with previous performance 
except for spatial memory which declined further to the 8* percentile.
At eight months postpartum, it was revealed that Participant D’s son had 
recently undergone a procedure to correct testicular mal-descent. Testicular mal- 
descent sometimes referred to as cryptorchidism occurs in 1-6000 births and is 
thought to be caused by low gestational testosterone and/or testosterone receptor 
insensitivity (Bradshaw & Carr, 1986). The surgery was successful and the child was 
doing well. No other health related issues were reported. Symptom T-scores at this 
time were slightly elevated: psychoticism, 60; obsessive compulsive behavior, 62;
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interpersonal sensitivity, 63; and depression, 62. Her GSI was 58. DHEAS increased 
by 482 pg/mL from the previous test time but was within the normal range. Other 
hormone values were also within the normal range. Cognitive performance continued 
to improve. CVLT-II scores were all above the 50* percentile and spatial memory 
scores improved to the 25* percentile.
At 12 months postpartum no SCL scores were above 60, DHEAS 
concentrations fell -300 pg/mL. All other hormones remained within normal ranges. 
Cognitive performance remained stable, except for spatial memory which declined to 
the 10* percentile.
Participant E
Participant E had a difficult pregnancy and suffered from significant nausea 
and vomiting throughout the entire pregnancy. At Tl she was showing signs of 
distress with elevated SCL-90-R scores across several domains. Her T-scores were as 
follows: anxiety, 73; hostility, 55; phobia, 76; paranoia, 60; psychoticism, 65; 
somatization, 72; obsessive compulsive behavior, 73; interpersonal sensitivity 69; 
depression, 72; and her GSI was 73. Despite the difficulties she reported being 
excited about the birth and was particularly interested in having the nausea dissipate. 
Her cognitive performance was below average during pregnancy, ranging from the 
16* percentile in Trial 1 and Trial B, long delay recall measures to the 32"  ^percentile 
for short delay and the 47* percentile for total immediate recall in the CVLT-II. Her 
attentional capacity and cognitive processing speed was somewhat below the mean 
but her motor processing and fine motor skills were at or above normative mean 
performance. Unlike Participant D who showed significant impairment in spatial
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memory, Participant E performed above average on this measure scoring in the 79* 
percentile.
Following parturition Participant E suffered significant anxiety and was 
immediately plagued by violent and aggressive thoughts typically involving the death 
or injury of her infant or herself. The severity of her distress increased significantly as 
is seen with the increase in SCL-90-R symptom T-scores: anxiety, 80; hostility, 61; 
phobia, 76; paranoia, 57; psychoticism, 71; somatization, 80; obsessive compulsive 
behavior, 80; interpersonal sensitivity, 67; depression, 74; and her GSI was 75. 
Concurrent with the psychiatric distress, participant D experienced significant 
changes in circulating androgens. Pregnancy DHEAS and testosterone concentrations 
were 596 pg/mL and 19 pg/mL respectively. Postpartum DHEAS jumped to 2799 
pg/mL while testosterone concentrations rose to 33 pg/mL.
In addition to the violent images, participant E suffered from periods of 
autonomic instability (greater than twice daily) that were marked by increased heart 
rate, chest pain, leg pain, difficulty breathing and night sweats for which she sought 
medical attention. Various tests were run and all were negative. Detailed information 
was not disclosed to this investigator. At 10 days postpartum she developed mastitis, 
concurrent with a high fever and was prescribed the antibiotic Diaclox. She was 
encouraged repeatedly by this investigator to seek treatment for her psychological 
distress, but she declined to do so. Phone conversations with the investigator 
indicated no remission in either physiological or psychological symptoms over the 
course of the first month postpartum. At approximately one month postpartum, she 
sought medical treatment and was prescribed citalpram hydrobromide (Celexa) but
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did not receive counseling. She remained on Celexa for approximately one month, at 
which time she was prescribed Lexapro. Postpartum cognitive performance improved 
or remained stable across all domains except for spatial memory, which declined 
significantly from pregnancy to the 10 day postpartum testing session.
At four months postpartum. Participant E was still taking Lexapro and 
suffering from psychiatric symptoms but she reported that the occurrence of 
autonomic instability had diminished from twice daily to 2-3 times per week. The 
participant also reported that the medication had helped with her “motivation to get 
out of bed.” Although the autonomic instability had largely diminished she still 
suffered from night sweats. Moreover, the occurrence of obtrusive thoughts and 
subsequent compulsive avoidance behavior had remained the same or had increased. 
She reported being plagued by images of her daughter being mauled by dogs, of 
being stabbed, and of having the cable from the breast pump strangle her daughter. 
Again she was encouraged to seek treatment and refused, claiming that her symptoms 
had largely been minimized by the physician that had prescribed her the medication. 
Her SCL-90-R T-scores at this time were: anxiety, 77; hostility, 61; phobia, 76; 
paranoia, 67; psychoticism, 69; somatization, 66; obsessive compulsive behavior, 68; 
interpersonal sensitivity, 68; depression, 68; and GSI, 72.
Concurrent with the elevated SCL90-R T-scores, some supra-clinical hormone 
values were observed with the concentrations of DHEAS being almost three times 
above normal clinical ranges at 7212 pg/mL while her progesterone was at 700 
pg/mL. She was encouraged to follow-up with her physician regarding endocrine 
function. It is not known which endocrine tests were completed but the patient
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reported no abnormalities were identified. Cognitive performance remained stable or 
improved minimally. Verbal memory was at or just above average in all domains 
except for Trial B, proactive interference which remained at the 16* percentile. 
Spatial memory performance remained at the 42"*^  percentile.
At eight months postpartum, participant E’s psychiatric symptoms were still 
elevated though not as severely as at previous test times. She had stopped taking 
Lexapro at approximately five months postpartum and had not received counseling. 
Her DHEAS were still above the clinical cut off at 5731 pg/mL, more than twice the 
upper range of normal non-pregnant concentrations. In addition to the psychiatric 
distress, she reported an unusual skin condition marked by excessively scaly skin on 
her wrists, feet, ankles, knees and torso. Dermatological treatment had not provided 
relief. Based upon her hormone values, she was again encouraged to follow-up with 
her physician; the results of which are unknown as she dropped out from the study 
after this test time. Cognitive performance at eight months postpartum showed no 
significant changes fi’om the previous test times and remained within or just below 
average.
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CHAPTER 5
DISCUSSION 
Trends in Postpartum Symptomatology
The purpose of the study was to examine prospectively the longitudinal trends 
in postpartum psychiatric disturbances, cognitive performance and hormone values in 
a cohort of healthy, primigravid women. This study represents the first longitudinal, 
cohort investigation of these variables. Findings from this study confirm some, and 
dispute other, commonly held hypotheses regarding pregnancy and postpartum that 
had hereto not been tested. Perhaps the most important of these involves the onset and 
course of psychiatric disturbances relative to puerperal hormone changes.
Postpartum mental illness has heretofore been classified along the spectrum of 
mood disorders, predominantly based on unipolar depression not linked to organic 
factors. The DSM-IV allows for the onset of postpartum disorders within 30 days of 
parturition, but researchers regularly include cases as far out as one year post-delivery 
(Andrews-Fike, 1999; Gavin et al., 2005; Mowery & Lennon, 2001; Pfuhlmann et al., 
1998; Sing & Kauer, 1999; Wisner, Peindl & Hanusa, 1993; Wisner, Peindl &
Hanusa, 1995).
Data from Marrs (2006) and the present study support the time-limited onset 
put forth by the DSM-IV, by demonstrating that new cases of postpartum psychiatric 
distress are not likely to originate beyond four months post-delivery. Even though
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symptoms may wax and wane somewhat over the postpartum year, the most 
significant psychiatric symptoms emerge in the days following parturition and largely 
dissipate in all but the most serious cases by four months postpartum.
This general finding is consistent with data from a recent Danish registry 
study by Munk-Olsen et al. (2006) who reviewed the records of 1171 women over the 
course of 30 years and demonstrated that women were at significantly greater risk of 
needing either in-patient and/or out-patient psychiatric care in the first 19 days 
following parturition than at any other period in their lives. Similarly, Stowe et al., 
(2003) found that 66% of all cases of postpartum depression develop within three 
weeks postpartum and Klompenhouer and van Hulst (1991) who found that 70% of 
all cases of postpartum psychosis develop within 10 days of parturition.
Findings from Marrs (2006) and the present study suggest that the limited 
range of psychiatric symptoms considered by the DSM-IV and investigated by most 
researchers needs to be expanded. Although depression was certainly present in both 
Marrs (2006) and the current study and was, in both cases the most frequently 
ascribed to symptom cluster, depression was not the most debilitating symptom 
indicated by the obtained SCL-90-R T-scores. Rather, at four, eight and twelve 
months postpartum the mean T-scores for phobia, psychoticism and obsessive 
compulsive behavior scores generally exceeded depression T-scores. This may have 
been related to the type of questions that load on the depression scale. After all many 
depressive “symptoms” might be expected as a consequent of childbirth and even of 
child care and not indicative of true psychiatric dysfunction. Be that as it may, the 
data obtained in this study do indicate that anxiety type symptoms, including
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autonomie instability, phobia, obsessive behavior and some degree of psychoticism 
are at least as evident as depression in the postpartum. This finding is consistent with 
the few studies that have investigated co-morbid anxiety symptoms postpartum and 
found anxiety symptoms to be prevalent in both the immediate and late postpartum 
period (Austin, 2004; Reicher-Rossler & Fallahpour, 2003; Ross et al., 2002; Wenzel 
et al., 2005).
Thus, it is suggested that postpartum psychiatric distress hinges more on the 
anxiety than depressive disorders (Austin, 2004; Ross et al., 2002; Wenzel, Gorman 
& Stuart, 2001; Wisner et al., 1999). When the individual scores from the present 
study are considered, it is apparent that only elevated anxiety components persisted 
beyond four months postpartum. With the two most serious cases of postpartum 
psychiatric distress. Participants D and E, depression T-scores did not exceed anxiety 
symptom T-scores at any postpartum test time, and the primary complaint reported by 
both participants was anxiety with autonomic instability.
What distinguished these two participant’s cases from each other, was the 
presence of violently aggressive and obtrusive images and the degree of psychoticism 
in Participant E. Although both participants experienced similar levels of anxiety and 
autonomic instability, only Participant E experienced the intrusive images and, 
perhaps, as a consequence this extended her symptoms through eight months 
postpartum. Jennings et al 1999 found that violent, intrusive thoughts were more 
prevalent in postpartum women and contributed significantly to the severity of their 
symptomatology. Thus, while depression certainly played a role in postpartum
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psychiatrie distress, it was neither the most prominent nor the most persistent 
symptom and may in fact have been secondary to other symptoms.
In light of these findings, future research should be directed toward the 
development of a postpartum-specific assessment tool that addresses both the breadth 
and the depth of psychiatric symptoms, is capable of distinguishing between 
postpartum and non-postpartum psychiatric distress and is administered in closer 
proximity to the precipitating event.
Trends in Postpartum Cognitive Performance 
Cognitive deficits are an anecdotally accepted consequence of pregnancy that 
have thus far eluded empirical explanation. Research shows that upwards of 80% of 
pregnant women perceive that they have memory deficits during pregnancy (Brindle 
et al., 1991; Jarrahi-Zadeh et al., 1969; Sharp et al., 1993). However, very few studies 
have empirically demonstrated pregnancy related cognitive deficits.
Investigations by Buckwalter et al. (1999) and Marrs (2006) demonstrated 
significant verbal and spatial memory deficits during pregnancy and the immediate 
postpartum when compared to age, IQ and gender matched normative data but did not 
obtain consistent significant correlations between individual hormones or 
psychological symptoms and cognitive performance. Conversely, Vansten (2006) 
found no differences in cognitive performance between pregnant and non-pregnant 
women and no correlations between mood symptoms (as measured by the Profile of 
Mood States) and any aspect of cognitive performance.
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Review of the data from the present and the previous study (Marrs, 2006) 
indicates that some level of cognitive impairment may occur during pregnancy and 
persist through the immediate postpartum. Although in the present study, any deficits 
that occurred typically resolved in the course of the year-long postpartum period 
observed. Verbal and spatial memory, as measured by the CVLT-II and CFT 
respectively, were most notably impaired during pregnancy.
When compared to normative data, the mean data for spatial memory obtained 
from the current participants showed no impairment in spatial memory measured at 
10 days postpartum and at eight months postpartum but did show impairment at four 
and twelve months postpartum. Further review of CFT performance demonstrated 
that improvement occurred at those test times when the Taylor alternate form was 
administered. Researchers speculate that the Rey CFT is more difficult than other 
alternate CFT forms and that scores on the standard form are at least five points lower 
than those observed on the alternate forms (Spreen & Strauss, 1998). When mean 
scores on the alternate forms were adjusted for the five point difference, impaired 
performance across all test times was observed. These obtained and adjusted low 
scores across trials were particularly noteworthy insofar as only minimal practice 
effects were exhibited. Despite having been exposed to the same figure on three 
different occasions, recall scores improved by less than 10% per trial.
Verbal memory scores were substantially depressed during pregnancy and the 
early postpartum. However, except for Trial B, the measure of proactive interference, 
verbal memory scores generally showed a significant linear increase across the one 
year postpartum period. Bolstering performance on the recall measures were semantic
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memory skills. Semantic memory scores across all trials, but especially at four, eight 
and twelve months postpartum were significantly higher than individual verbal 
memory recall measures.
The increasing trends in recall scores and semantic clustering across the 
postpartum contrast with the uniformly poor learning slope measure and Trial B. Trial 
B measures the individual’s ability to adequately suppress irrelevant information 
influences the amount of information that can be retrieved from working memory 
(Jonides & Nee, 2006). A discrepancy of greater than a 1.5 point difference in z-score 
between Trial 1 and Trial B (Trial 1 > Trail B) is suggestive of impairment (Bonders, 
2006). This criterion was met during pregnancy, postpartum and again at twelve 
months postpartum and suggests the possibility of impairment in working memory.
Trends in Postpartum Hormones
Puerperal hormone concentrations are reported to increase during pregnancy, 
decrease following delivery, and return to “normal” in the ensuing months as the 
cyclicity of reproductive hormones returns (Illingworth & McNeilly, 1998). This 
hypothesis has generally been confirmed for the reproductive hormones such as 
progesterone, estrone, estradiol and estriol, but not for the androgenic hormones such 
as DHEAS and testosterone. There is, however, a paucity of data regarding the 
reproductive hormones in the months following parturition and basically no data 
regarding postpartum trends the non-reproductive adrenal androgens. Accordingly, 
the impact of these hormones on postpartum mental health is unclear.
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Marrs (2006) showed that progesterone, estrone, estradiol and estriol were 
elevated in late pregnancy and decreased significantly by the 10 day postpartum 
testing session. DHEAS and testosterone concentrations did not follow this pattern. 
Testosterone concentrations were low in late pregnancy contrary to published reports 
(Bammann, Coulam & Jiang, 1980), while DHEAS concentrations were somewhat 
elevated in late pregnancy and then rose dramatically following parturition, again 
contrary to published reports (Milewich et al., 1978; Soldin et al., 2005; Tagawa et 
al., 2004). Moreover, both the low late pregnancy and the elevated puerperal DHEAS 
concentrations were significantly associated with the breadth and severity of 
psychiatric symptoms.
Thus, it was postulated in the present study, that the degree to which DHEAS 
returned to within normal non-pregnant concentrations would coincide with 
improvement in psychiatric symptomatology. Inasmuch as only low late pregnancy 
and not postpartum testosterone concentrations were associated with psychiatric 
symptoms in Marrs (2006), testosterone was not expected to be a factor in the present 
study. It was also postulated that if DHEAS concentrations remained above the 
normal clinical values, psychiatric symptoms would persist. Moreover, to the degree 
that DHEAS and by association DHEA might affect the metabolism of other steroid 
hormones, chronically elevated DHEAS concentrations were expected to elicit 
unspecified changes in the circulating values of other steroids hormones.
The findings from this study, although preliminary and necessarily limited by 
the small number of participants, support each of these hypotheses. In the present 
study, DHEAS was the single largest contributor to postpartum distress across all test
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times with almost twice as many significant associations as any other hormone 
measured. In the case of the anxiety type disorders such as anxiety, phobia, paranoia, 
psychoticism and obsessive compulsive behavior, DHEAS accounted for upwards of 
80% percent of the variance in symptom severity. Although statistical significance 
must be interpreted cautiously herein light of the small participant sample, these data 
suggest that DHEAS plays an integral role in postpartum mental health.
Analyses of individual cases, illustrate both the impact of acutely elevated 
DHEAS on psychiatric well-being and the persistence of psychiatric and 
physiological distress associated with chronically elevated DHEAS. In current study, 
DHEAS concentrations increased dramatically following parturition in seven of the 
nine participants and for five of those seven, elevated GSI scores indicated 
psychiatric distress. Of those five participants, DHEAS values of two participants 
exceeded the upper limit (>2500 pg/mL) of what is considered normal for non­
pregnant women.
The two participants, D and E, whose DHEAS values exceeded the clinical 
cutoff in the immediate puerperium, were the most severely distressed of the group 
and reported experiencing symptoms at least through the first couple of months 
following delivery. Unfortunately, testing did not begin again until four months 
postpartum. However, by four months postpartum, DHEAS concentrations in 
Participant D and the other participants had returned to within normal ranges. 
Participant D’s DHEAS remained within the normal limits for the duration of the 
study and her symptoms largely dissipated, whereas the DHEAS values of other
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participants increased beyond the reference range intermittently and in parallel with 
symptom elevations.
DHEAS concentrations in Participant E, however, continued to increase and 
by four months were at >7200 pg/mL, well beyond what is considered normal. In 
conjunction, her psychiatric symptoms persisted and other hormone values began 
showing signs of irregularity. Namely, progesterone concentrations moved beyond 
the normal luteal phase values (>600pg/mL) even though she had not yet begun to 
menstruate. At eight months, although her DHEAS concentrations had decreased 
somewhat, they were still well above the normal range and her testosterone and 
estriol, had moved significantly above normal non-pregnant values at this time.
Concurrent with these hormone changes and possibly in large part because of 
them, significant correlations between progesterone and psychiatric symptoms 
appeared at four months and again at twelve months postpartum. In Marrs (2006) 
progesterone was not associated with psychiatric symptoms at either test time and so 
it was unexpected for progesterone to be significantly correlated with distress in the 
present study. It is possible that the correlations between progesterone and symptoms 
at twelve months were spurious. Participant E was not available for testing at this 
time and thus, both her hormone values and symptom scores were estimated.
Inasmuch DHEAS, and by association DHEA, impact the synthesis of many 
hormones via enzymatic regulation (Labrie et al., 1997: Genazzani et al., 2003; 
Ueshiba et al. ,2002), it is speculated that elevated DHEAS observed at four months 
postpartum, was associated with the increase in circulating progesterone. The
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consequent development of significant correlations between progesterone and 
symptoms may support this hypothesis.
As the reservoir for DHEA, increased DHEAS values, often correspond to 
increased DHEA, testosterone and estradiol and have been found to influence other 
hormone values such as allopregnanolone concentrations (Genzanni et al., 2006). 
Allopregnanolone is the primary metabolite of progesterone. It is speculated that 
DHEA up-regulates 17, 20 lyase activity and shifts metabolism towards the 
progesterone pathway (Genzanni et al., 2006) presumptively increasing progesterone 
concentrations as well as concentrations of this metabolite. Barring complete 
abrogation of STS activity, for which there is no evidence of in the current study, 
high concentrations of DHEAS would be expected to increase DHEA values to some 
degree. The spike in progesterone and concurrent associations with symptoms could 
reflect this shift.
With elevated DHEAS, testosterone and estradiol concentrations are expected 
to increase. This has been established with PCOS and hyperandrogénie women where 
DHEAS, DHEA and the entire aromatase pathway is up-regulated significantly (Carr, 
2001; Elsenbruch, 2003; Yildiz, 2004). This appeared not to occur here, with mean 
concentrations for both hormones falling at the lower end of the non-pregnant, non­
postpartum, reference ranges. However, since there are no established salivary 
reference ranges for postpartum and lactating women, and data on menstrual cycle 
phase was not collected in the present study, it is impossible to discern how these 
factors might have influenced the observed hormone values.
143
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Nevertheless, with elevated DHEAS, elevated testosterone and estradiol are 
expected. Review of the individual hormones values reveals that the women with the 
highest DHEAS values also had the highest testosterone values. Even though their 
testosterone values fell squarely within the non-pregnant range at 15-23 pg/mL, these 
values were -100% greater than those of the of the other participants. Consequently, 
DHEAS and testosterone were significantly correlated at this and the subsequent test 
times.
Testosterone which had been negatively associated with onset of symptoms in 
Marrs (2006) was positively associated with a myriad of symptoms at four months 
postpartum. The directional shift in this correlation was particularly striking insofar as 
mean circulating concentrations of testosterone at four months postpartum were 50% 
lower than those observed during pregnancy when testosterone was associated 
negatively with symptoms. As was speculated with progesterone, the testosterone to 
behavior correlations may be more related to the associations between DHEAS and 
symptoms and DHEAS and testosterone than to actual associations between 
testosterone and symptoms, especially in light of the difference in testosterone values 
between pregnancy and postpartum.
It is also possible that factors in pregnancy versus postpartum 
pharmacokinetics account for the absolute difference in testosterone values that are 
now associated with symptoms. The amount of testosterone required to elicit a 
cellular or behavioral response during pregnancy could appear higher than what is 
required postpartum because of the increased plasma volume during pregnancy. The 
relative difference between the two values may actually represent similar
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concentrations of hormone per unit of volume, if that could be calculated. This would 
suggest that there is a range of effective hormone values per unit volume that when 
breached elicits compensatory reactions in other hormones or enzymes, of which 
psychiatric symptoms are simply the outward manifestation. What this range is and 
how it relates to the other hormones is unclear.
Estradiol, which is a direct metabolite of testosterone, was not correlated with 
testosterone at any test time nor was it correlated with any other hormone. As in 
Marrs (2006) estradiol was not correlated with symptoms. Mean estradiol values fell 
within the normal non-pregnant, non-postpartum range, although the inter-individual 
variability was great and may have been related to menstrual phase variation. Its lack 
of association with testosterone may suggest an alternate metabolic pathway, perhaps 
the bioconversion of estrone>estradiol. However, this pathway typically favors the 
estradiol to estrone conversion versus the estrone to estradiol conversion (Stanczyk, 
1998).
Estriol concentrations which had not been associated with symptoms either 
during pregnancy or following parturition were significantly and positively associated 
with a myriad of symptoms at eight months postpartum even though circulating 
values were some 98% less than during pregnancy. Again, the change in plasma 
volume may have contributed somewhat to the relative change in estriol. However, 
unlike pregnancy testosterone which is thought to represent mostly maternal synthesis 
(Triosi et al., 2003), estriol is largely of fetal origin (Challis & Lye, 1998). Indeed, 
expression of the hepatic enzyme 16a-0H that converts DHEAS to estriol is reported 
to be extremely low in adulthood (Lacroix, Sonnier, Moncion, Cheron & Cresteil,
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1997; Leeder et al., 2005; Stevens et al., 2003). So it is particularly intriguing that 
postpartum estriol concentrations observed in this study were not only at the high end 
of non-pregnant clinical reference ranges but were also associated with symptoms. 
Like the elevated progesterone, elevated estriol may represent a compensatory 
reaction related to elevated DHEAS i.e. up-regulated hepatic enzymes to increase 
metabolic clearance with the ensuing correlations between this hormone and 
symptoms simply denoting that change.
The cause of the postpartal increase in DHEAS remains to be investigated, but 
data from this study, when combined with the findings from the various cancer 
studies cited previously and the work by Maayan et al. (2005) point to diminished 
STS activity. Research on STS inhibitors for the treatment of hormone dependent 
cancers, indicates that STS inhibition not only elicits an increased ratio of sulfated to 
non-sulfated hormones, combined with a decrease in downstream androgens such as 
testosterone and estradiol (Gell et al., 1998; Pasqualini & Chetrite, 2001; Stanway et 
al., 2006), but also, mediates behavioral changes in rodent models (Nicholas et al., 
2001) and psychiatric distress in human patients (Stanway et al., 2006).
Maayan and colleagues found that withdrawal from elevated estradiol in 
rodent pseudo-pregnancy was associated with diminished STS activity and a 
consequent increase in cortical DHEAS, whereas Pasqualini and Chetrite 2001 
demonstrated that elevated estradiol alone, could effectively diminish STS activity. 
Based upon those findings, it is postulated that the continued increase in estradiol 
concentrations through pregnancy negatively impacts STS activity, but because of 
abundant placental STS (Dibbelt & Kuss, 1991), the affects are not observed fully
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until after parturition. The resultant increase postpartum DHEAS may simply reflect a 
transient diminishment of STS activity that over time, will return to non-pregnant 
levels.
It also possible, that for some women the physiological condition of 
pregnancy unmasks a previously latent endocrine pathology. This hypothesis was 
presumptively supported by the medical conditions of Participant D’s son and 
Participant E herself. Both participants disclosed the presence of disorders that if 
genetically verified, are consistent with congenitally impaired STS activity.
Participant D’s son had been bom with a disorder called crytorchidism or 
testicular mal-descent, a condition that is present in 1-6000 male births. Participant E, 
who had a female child, developed a skin condition strikingly similar to the X-linked 
ichthyosis that is associated with STS deficiency in male children and occurs in 1- 
6000 births as well. Both conditions may be caused by similar genetic mutations that 
impair STS activity (Bradshaw & Carr, 1986). Female carriers of this mutation do not 
express the aforementioned disorders, but have been reported to acquire similar skin- 
related conditions (Reed et al., 2005). Some evidence suggests that female carriers 
express significantly less STS activity than women who do not carry this mutation 
(Epstein & Leventhal, 1981). Unfortunately, there is only one published report where 
STS activity was measured in the female carriers’ of the mutation and there are no 
published reports regarding any other potential behavioral or physiological 
manifestations. Nevertheless, the co-manifestation of STS related medical 
conditions, elevated DHEAS and psychiatric symptoms points to compromised STS 
activity in the etiology of postpartum psychopathology. Whether the enzyme changes
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are transient as much of the data in this study suggest or chronic, as was potentially 
exhibited by participant E requires additional investigation.
Because multiple factors are capable of up- and/or down-regulating STS 
activity, including estradiol, it is not clear how the menstrual cycle affects the balance 
between DHEA and DHEAS. The intermittent increases in individual DHEAS values 
observed in this study, combined with the consequent symptom elevations could 
reflect menstrual cycle variations in STS. It might be that upon investigation of these 
factors, STS activity is found to mediate the severity of premenstrual syndrome by 
way of increased DHEAS. Inasmuch as women with premenstrual distress are 
reported to have a higher incidence of postpartum psychiatric disturbances (Bloch et 
al., 2005), it is possible that STS activity contributes to both disorders. Further 
examination of the associations between DHEAS and/or STS and female 
psychopathology might reveal such an association.
Conclusion
While a preliminary investigation with a limited number of participants, 
results from this study provide several important insights regarding the onset, course 
and hormonal correlates of peripartal psychiatric disturbances and cognitive 
functioning. Results from this study show that psychiatric disturbances are more 
prevalent and more severe in the immediate postpartum than in the months following 
parturition. A large number of the psychiatric disturbances are associated with 
elevated DHEAS, which in turn appears to influence the equilibrium of other 
hormones. In some women the distress is transient and abates as DHEAS values 
return to within normal reference ranges. In others, the increase in postpartal DHEAS
148
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
is more drastic and chronic with corresponding symptoms that are more severe and 
persistent. Whether transient or chronic, postpartum psychiatric symptoms develop in 
association with puerperal hormone changes and cannot be relegated to the realm of 
psychosocial stressor.
Data from this study also demonstrated that puerperal cognitive deficits, 
although not associated consistently with puerperal hormone changes or mood 
changes do exist, and appear to involve some aspect of working memory. Deficits in 
both verbal and spatial memory were observed during pregnancy. Review of the 
longitudinal trends in these cognitive dimensions suggests many aspects of verbal 
memory improve, but that difficulties with proactive interference persist through the 
year. Spatial memory does not appear to improve. Collectively, these data suggest 
that motherhood negatively impacts working memory.
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EXHIBITS
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Tables
Table 1: Participant Data
Participant pregnancy and health status across test times.
Participants
Trial A B C D E F G H 1
Length o f  Pregnancy 288 277 268 289 272 289 273 275 274
Delivery Type V V V V V V V V V
Gender Girl Boy Boy Boy Girl Boy Boy Boy Boy
Breastfeeding 1
2 X X X X X X X
3 X X X X X X X
4 X ? X
5 ? X
Medication 1
2 Diaclox Smoking
3 Yasmin Levora Lexapro Celexa Yasmin Smoking
4 Yasmin Levora Lexapro* Yasmin Smoking
5 Yasmin Levora Yasmin Smoking
Menstruation 1
2
3 X X X X
4 X X X X X X
5 X X X X X X X
Working 1 FT FT . FT FT
2
3 PT PT PT PT
4 PT PT PT PT
5 PT PT PT PT
Average length o f  gestation 278 days. V: vaginal. No record o f  breastfeeding status for Participant E at T5 or Participant F at T4. 
•Participant E was taking medication until approximately five months postpartum. Diaclox is antibiotic. Lexapro and Celexa are anti- 
depressants.Yasmin and Levora are oral contraceptives. Participant H was 5 weeks pregnant at T5.
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Table 2: Symptom Checklist 90-R scores
Mean SCL-90-R scores across test times.
37-W eeks < 10-Days 4-M onths 8-M onths 12-M onths
Pregnant___________ Postpartum __________ Postpartum__________ Postpartum __________ Postpartum
Symptom Mean SD SYM Mean SD SYM Mean SD SYM M ean SD SYM Mean SD SYM
ANX 52.56 10.74 11% 56.22 14.25 33% 48.89 12.31 11% 51.06 11.13 11% 48.44 12.83 11%
HOS 54.67 5.79 0% 55.56 6.57 44% 46.33 7.16 11% 50.56 6.52 0% 52.67 7.87 22%
PHOB 54.67 11.00 22% 57.79 10.93 55% 52.56 9.39 11% 52.89 9.39 11% 51.67 9.92 11%
PAR 50.22 6.42 11% 48.89 5.95 0% 47.83 8.60 11% 49.72 6.51 11% 48.22 7.17. 11%
PSY 52.44 6.46 22% 59.67 7.42 ' 44% 51.44 7.20 11% 51.22 7.12 22% 52.61 8.18 22%
SOM 60.11 IL82 66% 60.44 12.83 55% 46.72 12.41 22% 46.78 10.69 11% 46.89 11.45 11%
OC 61.89 8.19 44% 61.89 9.10 44% 50.79 11.57 22% 53.89 11.13 33% 52.44 12.47 33%
IS 56.22 6.67 33% 54.56 11.06 44% 53.78 10.23 33% 51.78 10.33 44% 51.5 10.33 22%
DEP 61.88 5.40 66% 65.33 5.83 88% 50.33 11.70 22% 53.61 10.78 44% 51 13.31 22%
GSI 59.44 7.52 44% 61.33 8.28 55% 49.33 11.64 11% 50.5 11.33 22% 45.17 20.49 22%
SYM: percent sym ptom atic (T score >60); ANX: anxiety; HOS: hostility; PHOB: phobia; PAR: paranoia; PSY: 
psychoticism ; SOM: som atization; DC: obsessive com pulsive behavior; IS: interpersonal sensitivity; DEP: depression; 
GSI: global severity index.
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Table 3: Longitudinal trends in pregnancy and postpartum symptoms
Repeated measures, contrast and trend analyses fo r  SCL-90-R scores across the year.
ANX HOS PHOB PA R PSY SOM OC IS DEP GSI
M ain Effect 0.003 0.013 0.000 0.000 0.000 0.000 0.000
Trend Type Cubic Cubic Linear Cubic Linear Linear
Significance 0.021 0.001 0.001 0.003 0.007 0.016
T l vsT  2 0.006
T2 vs 13 0.008 0.041 0.003 0.001 0.001 0.002 0.000
T3 vs 1 4 0.038 0.028
T4 vs T5
T l vs 15 0.001 0.011 0.042 0.016 0.036
T2 vs T5 0.030 0.010 0.002 0.004 0.005 0.016
T3 vs T5 0.039
T l vs T3 0.020 0.006 0.001 0.007 0.001
T l vs T4 0.037 0.005 0.005 0.022 0.020
T3 vs Previous 0.006 0.002 0.001 0.003 0.000
T4 vs Previous 0.032 0.018 0.038 0.043
T5 vs Previous 0.002 0.046
T l:  37 w eeks pregnant; T2: < 10  days posptartum ; T3: four months postpartum ; T4: eight m onths postpartum ; T5: twelve 
months postpartum ; ANX: anxiety; HOS: hostility; PHOB: phobia; PAR: paranoia; PSY: psychoticism ; SOM: 
somatization; OC: obsessive com pulsive behavior; IS: interpersonal sensitivity; DEP: depression; GSI: global severity 
index.
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Table 4: Longitudinal trends in pregnancy and postpartum cognitive performance
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Mean cogntive data across test times.
37 Weeks 
Pregnant
<10-Days
Postpartum
4-Months
Pospartum 8-Months Postpartum  12-Months Postpartum
Normative
Data
Mean SD % Mean SD % Mean SD % Mean SD % Mean SD % Mean SD
Complex Figure Test Copy 34.11 1.62 77.00 34.67 1.94 82.00 31.06 7.27 42.00 33.16 3.22 68.00 31.00 6.67 59.00 31.75 3.21
Recall 17.94 8.67 28.00 23.22 0.22 68.00 19.56 -0.34 25.00 20.72 5.94 45.00 19.50 8.59 37.00 21.8 6.56
PASAT 2.4 41.11 7.34 43.00 49.56 7.20 73.00 51.06 3.63 77.00 52.11 6.45 81.00 53.22 4.76 82.00 43.40 10.20
2 39.33 7.65 39.00 46.00 6.12 66.00 48.00 0.60 73.00 47.61 7.79 70.00 49.06 6.98 77.00 41.90 10.20
1.6 32.22 4.76 47.00 36.78 6.12 61.00 39.22 0.50 73.00 41.11 7.66 75.00 41.78 9.81 77.00 33.10 12.20
1,4 24.33 6.26 47.00 29.56 6.00 66.00 28.56 0.35 63.00 30.94 8.97 72.00 30.89 6.68 72.00 24.90 10.60
Verbal Fluency FAS 44.67 8.26 50.00 47.89 12.29 61.00 48.56 13.01 63.00 50.56 12.35 70.00 49,61 11.99 68.00 44.70 11.20
Animal 20.33 6.89 61.00 21.11 5.53 66.00 21.56 4.50 70.00 22.22 4.81 73.00 21.44 4.55 68.00 19.00 5.20
Design Fluency Free 18.89 7.54 70.00 23.67 6.82 91.00 26.56 9.15 96.00 23.00 9.90 88.00 22.56 8.73 87.00 15.50 6.10
Fixed 18.55 4.56 47.00 23.67 5.83 81.00 21.88 7.47 70.00 20.78 9.44 63.00 25.00 5.68 87.00 18.90 5.60
Finger Tapping Preferred 44.91 4.96 55.00 46.82 5.73 67.00 45.17 3.90 55.00 46.00 4.20 61.00 45.13 3.84 55.00 44.30 5.80
Non-Preferred 41.16 3.50 55.00 41.82 3.24 59.00 41.00 1.90 54.00 41.62 2.59 56.00 40.74 3.01 50.00 40.60 5.60
Purdue Pegboard Preferred 15.11 2.20 30.00 15.78 2.22 45.00 15.89 1.76 49.00 16.05 1.98 47.00 16.44 1.81 62.00 15.94 1.61
Non-Preferred 14.44 1.81 26.00 14.22 1.79 23.00 15.05 1.67 39.00 15.22 1.56 41.00 15.67 1.58 49.00 15.63 1.89
Normative scores from Spreen and Strauss, (1998).
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Table 5: Verbal Memory Performance
CVLT-II Scores and percentile rank compared to normative data across test times.
IM
Recall 1
IM IM 
Recall Total Recall B
Delayed 
Short Free
Delayed 
Long Free
Semantic
Clustering*
Learning
Slope*
37 Weeks Pregnant Mean 7.00 52.00 5.89 10.33 11.78 1.42 1,27
SD 2.00 6.52 1.90 1.93 2.28 1.90 0.59
Z-score -0.67 -1.86 -2.21 -2.89 -0.96 0.00 -0.50
Centile 25% 3% 1% 0% 17% 50% 32%
<10 Days Postpartum Mean 7.22 53.22 5.78 10.67 11.44 2.30 1,33
SD 1.79 6.26 1.20 3,36 2,30 1,94 0.70
Z-score -0.48 -1.61 -2.32 -2.61 -1.13 0,50 -0.50
Centile 32% 5% 0% 0% 13% 70% 32%
4-Months Postpartum Mean 8.22 60.64 6.94 13.44 13.69 3,78 1.32
SD 1.86 7.86 1.13 2.40 2.16 2,51 0,75
Z-score 0.33 -0.13 -1.16 -0.30 -0.01 1.50 -0.50
Centile 63% 45% 12% 38% 50% 94% 32%
8-Months Postpartum Mean 7.97 58.69 6.92 13.00 13.00 3.69 1.43
SD 1.52 7.34 1.47 2.63 2.10 2,23 0,67
Z-score 0.14 -0.52 -1.18 -0.66 -0.35 1,50 0,00
Centile 56% 30% 12% 25% 37% 94% 50%
12-Months Postpartum Mean 9.03 62.39 7.00 13,83 13.31 3.59 1.26
SD 2.03 5.98 2.06 1.84 2.51 2,11 0.78
Z-score 1.02 0,21 -1.10 0.02 -0.20 1.50 -0,50
Centile 84% 58% 14% 51% 42% 94% 32%
IM: immediate; centiles derived from age and IQ-matched normative data reported in Spreen and Strauss (1998), IQ-matched 
normative data not available for semantic clustering and learning slope (Delis et al., 2000). Alternate forms were used at 10 days and 
8 months postpartum.
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Table 6: Longitudinal trends in pregnancy and postpartum verbal memory
Repeated measures, contrast and trend analyses for CVLT-II across test times.
IM Recall IM Recall IM Recall Delayed Delayed Semantic Learning
1 1-5 B Short Free Long Free Short Curve
Main Effect 0.001 0.000 0.000 0.001
Trend Type Linear Linear Linear Linear Linear
Significance 0.000 0.001 0.041 0.000 0.005
Tl vsT 2
T2 vs T3 0.016 0.039
T3 vs T4
T4 vs T5 0.039
Tl vs T5 0.000 0.003 0.000 0.015
T2 vs T5 0.005 0.020
T3 vs T5
Tl vs T3 0.000 0.009 0.008
Tl vs T4 0.012 0.004 0.014
T3 vs Previous 0.043 0.004
T4 vs Previous 0.008 0.015
T5 vs Previous 0.004 0.007 0.006
IM: immediate; CFT: complex figure test; Tl: 37 weeks pregnant; T2: <10 days posptartum; T3: 
four months postpartum; T4: eight months postpartum; T5: twelve months postpartum.
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Table 7; Mean hormone values
Hormone values across all test times and reference ranges.
37 Weeks 
Pregnant
<10 Days 
Postpartum
4-Months
Postpartum
8-Months
Postpartum
12-Months
Postpartum Reference Ranges*
Mean SD Mean SD Mean SD Mean SD Mean SD Follicular Luteal
pg/mL pg/mL pg/mL pg/mL pg/mL pg/mL
Progesterone 1454.36 537.68 73.47 19.81 171.47 231.69 64.53 38.79 95.96 128.63 10-250 100-600
DHEAS 865.98 642.79 1725.34 1276.18 1979.02 2208.82 1851.31 1626.92 2125.79 1305.98 220-2500 220-2500
Testotsterone 22.82 24.11 25.1 26.74 9.23 8.01 25.44 25.65 19.32 8.66 3-49 3-49
Estradiol 13.38 7.36 7.24 8.69 14.57 10.65 12.77 17.69 4.74 8.39 1-25 .5-25
Estriol 452.20 24.10 12.81 6.11 9.05 4.30 14.30 5.52 13.91 5.65 .5-16 .5-16
’ Reference ranges for non-pregnant, non-postpartum women. The follicular phase occurs during the early part o f the cycle until 
ovulation between days 14-16 and corresponds with a peak in estradiol. The luteal phase occurs during days 20-22 and corresponds 
with a peak in progesterone.
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Table 8: Individual hormone values
Individual hormone values and changes across test times.
37 weeks <10 Days Percent 4-Months Percent 8-Months Percent 12-Months Percent
Pregnant Postpartum Change Postpartum Change Postpartum Change Postpartum Change
Progesterone pe'mL
Participant A 1647.9 110 -93.32% 36.5 -66.82% 22.7 -37.81% 174 666.52%
Participant B 1226.4 51.7 -95.78% 53 2.51% 52.35 -1.23% 24.1 -53.96%
Participant C 1241.7 69.1 -94.44% 89.3 29.23% 24.1 -73.01% 14.9 -38.17%
Participant D 2272.3 77.3 -96.60% 58 -24.97% 64.4 11.03% 17 -73.60%
Participant E 1360.5 59.7 -95.61% 755.5 1165.49% 54.4 -92.80% 407.6 649.26%
Participant F 2063.1 63.6 -96.92% 125.3 97.01% 129.2 3.11% 99.2 -23.22%
Participant G 433.4 84.5 -80.50% 285.7 238.11% 127.4 -55.41% 22.7 -82.18%
Participant H 1215.4 93.7 -9229% 88.5 -5.55% 54.7 -38.19% 83.3 52.29%
Participant I 1628.5 51.6 -96.83% 51.4 -0.39% 51.5 0.19% 20.8 -59.61%
DHEAS pg'mL
Participant A 135.5 626.6 362.44% 498.9 -20.38% 610.9 22.45% 1112.9 82.17%
Participant B 316.2 764.1 141.65% 1061.5 38.92% 698.85 -34.16% 633.6 -9.34%
Participant C 1038.1 1393.9 34.27% 708.9 -49.14% 618.6 -12.74% 1048.3 69.46%
Participant D 640.4 4551.5 610.73% 1187.2 -73.92% 1669.3 40.61% 1315.1 -21.22%
Participant E 596.1 2799.2 369.59% 7212.7 157.67% 5731.2 -20.54% 4265.2 -25.58%
Participant F 2118.6 1707.5 -19.40% 1148.8 -32.72% 2035.6 77.19% 3411 67.57%
Participant G 1608.6 1965.3 22.17% 3924.6 99.69% 1766.3 -54.99% 3472.7 96.61%
Participant H 426.2 1074.7 152.16% 1266.05 17.80% 2672.7 111.11% 1457.4 -45.47%
Participant I 914.1 645.3 -29.41% 802.5 24.36% 858.3 6.95% 2415.9 181.48%
Testosterone pg'mL
Participant A 21.9 0.4 -98.17% 2.2 450.00% 8.1 268.18% 9.9 22.22%
Participant B 11.2 5.9 -47.32% 2.3 -61.02% 4.7 104.35% 3.5 -25.53%
Participant C 73.4 16.3 -77.79% 4.9 -69.94% 6.4 30.61% 18.9 195.31%
Participant D 48.4 25 -48.35% 3.9 -84.40% 7.6 94.87% 17.6 131.58%
Participant E 19.9 33.4 67.84% 23 -31.14% 83.4 262.61% 28.2 -66.19%
Participant F 3.7 56.5 1427.03% 6.1 -89.20% 29.7 386.89% 17.9 -39.73%
Participant G 2.6 78.1 2903.85% 20.2 -74.14% 43 112.87% 31.4 -26.98%
Participant H 0.1 6.8 6700.00% 15.05 121.32% 31.8 111.30% 23.3 -26.73%
Participant I 24.2 3.5 -85.54% 5.4 54.29% 14.3 164.81% 23.2 62.24%
Estradiol pg/rrL
Participant A 6.5 5.6 -13.85% 4.3 -23.21% 0.6 -86.05% 0.6 0.00%
Participant B 8.2 1.9 -76.83% 18.3 863.16% 8.1 -55.74% 8 -1.23%
Participant C 28.7 8.3 -71.08% 30.2 263.86% 0.3 -99.01% 0.2 -33.33%
Participant D 13.1 1.5 -88.55% 1.9 26.67% 7.2 278.95% 0.2 -97.22%
Participant E 6.6 6.8 3.03% 10.4 52.94% 3.5 -66.35% 6.7 91.43%
Participant F 17.3 1 -94.22% 1.6 60.00% 30.4 1800.00% 0.2 -99.34%
Participant G 19.7 11 -44.16% 16.6 50.91% 5.4 -67.47% 0.8 -85.19%
Participant H 9 28.3 214.44% 26.95 -4.77% 53.4 98.14% 25.6 -52.06%
Participant I 11.3 0.8 -92.92% 20.9 2512.50% 6.05 -71.05% 0.4 -93.39%
Estriol pg'rrL
Participant A 341.4 9.7 -97.16% 7.6 -21.65% 11.9 56.58% 23.7 99.16%
Participant B 320.3 8.8 -97.25% 4.1 -53.41% 10.7 160.98% 12.6 17.76%
Participant C 835.6 10.9 -98.70% 9.7 -11.01% 10.9 12.37% 12.7 16.51%
Participant D 595.8 15.6 -97.38% 8 -48.72% 15.6 95.00% 15 -3.85%
Participant E 271.9 6.9 -97.46% 11.3 63.77% 26.6 135.40% 18.95 -28.76%
Participant F 199.6 21.7 -89.13% 3.8 -82.49% 10.7 181.58% 8.5 -20.56%
Participant G 356.1 21 -94.10% 6.8 -67.62% 15.4 126.47% 16.3 5.84%
Participant H 389 16.2 -95.84% 17.2 6.17% 18.2 5.81% 13.2 -27.47%
Participant 1 760.1 4.5 -99.41% 13 188.89% 8.75 -32.69% 4.2 -52.00%
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Table 9: Hormone to hormone correlations
Hormone to hormone correlations.
Trial PROG DHEAS TEST E3
PROG 1
2
3 982*** ,818**
4
5
DHEAS 1
2
3
4 .930***
5
TEST 1 .784*
2 .728*
3 .818** .868**
4 .936*** .849**
5 .740*
E3 1
2
3
4 .930***
5
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Table 10: Longitudinal trends in pregnancy and postpartum hormones
Repeated measures, contrast and trend analyses for hormone values across test times.
Progesterone DHEAS Testosterone Estradiol Estriol
Main Effect 0.000 0.000
Trend Type Linear Linear Cubic Linear
Significance 0.000 0.049 0.044 0.000
Tl vsT2 0.000 0.000
T2 vs T3 0.490
T3 vs T4 0.031 0.022
T4 vs T5
Tl vsT5 0.000 0.008 0.000
T2 vs T5
T3 vs T5 0.000 0.021
Tl vs T3 0.000 0.000
Tl vs T4 0.000 0.000
T3 vs Previous 0.002 0.000 0.024
T4 vs Previous 0.000 0.000
T5 vs Previous 0.000 0.000 0.005
1 1 .  w c c i v a  y i c g i i m i L ,  i  V  u a y a
postpartum; T5; twelve months postpartum.
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Table 11: Hormone to symptom correlations
Table 11. H orm one to m ood correlations across test times.
Trial A N X  H O S PH O B  PA R PSY  SO M O C  IS D EP GSI
Progesterone 1
2
3
4
5
.795* .684* .990*** .745* 
.817** .752*
.821**
.772* .721*
D H EA S 1
2 .774* .734* .757* .667*
3 .740* .987*** .692* .779* .741* .667* .693*
4 .922*** .703* .714*
5
T estosterone 1
2
3 .669* .852** .813** .705* .684*
4 .958***
5
Estradiol 1
2
3
4
5
Estriol 1
2
3 .730*
4 .776* .909** .705* .697* .676* .705*
5
O C: obsessive com pulsive behav io r; IS: in terpersonal sensitivity; D E P: depression ; G SI: g lobal severity  
index; *p< .05,**p< .01,***p< .001.
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Figure 1 : Maternai fetal-placental steroidogenesis
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F igure 2: A d ren a l a n d  p e r ip h e ra l s te ro idogen esis
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Figure 3: Percentage o f symptomatic women
A n x ie ty  and  D e p r e s s iv e  S y m p to m s
100 - I
80 -
60 -
40  -
«r20 -
— A N X  
PHOB
■ - OC
— DEP
37 W eek s  
Pregnant
<10  D ays  
Postp artum
4-M on th s  
Postp artum  
T e s t  T im e
8-M on th s
P ostp artum
12-M on th s
Postp artum
P sy c h o tic  S ym p tom s
100 n
80
60  - PSY
40 -
-  P A R
20  -
8-M on th s
P ostp artum
12-M onths
P ostp artu m
37 W eek s  
Pregnant
< 10  D a y s  
P ostp artum
4 -M o n th s
Postpartum
T e s t  T im e
A s s o c ia t e d  S y m p to m s
100 n
80 -
—  HOS
- - SOM
60 -
40
20  -
<10 D a y s 4-M onths 8-M onths 12-M onths
Pregnant Postpartum  Postpartum  Postpartum  Postpartum
T e s t  T im e
37 W eek s
S e v e r ity  o f  S y m p to m s
100 -,
80 -
60  -
GSI
40  -
20  -
12-M onths
Postp artum
8-M on th s
Postpartum
4-M on th s
P ostpartum
T e s t  T im e
37 W eek s  
Pregnant
< 10  D a y s  
P ostp artum
ANX: anxiety; PHOB: phobia; OC: obsessive compulsive behavior; DEP: depression; PSY: psychoticism; 
PAR: paranoia; HOS: hostility; SOM: somatization; IS: interpersonal sensitivity; GSI: global severity index.
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Figure 4: Longitudinal trends in pregnancy and postpartum cognitive performance
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CFT: complex figure test; PASAT: paced auditory serial addition test; FTT-P: finger-tapping test preferred 
hand; FTT-NP: finger-tapping test non-preferred hand; PPT-Purdue pegboard test preferred hand; PPT-NP: 
Purdue pegboard test non-preferred hand.
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Figure 5: Longitudinal trends in pregnancy and postpartum verbal memory
Verbal Memoiy
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CVLT-II: California Verbal Learning Test-II; IM: immediate.
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Figure 6: Longitudinal trends in pregnancy and postpartum hormones
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Thank-you for participating in this study. Your participation will yield important 
information about postpartum mental illness.
Instructions for Saliva Collection
1. Upon rising on the morning of testing, before eating, drinking, breastfeeding* 
or brushing teeth, place specimen vial to bottom lip and spit into vial.
2. Fill vial with at least 8 ml of saliva.
3. Close vial.
4. Clean vial with paper towel
5. Label vial with your 6-digit identification code (first initiai, last initial, mm/yy of
birth date, ex; AB0264), date and time of specimen collection.
6. Place vial in zip-iock baggie and refrigerate.
7. Specimen will be picked-up during your scheduled session.
Helpful Hints
*if you feel that you have to breastfeed prior to specimen collection, please wait 2 
hours before attempting to spit into the vial. Please note on the label the time of 
breastfeeding and the time that the specimen was collected.
If you have difficulty producing the desired amount of salvia, imagine sucking on 
a sour lemon, or cut open a lemon (but dont eat it). The thought or sight of a sour 
lemon will initiate salivation.
Some women prefer to wrap a paper towel around the vial while spitting so as to 
collect any excess saliva.
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